<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30104956</article-id>
<article-id pub-id-type="pmc">6077210</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2018.00258</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Physiological Roles and Therapeutic Potential of Ca<sup>2+</sup> Activated Potassium Channels in the Nervous System</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kshatri</surname>
<given-names>Aravind S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/575621/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gonzalez-Hernandez</surname>
<given-names>Alberto</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/575054/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Giraldez</surname>
<given-names>Teresa</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/36621/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Basic Medical Sciences, Medical School, Universidad de La Laguna</institution>, <addr-line>Tenerife</addr-line>, <country>Spain</country></aff>
<aff id="aff2"><sup>2</sup><institution>Instituto de Tecnologias Biomedicas, Universidad de La Laguna</institution>, <addr-line>Tenerife</addr-line>, <country>Spain</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Florian Lesage, Centre National de la Recherche Scientifique (CNRS), France</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Ramon Latorre, Universidad de Valparaíso, Chile; James S. Trimmer, University of California, Davis, United States</p>
</fn>
<corresp id="c001">*Correspondence: Teresa Giraldez, <email>giraldez@ull.edu.es</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>11</volume>
<elocation-id>258</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Kshatri, Gonzalez-Hernandez and Giraldez.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Kshatri, Gonzalez-Hernandez and Giraldez</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Within the potassium ion channel family, calcium activated potassium (K<sub>Ca</sub>) channels are unique in their ability to couple intracellular Ca<sup>2+</sup> signals to membrane potential variations. K<sub>Ca</sub> channels are diversely distributed throughout the central nervous system and play fundamental roles ranging from regulating neuronal excitability to controlling neurotransmitter release. The physiological versatility of K<sub>Ca</sub> channels is enhanced by alternative splicing and co-assembly with auxiliary subunits, leading to fundamental differences in distribution, subunit composition and pharmacological profiles. Thus, understanding specific K<sub>Ca</sub> channels’ mechanisms in neuronal function is challenging. Based on their single channel conductance, K<sub>Ca</sub> channels are divided into three subtypes: small (SK, 4–14 pS), intermediate (IK, 32–39 pS) and big potassium (BK, 200–300 pS) channels. This review describes the biophysical characteristics of these K<sub>Ca</sub> channels, as well as their physiological roles and pathological implications. In addition, we also discuss the current pharmacological strategies and challenges to target K<sub>Ca</sub> channels for the treatment of various neurological and psychiatric disorders.</p>
</abstract>
<kwd-group>
<kwd>SK channels</kwd>
<kwd>IK channels</kwd>
<kwd>BK channels</kwd>
<kwd>modulators</kwd>
<kwd>drug discovery</kwd>
<kwd>nervous system</kwd>
<kwd>neurological disease</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">European Research Council<named-content content-type="fundref-id">10.13039/501100000781</named-content></funding-source>
<award-id rid="cn001">ERC-CoG-2014-648936</award-id>
</award-group>
<award-group>
<funding-source id="cn002">Ministerio de Economía y Competitividad<named-content content-type="fundref-id">10.13039/501100003329</named-content></funding-source>
<award-id rid="cn002">BFU2015-66490</award-id>
<award-id rid="cn002">RYC-2012-11349</award-id>
<award-id rid="cn002">FPU15/02528</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="251"></ref-count>
<page-count count="18"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Ca<sup>2+</sup>-activated potassium channels (K<sub>Ca</sub> channels) constitute a heterogeneous family of ion channels with variable biophysical and pharmacological properties. These channels share a common functional role by coupling the increase in intracellular Ca<sup>2+</sup> concentration to hyperpolarization of the membrane potential. This intrinsic feature allows K<sub>Ca</sub> channels to play key roles in controlling cellular excitability and maintaining K<sup>+</sup> homeostasis and cell volume in non-excitable cells. According to their single-channel conductances, K<sub>Ca</sub> channels are divided into three main subfamilies: SK (small conductance; ∼4–14 pS), IK (intermediate conductance; ∼32–39 pS) and BK (big conductance; ∼200–300 pS) channels. K<sub>Ca</sub> channels are expressed in the plasma membrane as tetramers of α subunits. The gene encoding the α subunit (<italic>slo</italic>; <italic>KCNMA1</italic>) of BK channels (KCa1.1; slo1) was cloned in the early 1990s from <italic>Drosophila</italic> (<xref ref-type="bibr" rid="B11">Atkinson et al., 1991</xref>; <xref ref-type="bibr" rid="B4">Adelman et al., 1992</xref>) and mice (<xref ref-type="bibr" rid="B31">Butler et al., 1993</xref>). SKα subunits are products of the <italic>KCNN1</italic> (K<sub>Ca</sub>2.1; SK1), <italic>KCNN2</italic> (K<sub>Ca</sub>2.2; SK2) and <italic>KCNN3</italic> (K<sub>Ca</sub>2.3; SK3) genes (<xref ref-type="bibr" rid="B115">Köhler et al., 1996</xref>), whereas IKα (K<sub>Ca</sub>3.1; IK1; SK4) are encoded by the <italic>KCNN4</italic> gene (<xref ref-type="bibr" rid="B96">Ishii et al., 1997b</xref>; <xref ref-type="bibr" rid="B104">Joiner et al., 1997</xref>). Phylogenetic analysis reveals that K<sub>Ca</sub> channels belong to two well defined groups (<xref ref-type="bibr" rid="B222">Wei et al., 2005</xref>), a division that is paralleled by biophysical properties regarding voltage dependence or the Ca<sup>2+</sup> sensitivity and regulatory mechanisms.</p>
<p>The first group comprises SK and IK channels. As shown in <bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>, α subunits of these channels consist on six transmembrane helices (S1–S6; the pore region is formed by helices S5 and S6) and cytosolic N- and C-terminal domains. One of their biophysical characteristics is that their function is independent of membrane voltage (<xref ref-type="bibr" rid="B83">Hirschberg et al., 1999</xref>). These channels are activated by low intracellular Ca<sup>2+</sup> concentrations (≈ 0.5 μM) through a mechanism consisting on the existence of a calmodulin (CaM) binding-domain (CaMBD) within the channel’s protein (<xref ref-type="bibr" rid="B64">Fanger et al., 1999</xref>; <xref ref-type="bibr" rid="B2">Adelman, 2016</xref>). The C-lobe region of CaM is associated to the CaMBD domains following a 1:1 stoichiometry, in a Ca<sup>2+</sup>-independent manner (<xref ref-type="bibr" rid="B124">Lee and MacKinnon, 2018</xref>) (<bold>Figure <xref ref-type="fig" rid="F1">1B</xref></bold>). Binding of Ca<sup>2+</sup> to the N-lobes of CaM forces the CaM-CaMBD monomers to arrange structurally into a “dimer of dimers” conformation, pulling the bundle-crossed helices of the pore to open the channel (<xref ref-type="bibr" rid="B177">Schumacher et al., 2001</xref>; <xref ref-type="bibr" rid="B124">Lee and MacKinnon, 2018</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Topology and structures of SK/IK and BK channels. <bold>(A)</bold> Schematic protein topology of one SKα-subunit including the CaM bound to the CaMBD (represented as an orange hexagon). <bold>(B)</bold> Full-length structure of the Ca<sup>2+</sup>-CaM bound IK channel (PDB: 6CNN). The CaM N-lobe binds Ca<sup>2+</sup> ions after association of CaM to the SK channel C-lobe. <bold>(C)</bold> Schematic topology of one BKα-subunit. Binding sites for divalent cations are located in the cytosolic C-terminal region of the channel. Each α subunit contains two high affinity Ca<sup>2+</sup> binding sites (represented as green circles) and one low affinity Ca<sup>2+</sup> and Mg<sup>2+</sup> binding site, formed by residues from RCK1, S0–S1 and S2–S3 intracellular loops (purple circle). <bold>(D)</bold> Ca<sup>2+</sup>-bound BKα homotetramer full-length structure from <italic>Aplysia californica</italic> (PDB: 5TJ6).</p>
</caption>
<graphic xlink:href="fnmol-11-00258-g001"></graphic>
</fig>
<p>BK channels belong to the second group in the K<sub>Ca</sub> family (for a recent review, see <xref ref-type="bibr" rid="B123">Latorre et al., 2017</xref>). The topology of BK α subunits differs from the SK/IK group in the existence of an additional transmembrane helix S0 which drives the N-terminus to the extracellular side of the plasma membrane (<bold>Figure <xref ref-type="fig" rid="F1">1C</xref></bold>). The large cytosolic C-terminal region of these channels is composed of two non-identical “regulator for conductance of potassium” domains (RCK1 and RCK2), each one containing a high affinity Ca<sup>2+</sup> binding site (K<sub>d</sub> = 0.8–11 μM; (<xref ref-type="bibr" rid="B175">Schreiber et al., 1999</xref>; <xref ref-type="bibr" rid="B233">Xia et al., 2002</xref>; <xref ref-type="bibr" rid="B198">Sweet and Cox, 2009</xref>). In the tetramer, four RCK1-RCK2 tandems form a structure known as the “gating ring” (<xref ref-type="bibr" rid="B230">Wu et al., 2010</xref>; <xref ref-type="bibr" rid="B241">Yuan et al., 2011</xref>; <xref ref-type="bibr" rid="B84">Hite et al., 2017</xref>; <xref ref-type="bibr" rid="B202">Tao et al., 2017</xref>) (<bold>Figure <xref ref-type="fig" rid="F1">1D</xref></bold>). An additional regulatory site located at the interface between the gating ring and transmembrane region exhibits millimolar affinity for divalent cations such as Mg<sup>2+</sup> (<bold>Figure <xref ref-type="fig" rid="F1">1D</xref></bold>) (<xref ref-type="bibr" rid="B181">Shi et al., 2002</xref>; <xref ref-type="bibr" rid="B233">Xia et al., 2002</xref>; <xref ref-type="bibr" rid="B236">Yang et al., 2008</xref>). In contrast to SK and IK channels, BK are allosterically activated by both changes in the membrane voltage and intracellular Ca<sup>2+</sup> (<xref ref-type="bibr" rid="B86">Horrigan and Aldrich, 2002</xref>). Similarly to other voltage-gated ion channels, the membrane voltage is sensed by charged amino acids within segments S2, S3, and S4 in the transmembrane region (<xref ref-type="bibr" rid="B50">Diaz et al., 1998</xref>; <xref ref-type="bibr" rid="B134">Ma et al., 2006</xref>; <xref ref-type="bibr" rid="B125">Lee and Cui, 2010</xref>; <xref ref-type="bibr" rid="B202">Tao et al., 2017</xref>). In contrast to SK and IK channels, Ca<sup>2+</sup> directly activates BK channels by binding to the specific Ca<sup>2+</sup> binding sites in the gating ring region, without involving CaM. Binding of Ca<sup>2+</sup> results on structural rearrangements of the gating ring region, ultimately leading to pore opening (<xref ref-type="bibr" rid="B243">Yusifov et al., 2008</xref>, <xref ref-type="bibr" rid="B242">2010</xref>; <xref ref-type="bibr" rid="B125">Lee and Cui, 2010</xref>; <xref ref-type="bibr" rid="B99">Javaherian et al., 2011</xref>; <xref ref-type="bibr" rid="B241">Yuan et al., 2011</xref>; <xref ref-type="bibr" rid="B173">Savalli et al., 2012</xref>; <xref ref-type="bibr" rid="B87">Hoshi et al., 2013</xref>). It has been proposed that the interaction of the gating ring with the voltage-sensing region of the channel plays an important role in this process (<xref ref-type="bibr" rid="B84">Hite et al., 2017</xref>; but see also <xref ref-type="bibr" rid="B251">Zhou et al., 2017</xref>) Importantly, the biophysical properties of K<sub>Ca</sub> channels such as the voltage and Ca<sup>2+</sup> sensitivities as well as their pharmacological characteristics are greatly influenced by the co-assembly with auxiliary subunits (e.g., β<sub>1-4</sub>, γ<sub>1-4</sub>; see below).</p>
<p>Members of the two groups comprising the K<sub>Ca</sub> channels family also differ in their structural features. Available crystal structures of the SK CaMBD region bound to CaM have contributed to advance our knowledge about the regulation of these channels by various effectors (<xref ref-type="bibr" rid="B177">Schumacher et al., 2001</xref>, <xref ref-type="bibr" rid="B176">2004</xref>; <xref ref-type="bibr" rid="B246">Zhang et al., 2012a</xref>,<xref ref-type="bibr" rid="B247">b</xref>, <xref ref-type="bibr" rid="B249">2013</xref>; <xref ref-type="bibr" rid="B248">Zhang M. et al., 2014</xref>; <xref ref-type="bibr" rid="B151">Nam et al., 2017</xref>). Until very recently, structural information about BK channels was the most extensive, including X-ray crystal structures of the isolated C-terminal region known as the “gating ring” (<xref ref-type="bibr" rid="B230">Wu et al., 2010</xref>; <xref ref-type="bibr" rid="B241">Yuan et al., 2011</xref>) as well as cryo-EM structures of the full-length channel obtained in the presence and absence of Ca<sup>2+</sup> (<xref ref-type="bibr" rid="B84">Hite et al., 2017</xref>; <xref ref-type="bibr" rid="B202">Tao et al., 2017</xref>; see also <xref ref-type="bibr" rid="B73">Giraldez and Rothberg, 2017</xref>; <xref ref-type="bibr" rid="B251">Zhou et al., 2017</xref>) (<bold>Figure <xref ref-type="fig" rid="F1">1D</xref></bold>). Exciting new results from the MacKinnon laboratory bring now to light the cryo-electron microscopy (cryo-EM) structures of a human IK-CaM complex in closed and activated states, unveiling unprecedented insights about their gating mechanism (<xref ref-type="bibr" rid="B124">Lee and MacKinnon, 2018</xref>) (<bold>Figure <xref ref-type="fig" rid="F1">1B</xref></bold>).</p>
<p>The SK, IK, and BK subfamilies show distinct tissue distribution and pharmacology. SK channels are predominantly expressed in the nervous system and are typically inhibited by the bee venom apamin (<xref ref-type="bibr" rid="B160">Park, 1994</xref>; <xref ref-type="bibr" rid="B190">Stocker and Pedarzani, 2000</xref>). IK channels are mainly distributed in blood, epithelial cells and in some peripheral neurons and are sensitive to the antifungal drug clotrimazole (<xref ref-type="bibr" rid="B70">Gardos, 1958</xref>; <xref ref-type="bibr" rid="B101">Jensen et al., 1998</xref>). BK channels are the most diverse group of K<sub>Ca</sub> channels. They are ubiquitously expressed and sensitive to iberiotoxin, charybdotoxin, and paxilline (<xref ref-type="bibr" rid="B123">Latorre et al., 2017</xref>). The diversity of K<sub>Ca</sub> physiological roles is widened by the existence of numerous splicing variants (specially for BK and SK channels) in different tissues (<xref ref-type="bibr" rid="B152">Navaratnam et al., 1997</xref>; <xref ref-type="bibr" rid="B182">Shipston, 2001</xref>; <xref ref-type="bibr" rid="B35">Chen et al., 2005</xref>; <xref ref-type="bibr" rid="B174">Scholl et al., 2014</xref>), as well as their association with auxiliary subunits. In vertebrates, BK channels co-assemble with modulatory β (β<sub>1-4</sub>) and γ (γ<sub>1-4</sub>) subunits to modify the channel functional properties and pharmacology (<xref ref-type="bibr" rid="B123">Latorre et al., 2017</xref>). In addition, K<sub>Ca</sub> channels in neurons are closely associated to Ca<sup>2+</sup> sources such as voltage-gated Ca<sup>2+</sup> channels (VGCC) (<xref ref-type="bibr" rid="B136">Marrion and Tavalin, 1998</xref>; <xref ref-type="bibr" rid="B204">Tonini et al., 2013</xref>; <xref ref-type="bibr" rid="B169">Rudolph and Thanawala, 2015</xref>; <xref ref-type="bibr" rid="B212">Vivas et al., 2017</xref>), transient receptor potential vanilloid (TRPV) channels (<xref ref-type="bibr" rid="B229">Wu et al., 2013</xref>; <xref ref-type="bibr" rid="B66">Feetham et al., 2015</xref>) and <italic>N</italic>-methyl-<sc>D</sc>-aspartate receptors (NMDAR) (<xref ref-type="bibr" rid="B94">Isaacson and Murphy, 2001</xref>; <xref ref-type="bibr" rid="B154">Ngo-Anh et al., 2005</xref>) allowing the precise regulation of membrane excitability and spike firing patterns.</p>
<p>Mutation of genes encoding K<sub>Ca</sub> channels and subsequent loss- or gain-of-function of these channels has been directly linked to a wide range of human diseases (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). Over the last two decades, numerous studies have contributed to decipher the potential role of K<sub>Ca</sub> channels in these diseases at the molecular level, paving the way for novel therapies. However, despite our current understanding about tissue specific distribution, functional diversity and clinical impact of K<sub>Ca</sub> channels, they still remain underexploited as targets for drug discovery. In this review, we summarize the most recent knowledge about K<sub>Ca</sub> channels, focusing on their potential as therapeutic targets in the nervous system and analyzing the factors that could contribute to the difficulties to develop novel K<sub>Ca</sub> channel modulators. Some excellent reviews in the last few years relate to individual members of the K<sub>Ca</sub> family, or are centered on particular aspects of K<sub>Ca</sub> physiopathology (<xref ref-type="bibr" rid="B61">Faber, 2009</xref>; <xref ref-type="bibr" rid="B120">Lam et al., 2013</xref>; <xref ref-type="bibr" rid="B80">Gueguinou et al., 2014</xref>; <xref ref-type="bibr" rid="B42">Contet et al., 2016</xref>; <xref ref-type="bibr" rid="B195">Sugunan et al., 2016</xref>). Here we initially describe the functional roles of K<sub>Ca</sub> channels in the nervous system, including their protective roles. Subsequently, the pathologies associated to malfunction of these channels are detailed. Known activators and inhibitors of K<sub>Ca</sub> channels are presented in the third section of the review, as they may constitute the molecular basis of potential therapeutic strategies to treat a wide range of neurological disorders. Finally, we discuss the possible reasons why little progress has been made toward development of such strategies despite intense research efforts in academia and industry.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Mutations in K<sub>Ca</sub> channels that are associated in human diseases, their location in the channel protein, functional implications and related references.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Gene/protein</th>
<th align="left" colspan="1" rowspan="1" valign="top">Disease phenotype</th>
<th align="left" colspan="1" rowspan="1" valign="top">Mutation/location in the protein</th>
<th align="left" colspan="1" rowspan="1" valign="top">Functional effects</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic><sup>∗</sup>KCNN3</italic>/SK3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Idiopathic non-cirrhotic portal hypertension</td>
<td align="left" colspan="1" rowspan="1" valign="top">V450L/intracellular loop between the S4 and S5 transmembrane segments</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>De novo</italic> mutation</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B116">Koot et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Functional effects currently unknown.</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>KCNN3</italic>/SK3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="left" colspan="1" rowspan="1" valign="top">hSK3Δ (<italic>L283fs287X</italic> mutation)/N-terminal cytoplasmic region (deletion)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Suppresses SK currents Disrupts SK-NMDAR coupling</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B142">Miller et al., 2001</xref>; <xref ref-type="bibr" rid="B186">Soden et al., 2013</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic><sup>∗</sup>KCNMB1</italic>/BKβ1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Diastolic hypertension</td>
<td align="left" colspan="1" rowspan="1" valign="top">E65K/Extracellular loop connecting β1 two transmembrane segments.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gain-of-function mutation rendering enhanced Ca<sup>2+</sup> sensitivity</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B67">Fernandez-Fernandez et al., 2004</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>KCNMA1</italic>/BKα</td>
<td align="left" colspan="1" rowspan="1" valign="top">Generalized epilepsy and paroxysmal dyskinesia</td>
<td align="left" colspan="1" rowspan="1" valign="top">D434G/RCK1 domain</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gain-of-function mutation leading to enhanced Ca<sup>2+</sup> sensitivity</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B57">Du et al., 2005</xref>; <xref ref-type="bibr" rid="B237">Yang J. et al., 2010</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>KCNMA1</italic>/BKα</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epilepsy</td>
<td align="left" colspan="1" rowspan="1" valign="top">N995S/RCK2 domain</td>
<td align="left" colspan="1" rowspan="1" valign="top">D<italic>e novo</italic> mutation Shifts the voltage dependence to more negative potentials without altering Ca<sup>2+</sup> sensitivity</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B127">Li et al., 2018</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>KCNMB3</italic>/BKβ3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Idiopathic generalized epilepsy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Del A750/C-terminal region (truncation of 21 amino acids)</td>
<td align="left" colspan="1" rowspan="1" valign="top">BK inactivation</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B90">Hu et al., 2003</xref>; <xref ref-type="bibr" rid="B131">Lorenz et al., 2007</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>This table includes other mutations not linked to neurological diseases that are not discussed in detail in the main text (indicated with asterisks).</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Neuronal Expression and Functional Roles of K<sub>Ca</sub> Channels</title>
<p>K<sub>Ca</sub> channels are expressed in neurons and other cell types in the central nervous system (CNS), where they are involved in a large variety of physiological functions. Due to the vast distribution of K<sub>Ca</sub> channels and their pleiotropic roles in the CNS, functional studies have been performed in different neuronal types, developmental stages or animal species. It is important to take into account the diversity of these approaches when interpreting the results described in the present review.</p>
<p>Activation of SK channels regulates firing in pacemaker neurons of midbrain and cerebellum, which is critical for muscle coordination and movement (<xref ref-type="bibr" rid="B226">Wolfart and Roeper, 2002</xref>; <xref ref-type="bibr" rid="B227">Womack and Khodakhah, 2003</xref>). In many neurons, action potentials are followed by a medium-duration after-hyperpolarization (mAHP) that affects their intrinsic excitability (<xref ref-type="bibr" rid="B3">Adelman et al., 2012</xref>). In numerous neuron types, the mAHP underlying current (<italic>I</italic><sub>m</sub>AHP), which can last up to hundreds of milliseconds, is Ca<sup>2+</sup>-dependent but voltage-insensitive and is blocked by apamin but not by BK channel blockers, suggesting the involvement of SK channels (<xref ref-type="bibr" rid="B170">Sah, 1996</xref>; <xref ref-type="bibr" rid="B191">Stocker et al., 1999</xref>; but see <xref ref-type="bibr" rid="B79">Gu et al., 2005</xref>). The three SK channel α subunits, SK1, SK2 and SK3 display characteristics similar to I<sub>m</sub>AHP in heterologous expression systems but fail to fully reproduce the pharmacological and biophysical properties observed <italic>in vivo</italic> (<xref ref-type="bibr" rid="B191">Stocker et al., 1999</xref>). This conundrum may be explained by the existence of SK heteromultimeric channels, which have been also described in heterologous expression systems (<xref ref-type="bibr" rid="B95">Ishii et al., 1997a</xref>). The idea that SK channels can assemble either as homo- or heteromultimeric channels <italic>in vivo</italic> is supported by their expression pattern in brain, which is overlapping in many regions (<xref ref-type="bibr" rid="B190">Stocker and Pedarzani, 2000</xref>). Interestingly, recent evidence shows that SK channels preferentially form species-specific heteromultimers when expressed in HEK cells, by interaction of their C-terminal regions (<xref ref-type="bibr" rid="B206">Tuteja et al., 2010</xref>; <xref ref-type="bibr" rid="B41">Church et al., 2015</xref>). These authors also show the physiological relevance of SK heteromultimers in CA1 pyramidal neurons (<xref ref-type="bibr" rid="B41">Church et al., 2015</xref>) and cardiomyocytes (<xref ref-type="bibr" rid="B206">Tuteja et al., 2010</xref>), highlighting the need of further studies to address the implications of heteromeric SK channels in brain and heart.</p>
<p>A role of SK channels in dendritic spines of pyramidal neurons in hippocampus and amygdala has been postulated, where they may regulate the amplitude of excitatory postsynaptic potentials (EPSPs) (<xref ref-type="bibr" rid="B63">Faber et al., 2005</xref>; <xref ref-type="bibr" rid="B154">Ngo-Anh et al., 2005</xref>; <xref ref-type="bibr" rid="B20">Bloodgood and Sabatini, 2007</xref>). During EPSPs, activation of SK channels limits Ca<sup>2+</sup> influx into the spines and dendrites, thus creating a negative feedback loop controlling EPSPs amplitude. In addition, this activation of SK channels may influence NMDAR receptor activation (via voltage-dependent Mg<sup>2+</sup> block), consequently affecting synaptic plasticity (<xref ref-type="bibr" rid="B154">Ngo-Anh et al., 2005</xref>). In agreement with this, blockade of SK channels in pyramidal neurons from hippocampus (<xref ref-type="bibr" rid="B189">Stackman et al., 2002</xref>) and amygdala (<xref ref-type="bibr" rid="B63">Faber et al., 2005</xref>; <xref ref-type="bibr" rid="B154">Ngo-Anh et al., 2005</xref>) enhanced long-term potentiation (LTP), suggesting that dendritic SK channels may play an important role in memory and learning processes (<xref ref-type="bibr" rid="B189">Stackman et al., 2002</xref>).</p>
<p>IK channels are widely expressed throughout the body, excluding some excitable tissues such as cardiac muscle or skeletal muscle. IK channels regulate the membrane potential and Ca<sup>2+</sup> signaling and are responsible of activation and proliferation of vascular smooth cells and lymphocytes (<xref ref-type="bibr" rid="B205">Toyama et al., 2008</xref>; <xref ref-type="bibr" rid="B49">Di et al., 2010</xref>; <xref ref-type="bibr" rid="B239">Yu et al., 2013</xref>). Immunohistochemical staining experiments indicate that human enteric, sensory and sympathetic neurons also express IK channels (<xref ref-type="bibr" rid="B69">Furness et al., 2004</xref>; <xref ref-type="bibr" rid="B12">Bahia et al., 2005</xref>; <xref ref-type="bibr" rid="B146">Mongan et al., 2005</xref>). In the CNS, IK channels are mainly localized in microglia and endothelial cells (<xref ref-type="bibr" rid="B161">Pedarzani and Stocker, 2008</xref>). Microglial IK channels participate in controlling several functions including respiratory burst, proliferation, migration as well as lipopolysaccharide mediated nitric oxide production (<xref ref-type="bibr" rid="B110">Kaushal et al., 2007</xref>; <xref ref-type="bibr" rid="B156">Nguyen et al., 2017</xref>). Accumulating evidence indicates that IK channels are involved in the process of astrogliosis, which occurs in most forms of CNS insults (<xref ref-type="bibr" rid="B22">Bouhy et al., 2011</xref>; <xref ref-type="bibr" rid="B39">Chen et al., 2011</xref>; <xref ref-type="bibr" rid="B240">Yu et al., 2014</xref>). It has been proposed that, in addition to BK (see below), IK channels also contribute to neurovascular coupling in astrocytes (<xref ref-type="bibr" rid="B130">Longden et al., 2011</xref>).</p>
<p>In many neuron types including hippocampal CA1 and CA3 pyramidal cells, repetitive firing stimulus elicits a slow, long lasting hyperpolarization, which is referred to as slow AHP (sAHP) (<xref ref-type="bibr" rid="B3">Adelman et al., 2012</xref>). The development of sAHP prevents the generation of new action potentials, limiting hyperexcitation of neurons in response to a long lasting or repetitive stimulus. Several studies have suggested that both SK (<xref ref-type="bibr" rid="B129">Lima and Marrion, 2007</xref>) and Kv7 channels (<xref ref-type="bibr" rid="B208">Tzingounis and Nicoll, 2008</xref>; <xref ref-type="bibr" rid="B209">Tzingounis et al., 2010</xref>) may contribute to sAHP. However, this assertion is contradicted by other observations showing that blockers of those channels produce only a minor reduction of the sAHP current (I<sub>s</sub>AHP), suggesting that other channels are involved (<xref ref-type="bibr" rid="B228">Womble and Moises, 1993</xref>; <xref ref-type="bibr" rid="B164">Power and Sah, 2008</xref>). Furthermore, genetic ablation of SK1, SK2 or SK3 does not affect sAHP in CA1 pyramidal neurons (<xref ref-type="bibr" rid="B21">Bond et al., 2004</xref>). Although IK channels have been suggested to underlay sAHP (<xref ref-type="bibr" rid="B112">King et al., 2015</xref>), a recent study ruled out this hypothesis based on the pharmacological properties of I<sub>s</sub>AHP, which were unaltered in IK knockout mice (<xref ref-type="bibr" rid="B218">Wang K. et al., 2016</xref>). The molecular identity of the sAHP channels remains unknown.</p>
<p>BK channels are localized throughout the dendrites, axon, soma and synaptic terminals of neurons in different brain regions, including cortex and hippocampus (<xref ref-type="bibr" rid="B114">Knaus et al., 1996</xref>; <xref ref-type="bibr" rid="B77">Grunnet and Kaufmann, 2004</xref>; <xref ref-type="bibr" rid="B215">Wang et al., 2014</xref>), where they play key roles in action potential duration, firing frequency and neurotransmitter release (for a recent review, see <xref ref-type="bibr" rid="B42">Contet et al., 2016</xref>). It should be noted that depending on the subcellular location where they are expressed, BK channel isoforms may exhibit different biophysical and trafficking properties, determined by the subunit composition (assembly with auxiliary subunits) and alternative splicing (<xref ref-type="bibr" rid="B42">Contet et al., 2016</xref>). At the synaptic terminals, it has been proposed that tight spatial coupling between BK channels and VGCCs (<xref ref-type="bibr" rid="B136">Marrion and Tavalin, 1998</xref>) constitutes a molecular brake for neurotransmitter release, by the BK-mediated termination of action potentials (<xref ref-type="bibr" rid="B18">Bielefeldt and Jackson, 1993</xref>; <xref ref-type="bibr" rid="B89">Hu et al., 2001</xref>; <xref ref-type="bibr" rid="B150">Muller et al., 2007</xref>; <xref ref-type="bibr" rid="B42">Contet et al., 2016</xref>). In dendrites, this association is also relevant, contributing to regulation of the magnitude and duration of dendritic Ca<sup>2+</sup> spikes to influence action potential output (<xref ref-type="bibr" rid="B60">Engbers et al., 2013</xref>; <xref ref-type="bibr" rid="B93">Indriati et al., 2013</xref>). BK channels have the ability to shape the action potential waveforms and influence the frequency of firing in different ways. Pharmacological or genetic deletion of BK channels can increase or decrease the evoked or spontaneous firing frequency (<xref ref-type="bibr" rid="B18">Bielefeldt and Jackson, 1993</xref>; <xref ref-type="bibr" rid="B153">Nelson et al., 2003</xref>; <xref ref-type="bibr" rid="B78">Gu et al., 2007</xref>). Many studies have shown that blockade of BK channels using TEA, charybdotoxin or paxilline slows action potential repolarization and reduces the magnitude of the fast-duration AHP (<xref ref-type="bibr" rid="B1">Adams et al., 1982</xref>; <xref ref-type="bibr" rid="B192">Storm, 1987</xref>; <xref ref-type="bibr" rid="B171">Sah and McLachlan, 1992</xref>; <xref ref-type="bibr" rid="B245">Zhang and McBain, 1995</xref>; <xref ref-type="bibr" rid="B62">Faber and Sah, 2002</xref>). In the suprachiasmatic nucleus, BK channels contribute to spontaneous firing rate related to normal circadian behavioral rhythm (<xref ref-type="bibr" rid="B141">Meredith et al., 2006</xref>; <xref ref-type="bibr" rid="B225">Whitt et al., 2016</xref>; <xref ref-type="bibr" rid="B224">Whitt et al., 2018</xref>). Genetic ablation of the BKβ<sub>4</sub> subunit in neurons from the dentate gyrus (DG) augmented the fast AHP amplitude, sharpened the action potential and increased spike frequency (<xref ref-type="bibr" rid="B26">Brenner et al., 2005</xref>). These findings support the idea that BK channels are not strictly excitatory or inhibitory but can be dynamically regulated to control neuronal excitability (<xref ref-type="bibr" rid="B42">Contet et al., 2016</xref>). Regulatory mechanisms include coupling to accessory subunits (<xref ref-type="bibr" rid="B26">Brenner et al., 2005</xref>; <xref ref-type="bibr" rid="B225">Whitt et al., 2016</xref>) and different sources of intracellular Ca<sup>2+</sup> (<xref ref-type="bibr" rid="B214">Wang B. et al., 2016</xref>; <xref ref-type="bibr" rid="B224">Whitt et al., 2018</xref>).</p>
<p>Expression of BK has been also reported in astrocytes (<xref ref-type="bibr" rid="B178">Seidel et al., 2011</xref>; <xref ref-type="bibr" rid="B179">Seifert et al., 2018</xref>), where they have been related to astrocytic function connecting neuronal signaling to CNS vasculature (<xref ref-type="bibr" rid="B88">Howarth, 2014</xref>). Many studies have highlighted the role of astrocytic processes (endfeet) in modulating the vascular response by dynamically controlling intracellular Ca<sup>2+</sup> (<xref ref-type="bibr" rid="B68">Filosa et al., 2006</xref>; <xref ref-type="bibr" rid="B200">Takano et al., 2006</xref>; <xref ref-type="bibr" rid="B75">Girouard et al., 2010</xref>). It has been proposed that activation of BK channels by elevated Ca<sup>2+</sup> in astrocytic endfeet leads to vasodilation by the release of K<sup>+</sup> into the perivascular space (<xref ref-type="bibr" rid="B165">Price et al., 2002</xref>; <xref ref-type="bibr" rid="B68">Filosa et al., 2006</xref>). Interestingly, another study demonstrated that this mechanism can also mediate vasoconstriction, leading the authors to propose that BK channels may produce dual vascular responses depending on the Ca<sup>2+</sup> levels at the astrocytic endfoot (<xref ref-type="bibr" rid="B75">Girouard et al., 2010</xref>).</p>
<sec>
<title>Neuroprotective Roles of K<sub>Ca</sub> Channels</title>
<p>Dopamine (DA) neurons in the midbrain retrorubral field (RRF), substantia nigra <italic>pars compacta</italic> (SNc) and ventral tegmental area (VTA) influence the neurons in target areas due to their extensive axonal projections (<xref ref-type="bibr" rid="B137">Matsuda et al., 2009</xref>). Thus, DA neurons are involved in regulating essential processes such as fine motor control (<xref ref-type="bibr" rid="B17">Bernheimer et al., 1973</xref>) learning and memory (<xref ref-type="bibr" rid="B138">Matsumoto and Takada, 2013</xref>), cognitive processes (<xref ref-type="bibr" rid="B157">Nieoullon, 2002</xref>), response to stress (<xref ref-type="bibr" rid="B210">Ungless et al., 2010</xref>) and noxious stimuli (<xref ref-type="bibr" rid="B28">Brischoux et al., 2009</xref>). SK channels control the pattern of single spike firing of DA neurons both <italic>in vivo</italic> and <italic>in vitro</italic>, as demonstrated by the reduction in firing regularity observed after treating the cells with apamin (<xref ref-type="bibr" rid="B221">Waroux et al., 2005</xref>; <xref ref-type="bibr" rid="B102">Ji and Shepard, 2006</xref>). Some studies have postulated that SK channels may exert neuroprotective effects against progressive DA neuronal death (<xref ref-type="bibr" rid="B54">Dolga et al., 2014</xref>), by a proposed mechanism in which activation of SK channels in SNc neurons counteracts excitotoxicity associated to NMDAR overactivation (<xref ref-type="bibr" rid="B54">Dolga et al., 2014</xref>; <xref ref-type="bibr" rid="B58">Duda et al., 2016</xref>). Additionally, SK channels could directly regulate NAPDH oxidase function, thus hampering neuronal damage by preventing production of reactive oxygen species (ROS) in mitochondria (<xref ref-type="bibr" rid="B65">Fay et al., 2006</xref>; <xref ref-type="bibr" rid="B54">Dolga et al., 2014</xref>). In mouse CA1 pyramidal neurons, a protective role of SK2 channels has been described, based on the observation that direct activation of SK channels by 1-ethyl-2- benzimidazolinone (1-EBIO) significantly reduced neuronal death in a model of cerebral ischemia induced by cardiac arrest/cardiopulmonary resuscitation. This finding points to activation of SK channels as a potential neuroprotective target in cerebral ischemia (<xref ref-type="bibr" rid="B6">Allen et al., 2011</xref>).</p>
<p>Accumulating evidence supports multifaceted functions of IK channels (<xref ref-type="bibr" rid="B110">Kaushal et al., 2007</xref>; <xref ref-type="bibr" rid="B53">Dolga and Culmsee, 2012</xref>). Specifically, IK channels have been related to microglia activation by modulating Ca<sup>2+</sup> signaling, oxidative burst, proinflammatory cytokines production and microglia-mediated neuronal cell death (<xref ref-type="bibr" rid="B110">Kaushal et al., 2007</xref>). According to these proposed physiological roles, a recent study demonstrated that genetic ablation or <italic>in vivo</italic> pharmacological blockade of IK channels in the middle cerebral artery occlusion (MCAO) mouse model reduced the infarct area as well as improved neurological deficit by reducing microglia-associated neuronal death (<xref ref-type="bibr" rid="B38">Chen Y.J. et al., 2016</xref>).</p>
<p>A protective role of BK channels in the context of acute focal cerebral ischemia has been tested <italic>in vivo</italic> by performing MCAO in BK knockout mouse models, which showed higher post-ischemic mortality than their WT littermates (<xref ref-type="bibr" rid="B128">Liao et al., 2010</xref>). In this context, it was suggested that BK plays a neuroprotective role by counteracting NMDA-induced neurotoxicity, since genetic silencing or blockade of BK channels in organotypic hippocampal slice cultures (<xref ref-type="bibr" rid="B128">Liao et al., 2010</xref>) or cortico-striatal brain slice cultures (<xref ref-type="bibr" rid="B109">Katsuki et al., 2005</xref>) showed higher levels of NMDA-induced neuronal death when they were exposed to ischemic-like conditions.</p>
<p>K<sub>Ca</sub> channels are also expressed at inner mitochondrial membranes (mitoK<sub>Ca</sub>), where they have been suggested to be involved in neuroprotection by different mechanisms, some of which are still unknown (<xref ref-type="bibr" rid="B14">Bednarczyk, 2009</xref>). The activation of mitoSK channels in conditions of glutamate toxicity enhanced the mitochondrial resilience and reduced cell death in mouse hippocampal cell lines (<xref ref-type="bibr" rid="B55">Dolga et al., 2013</xref>; <xref ref-type="bibr" rid="B85">Honrath et al., 2017</xref>). Additionally, mitoBK channels were found to preserve neuronal cell viability by attenuating the overall ROSs production (<xref ref-type="bibr" rid="B119">Kulawiak et al., 2008</xref>; <xref ref-type="bibr" rid="B184">Skalska et al., 2009</xref>). In addition to these reports, several others have reviewed the importance of mitoK<sub>Ca</sub> channels as potential targets for neuroprotection (<xref ref-type="bibr" rid="B199">Szewczyk et al., 2010</xref>; <xref ref-type="bibr" rid="B13">Balderas et al., 2015</xref>; <xref ref-type="bibr" rid="B117">Krabbendam et al., 2018</xref>).</p>
</sec>
</sec>
<sec>
<title>Role of K<sub>Ca</sub> Channels in Neurological and Psychiatric Diseases</title>
<p>Concomitant with their physiological roles, alterations in K<sub>Ca</sub> function lead to excitability disorders that are characterized by abnormal firing of neuronal networks. The advancement of genetic linkage analysis over the past decades significantly facilitated the identification of specific loci associated to disease, many of which include genes encoding K<sub>Ca</sub> channels subunits (<xref ref-type="bibr" rid="B44">Cooper and Jan, 1999</xref>; see <bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). The role of these channels in disease has been also addressed using pharmacological tools. In this section we review the proposed contribution of BK and SK channels to neurological diseases. It is worth noting that, to our knowledge, no human diseases have been described in the literature involving K<sub>Ca</sub>3.1 (IK) channel mutations. Their potential as drug targets in neurodegenerative diseases and ischemic stroke is reviewed in latter sections referring to K<sub>Ca</sub> modulators.</p>
<sec>
<title>Role of SK Channels</title>
<p>Malfunction of SK channels has been related to epilepsy. In pilocarpine-treated epileptic rats, the expression and function of SK channels was significantly reduced (<xref ref-type="bibr" rid="B158">Oliveira et al., 2010</xref>). Using thalamic slices treated with bicuculline methiodide as an experimental model of absence epilepsy, <xref ref-type="bibr" rid="B113">Kleiman-Weiner et al. (2009)</xref> found that blockade of SK channels modulated epileptiform oscillations by reducing intrinsic excitability of reticular neurons with no effect on relay neurons, pointing to SK channels as potential therapeutical targets for this disease. The involvement of SK in epilepsy has been further studied by using different modulators (see following section in this review).</p>
<p>Schizophrenia is a progressive neurodegenerative disorder that is characterized by disintegration of processes involved in thinking and emotional responsiveness (<xref ref-type="bibr" rid="B163">Postmes et al., 2014</xref>), that has been linked to DA imbalance (<xref ref-type="bibr" rid="B27">Brisch et al., 2014</xref>). A spontaneous mutation of the SK3 channel gene (<italic>L283fs287X</italic>) resulting in the deletion of the protein N-terminal region was identified in human schizophrenia patients (<xref ref-type="bibr" rid="B23">Bowen et al., 2001</xref>) and the resulting altered channels (hSK3Δ) were found to dominantly suppress SK channel currents. (<xref ref-type="bibr" rid="B142">Miller et al., 2001</xref>). Selective expression of this SK3 mutant in mice DA neurons additionally reduced the coupling between the SK channels and NMDAR, leading to increased burst firing as well as amplification of DA release, ultimately impacting animal behavior (<xref ref-type="bibr" rid="B186">Soden et al., 2013</xref>). The results by <xref ref-type="bibr" rid="B186">Soden et al. (2013)</xref> additionally showed that functional deficits of SK channels can alter the balance between phasic and tonic DA signals, which are normally associated to the pathogenesis of schizophrenia (<xref ref-type="bibr" rid="B76">Grace, 1991</xref>).</p>
<p>Pathogenesis of Parkinson’s disease (PD), which is associated to death of DA neurons in the SNc (<xref ref-type="bibr" rid="B197">Surmeier et al., 2010</xref>) has been also related to K<sup>+</sup> channels dysfunction, including SK channels (<xref ref-type="bibr" rid="B220">Wang et al., 2008</xref>; <xref ref-type="bibr" rid="B37">Chen et al., 2018</xref>). This hypothesis is consistent with the observed roles of SK channels as regulators of dopaminergic neurotransmission in the SNc, protecting DA neurons from excitotoxic death (as reviewed in the previous section; see also <xref ref-type="bibr" rid="B54">Dolga et al., 2014</xref>). However, the role of SK channels in the etiology of PD remains elusive due to contradictory evidence. Some reports showed that activation of SK channels by NS309 in human DA neurons inhibited spontaneous firing, enhancing mAHP (<xref ref-type="bibr" rid="B102">Ji and Shepard, 2006</xref>), and reducing neurotoxicity (<xref ref-type="bibr" rid="B54">Dolga et al., 2014</xref>). These results suggest that increasing SK channel activity could boost or at least preserve levels of DA synthesis, which would in turn mitigate the long-term motor symptoms of PD. On the other hand, several studies have provided evidence that blockade of SK channels by apamin improved the symptoms of PD <italic>in vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="B56">Doo et al., 2010</xref>; <xref ref-type="bibr" rid="B111">Kim et al., 2011</xref>; <xref ref-type="bibr" rid="B7">Alvarez-Fischer et al., 2013</xref>). This idea was further strengthened by the fact that blocking SK channels restored minimal DA activity in the striatum, alleviating the non-motor symptoms induced by partial striatal DA lesions (<xref ref-type="bibr" rid="B34">Chen et al., 2014</xref>). A possible interpretation of these apparently contradictory results is that SK channel positive or negative modulators could be beneficial depending on the stage (early or late) of the disease.</p>
</sec>
<sec>
<title>Role of BK Channels in Neurological Diseases</title>
<p>BK malfunction has been related to seizures and epilepsy, although the role of these channels in this pathological condition seems to be complex. <italic>KCNMA1</italic> knockout mice did not show spontaneous seizures, suggesting that CNS excitability is unaffected and discarding a prominent role of BK hypoactivity in epileptogenesis (<xref ref-type="bibr" rid="B172">Sausbier et al., 2004</xref>). However, growing evidence associates BKα gain-of-function or loss-of-function to neuronal pro-excitatory or pro-inhibitory effects, which may depend on the cellular context (for recent reviews, see (<xref ref-type="bibr" rid="B155">N’Gouemo, 2014</xref>; <xref ref-type="bibr" rid="B42">Contet et al., 2016</xref>). A BKα gain-of-function mutation (D434G) showing larger macroscopic currents, increased intrinsic gating and Ca<sup>2+</sup> sensitivity was associated with a human syndrome of generalized epilepsy and paroxysmal dyskinesia (<xref ref-type="bibr" rid="B57">Du et al., 2005</xref>). Studies addressed to characterizing the mechanism underlying the strong functional impact of this mutation have greatly contributed to a better understanding of the biophysics of BK channels. Since the D434 site is located in the vicinity of the RCK1 Ca<sup>2+</sup> binding site of the BK channel, its alteration was found to affect the allosteric coupling between the Ca<sup>2+</sup> binding and the opening of the channel (<xref ref-type="bibr" rid="B237">Yang J. et al., 2010</xref>). Enhanced neuronal BK channel activity as a result of the D434G mutation would increase the fAHP, resulting in faster recovery of sodium channels from inactivation, enabling neuronal firing at higher frequency and ultimately leading to increased neuronal excitability and seizures (<xref ref-type="bibr" rid="B57">Du et al., 2005</xref>; <xref ref-type="bibr" rid="B51">Diez-Sampedro et al., 2006</xref>; <xref ref-type="bibr" rid="B216">Wang et al., 2009</xref>; <xref ref-type="bibr" rid="B237">Yang J. et al., 2010</xref>). In a recent study, <xref ref-type="bibr" rid="B127">Li et al. (2018)</xref> identified a <italic>de novo</italic> mutation in the BKα gene (N995S) associated with epilepsy but not with paroxysmal dyskinesia. In contrast to the D434G mutant, the N995S gain-of-function variant shows alterations of the channel’s sensitivity to voltage, but not to Ca<sup>2+</sup> (<xref ref-type="bibr" rid="B127">Li et al., 2018</xref>). This notion that hyperactivity of BK channels is related to hyperexcitability and seizures is further supported by their implication in pathogenesis of alcohol withdrawal seizures (<xref ref-type="bibr" rid="B71">Ghezzi et al., 2014</xref>). Furthermore, blockade of BK has been shown to reduce neuronal hyperexcitability in animal models of epilepsy and seizures, but does not present anticonvulsant effects in animals with no previous seizure episodes (<xref ref-type="bibr" rid="B103">Jin et al., 2000</xref>; <xref ref-type="bibr" rid="B180">Sheehan et al., 2009</xref>). BK pro-excitatory or pro-inhibitory effects can be additionally determined and modulated by association to regulatory subunits. A recent study by <xref ref-type="bibr" rid="B223">Whitmire et al. (2017)</xref> showed that β<sub>4</sub> expression in hippocampal DG granule neurons is downregulated following pilocarpine-induced seizures, leading to gain-of-function BK and increased excitability. This result is consistent with previously observed effects in β<sub>4</sub> knockout mice (<xref ref-type="bibr" rid="B216">Wang et al., 2009</xref>; <xref ref-type="bibr" rid="B223">Whitmire et al., 2017</xref>). Alteration of the BKβ<sub>3</sub> regulatory subunit as a consequence of a single base pair deletion (delA750) in the <italic>KCNMB3</italic> gene has also been associated to idiopathic generalized epilepsy in humans (<xref ref-type="bibr" rid="B131">Lorenz et al., 2007</xref>). This variant confers loss-of-function characteristics to BKα in heterologous expression systems by enhancing inactivation (<xref ref-type="bibr" rid="B90">Hu et al., 2003</xref>).</p>
<p>Two independent genome-wide association studies reported that single nucleotide polymorphisms in the <italic>KCNMA1</italic> gene encoding the BKα subunit (<xref ref-type="bibr" rid="B16">Beecham et al., 2009</xref>) and in the <italic>KCNMAB2</italic> gene (regulatory subunit BKβ<sub>2</sub>) (<xref ref-type="bibr" rid="B15">Beecham et al., 2014</xref>) are strongly linked to the pathophysiology of Alzheimer’s disease (AD). Intracellular application of amyloid β peptide (<italic>β</italic>) in neocortical pyramidal neurons from rats and mice increased neuronal excitability by reducing function of BK channels (<xref ref-type="bibr" rid="B234">Yamamoto et al., 2011</xref>). In AD and depression mice models, transcranial magnetic stimulation (TMS) reduced the depression-like behavior by a proposed mechanism in which the activation of BK channels by TMS would enhance hippocampal LTP and inhibit cortical excitability (<xref ref-type="bibr" rid="B196">Sun et al., 2011</xref>; <xref ref-type="bibr" rid="B217">Wang F. et al., 2015</xref>). Interestingly, TMS was found to improve cognitive functions in human AD patients (<xref ref-type="bibr" rid="B45">Cotelli et al., 2006</xref>; <xref ref-type="bibr" rid="B5">Ahmed et al., 2012</xref>).</p>
<p>BK malfunction has been also related to Fragile X syndrome (FXS), a monogenic form of intellectual disability and autism, associated to transcriptional silencing of the <italic>Fmr1</italic> gene encoding Fragile X mental retardation protein (FMRP) (<xref ref-type="bibr" rid="B211">Verkerk et al., 1991</xref>). Recent evidence has shown that FMRP regulates neurotransmitter release in CA3 neurons by directly interacting with BKβ4 subunits (<xref ref-type="bibr" rid="B47">Deng et al., 2013</xref>). Consistent with this hypothesis, <xref ref-type="bibr" rid="B82">Hebert et al. (2014)</xref> restored the FXS behavioral deficits in Fmr1 knockout mice by treating the animals with selective BK channel openers (see below). These results support the idea that BK channels may be potential therapeutic targets for FXS (<xref ref-type="bibr" rid="B25">Brager and Johnston, 2014</xref>; <xref ref-type="bibr" rid="B43">Contractor et al., 2015</xref>).</p>
<p>Habituation is a form of learning in which the behavioral response to a stimulus decreases following repeated exposure to the stimulus (<xref ref-type="bibr" rid="B166">Rankin et al., 2009</xref>). Habituation to the acoustic startle response is impaired in many psychiatric disorders including schizophrenia and autism (<xref ref-type="bibr" rid="B24">Braff et al., 1992</xref>; <xref ref-type="bibr" rid="B159">Ornitz et al., 1993</xref>). BK channels have been implicated in habituation by controlling synaptic transmission (<xref ref-type="bibr" rid="B207">Typlt et al., 2013</xref>). Recently, it has been shown that activation of BK channels and their subsequent phosphorylation are essential for synaptic depression underlying habituation (<xref ref-type="bibr" rid="B244">Zaman et al., 2017</xref>).</p>
</sec>
</sec>
<sec>
<title>Regulation of K<sub>Ca</sub> Channels and Implications for Therapeutic Approaches</title>
<p>As described in the previous sections, alterations in K<sub>Ca</sub> channels are associated to several genetically linked and acquired diseases. In this section we review the use of various K<sub>Ca</sub> modulators oriented toward disease treatment (summarized in <bold>Table <xref ref-type="table" rid="T2">2</xref></bold>), including some pharmacological considerations. The current state-of-the-art knowledge on the potential of K<sub>Ca</sub> channels as therapeutic targets is summarized in <bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold> by representing as a weighing scale the beneficial effects resulting from either activation (left side) or blockade (right side) of each K<sub>Ca</sub> subtype. Interestingly, SK and BK channels’ balance is tipped toward the activation side, which seems to be more beneficial than blockade. Conversely, for IK channels blockade is more favorable than activation.</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Functional roles of clinically available/potential modulators of K<sub>Ca</sub> channels.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Target</th>
<th align="left" colspan="1" rowspan="1" valign="top">Drug</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reported effects</th>
<th align="left" colspan="1" rowspan="1" valign="top">Comments</th>
<th align="left" colspan="1" rowspan="1" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SK</td>
<td align="left" colspan="1" rowspan="1" valign="top">1-EBIO</td>
<td align="left" colspan="1" rowspan="1" valign="top">-Positive effects on cerebral ischemia animal models</td>
<td align="left" colspan="1" rowspan="1" valign="top">-SK activator</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B6">Allen et al., 2011</xref>; <xref ref-type="bibr" rid="B121">Lappin et al., 2005</xref>; <xref ref-type="bibr" rid="B9">Anderson et al., 2006</xref>; <xref ref-type="bibr" rid="B158">Oliveira et al., 2010</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">-Reduces epileptiform activity in an acute model of epilepsy</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NS309</td>
<td align="left" colspan="1" rowspan="1" valign="top">Positive effects on DA neurons function related to Parkinson’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">-SK activator</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B102">Ji and Shepard, 2006</xref>; <xref ref-type="bibr" rid="B54">Dolga et al., 2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Chlorzoxazone</td>
<td align="left" colspan="1" rowspan="1" valign="top">Improves motor-coordination and other symptoms of episodic ataxia type-2</td>
<td align="left" colspan="1" rowspan="1" valign="top">-SK activator</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B8">Alvina and Khodakhah, 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">-FDA-approved treatment for spasticity</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Riluzole</td>
<td align="left" colspan="1" rowspan="1" valign="top">-Positive effects in arthritic pain model</td>
<td align="left" colspan="1" rowspan="1" valign="top">-SK activator</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B168">Ristori et al., 2010</xref>; <xref ref-type="bibr" rid="B203">Thompson et al., 2015</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">-Improves ataxia-related symptoms in human patients</td>
<td align="left" colspan="1" rowspan="1" valign="top">-FDA-approved treatment for ALS</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">DCEBIO</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduces recall of extinction memory in rats</td>
<td align="left" colspan="1" rowspan="1" valign="top">SK activator</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B46">Criado-Marrero et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Apamin</td>
<td align="left" colspan="1" rowspan="1" valign="top">-Improves Parkinson’s disease symptoms <italic>in vitro</italic> and <italic>in vivo</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SK inhibitor</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B48">Deschaux et al., 1997</xref>; <xref ref-type="bibr" rid="B92">Inan et al., 2000</xref>; <xref ref-type="bibr" rid="B189">Stackman et al., 2002</xref>; <xref ref-type="bibr" rid="B149">Mpari et al., 2005</xref>; <xref ref-type="bibr" rid="B56">Doo et al., 2010</xref>; <xref ref-type="bibr" rid="B235">Yang E.J. et al., 2010</xref>; <xref ref-type="bibr" rid="B111">Kim et al., 2011</xref>; <xref ref-type="bibr" rid="B7">Alvarez-Fischer et al., 2013</xref>; <xref ref-type="bibr" rid="B46">Criado-Marrero et al., 2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">-Positive effects on various memory deficits and spatial learning</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">IK</td>
<td align="left" colspan="1" rowspan="1" valign="top">TRAM-34</td>
<td align="left" colspan="1" rowspan="1" valign="top">-Positive effects in AD, ischemic stroke and multiple sclerosis mouse models</td>
<td align="left" colspan="1" rowspan="1" valign="top">IK inhibitor</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B167">Reich et al., 2005</xref>; <xref ref-type="bibr" rid="B38">Chen Y.J. et al., 2016</xref>; <xref ref-type="bibr" rid="B238">Yi et al., 2016</xref>; <xref ref-type="bibr" rid="B133">Lu et al., 2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">-Increases formalin-induced nociceptive behavior</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Senicapoc</td>
<td align="left" colspan="1" rowspan="1" valign="top">-Positive effects in sickled cell anemia disease (SAD)<sup>∗</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">-IK inhibitor</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B232">Wulff and Castle, 2010</xref>; <xref ref-type="bibr" rid="B188">Staal et al., 2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">-Reversed tactile allodynia in rats with peripheral nerve injury</td>
<td align="left" colspan="1" rowspan="1" valign="top">-Phase 3 clinical trials for SAD</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">-Phase 2 clinical trials for asthma</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">BK</td>
<td align="left" colspan="1" rowspan="1" valign="top">Isoprimaric acid (ISO)</td>
<td align="left" colspan="1" rowspan="1" valign="top">-Improves cognitive defects in AD animal models</td>
<td align="left" colspan="1" rowspan="1" valign="top">-BK activator</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B219">Wang L. et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">GoSlo</td>
<td align="left" colspan="1" rowspan="1" valign="top">-Inhibits spontaneous contractions in both bladder and corpus cavernosum smooth muscle tissues.</td>
<td align="left" colspan="1" rowspan="1" valign="top">-BK activator</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B122">Large et al., 2015</xref>; <xref ref-type="bibr" rid="B81">Hannigan et al., 2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Andolast</td>
<td align="left" colspan="1" rowspan="1" valign="top">Positive effects on asthma treatment</td>
<td align="left" colspan="1" rowspan="1" valign="top">-BK activator</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B135">Malerba et al., 2015</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">-Currently in late stage of phase 3 clinical trials for asthma</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">BMS204352</td>
<td align="left" colspan="1" rowspan="1" valign="top">-Positive effects on FXS animal models</td>
<td align="left" colspan="1" rowspan="1" valign="top">-BK and Kv7 activator</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B100">Jensen, 2002</xref>; <xref ref-type="bibr" rid="B30">Brown and Passmore, 2009</xref>; <xref ref-type="bibr" rid="B82">Hebert et al., 2014</xref>; <xref ref-type="bibr" rid="B244">Zaman et al., 2017</xref>; <xref ref-type="bibr" rid="B32">Carreno-Munoz et al., 2018</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">-Enhances short-term habituation</td>
<td align="left" colspan="1" rowspan="1" valign="top">-Phase 3 clinical trials for treatment of acute ischemic stroke<sup>∗</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">-Positive effects on spontaneous hypertensive rats model<sup>∗</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Zonisamide</td>
<td align="left" colspan="1" rowspan="1" valign="top">-Positive effects on a wide range of epilepsies and neuropsychiatric disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">-BK activator, Na<sup>+</sup> and Ca<sup>2+</sup> channel modulator</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B19">Biton, 2007</xref>; <xref ref-type="bibr" rid="B91">Huang et al., 2007</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">-Antiepileptic drug used clinically</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Iberiotoxin (IbTX)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Beneficial effects in rheumatoid arthritis animal models</td>
<td align="left" colspan="1" rowspan="1" valign="top">selective BKαβ<sub>1-3</sub> blocker</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B201">Tanner et al., 2018</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>This table includes additional information, not detailed in the main text, about K<sub><italic>Ca</italic></sub> modulators reported in the literature to treat diverse pathological conditions.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Therapeutic benefits of either activation (left) or blockade (right) of K<sub>Ca</sub> channels represented as a weighing scale. The heavier balance indicates the modulation (activation or blockade) that has been reported advantageous in a larger number of diseases. <bold>(A,C)</bold> In the case of SK and BK channels, activation shows more beneficial effects than inhibition. <bold>(B)</bold> For IK channels, pharmacological blockade has proven to be more advantageous than activation. For further information about the specific effects, see Tables and main text.</p>
</caption>
<graphic xlink:href="fnmol-11-00258-g002"></graphic>
</fig>
<sec>
<title>Modulators of SK Channels</title>
<p>Several modulators of SK function have been identified as the basis for potential treatment of neurological diseases. Chlorzoxazone (CZX) is a SK channel activator, which has been approved by the U.S. Food and Drug Administration (FDA) as a muscle relaxant to treat spasticity (<xref ref-type="bibr" rid="B132">Losin and McKean, 1966</xref>). In addition, it has been proposed to be a viable pharmacotherapeutic approach for episodic ataxia type-2 (EA2) treatment. Oral administration of CZX in an EA2 mouse model improved motor coordination and reduced the severity, frequency and duration of dyskinesia episodes with no side effects, by a proposed mechanism of restoring SK channels function (<xref ref-type="bibr" rid="B8">Alvina and Khodakhah, 2010</xref>).</p>
<p>Riluzole is the first FDA-approved treatment for amyotrophic lateral sclerosis (ALS) (<xref ref-type="bibr" rid="B143">Miller et al., 2012</xref>). Although the molecular target of riluzole remains elusive, many studies have proposed that it works by modulating SK channels (<xref ref-type="bibr" rid="B52">Dimitriadi et al., 2013</xref>; <xref ref-type="bibr" rid="B120">Lam et al., 2013</xref>). In spinal muscular atrophy animal models, treatment with riluzole ameliorated disease-related loss-of-function defects by acting on SK channels (<xref ref-type="bibr" rid="B52">Dimitriadi et al., 2013</xref>). A recent study demonstrated that riluzole inhibits supraspinally organized pain behavior in a rat model of arthritic pain by activating SK channels (<xref ref-type="bibr" rid="B203">Thompson et al., 2015</xref>). Beneficial effects of riluzole have also been reported for the treatment of spinocerebellar ataxia type 2 (SCA2), a disease involving irregular firing and eventual neuronal death of Purkinje cells (PC) (<xref ref-type="bibr" rid="B108">Kasumu and Bezprozvanny, 2012</xref>). Administration of riluzole in patients improved ataxia-related symptoms (<xref ref-type="bibr" rid="B168">Ristori et al., 2010</xref>). This result was paralleled in a SCA2 transgenic mouse model, in which treatment with the SK selective activator NS13001 alleviated the symptoms of the disease (<xref ref-type="bibr" rid="B107">Kasumu et al., 2012</xref>). The mechanism underlying the effect of riluzole seems to reside in the activation of SK2 channels predominant in PC (<xref ref-type="bibr" rid="B59">Durr, 2010</xref>), which has been implicated in regulation of tonic firing (<xref ref-type="bibr" rid="B97">Ito, 2002</xref>; <xref ref-type="bibr" rid="B213">Walter et al., 2006</xref>). Consistently with this hypothesis, <xref ref-type="bibr" rid="B213">Walter et al. (2006)</xref> observed an improvement in motor coordination as well as restored PC firing regularity after treatment of an ataxia mouse model with SK channel modulators.</p>
<p>Selective activation of SK channels could be an effective therapy in some epileptic conditions. Potentiation of SK channels using ethylbenzimidazolinone (EBIO) was shown to inhibit epileptiform bursting in rat hippocampal CA3 neurons (<xref ref-type="bibr" rid="B121">Lappin et al., 2005</xref>). Additionally, this activator also reduced seizure incidence following maximal electroshock and increased the threshold to pentylenetetrazole-induced seizures in mice (<xref ref-type="bibr" rid="B9">Anderson et al., 2006</xref>).</p>
<p><italic>In vivo</italic> infusion of SK activator 5,6-Dichloro-1-ethyl-1,3-dihydro-2<italic>H</italic>-benzimidazol-2-one (DCEBIO) in rats reduced recall of extinction memory, leading the authors to propose SK as a therapeutic target in anxiety disorders (<xref ref-type="bibr" rid="B46">Criado-Marrero et al., 2014</xref>). However, this result also suggests that the effect of SK activators on learning and memory should be taken into account in potential therapies.</p>
<p>The use of SK channel blockers has been also explored for disease treatment. Initial studies showed that SK blockers are not neuroprotective and might detrimentally accelerate neurodegeneration (<xref ref-type="bibr" rid="B148">Mourre et al., 1997</xref>). However, administration of apamin in rats and mice accelerated spatial learning (<xref ref-type="bibr" rid="B48">Deschaux et al., 1997</xref>; <xref ref-type="bibr" rid="B189">Stackman et al., 2002</xref>), promoted object recognition memory (<xref ref-type="bibr" rid="B149">Mpari et al., 2005</xref>) and facilitated the recall of extinction memory (<xref ref-type="bibr" rid="B46">Criado-Marrero et al., 2014</xref>). Additionally, apamin also mitigated the memory deficits associated to scopolamine- or electroconvulsive shock-induced amnesia (<xref ref-type="bibr" rid="B92">Inan et al., 2000</xref>). In summary, SK activators and blockers seem to be involved in distinct beneficial effects that would need to be balanced in order to design specific therapies.</p>
</sec>
<sec>
<title>Modulators of IK Channels</title>
<p>Consistent with the physiological roles of IK channels described in previous sections of this review, the selective inhibitor TRAM-34 (1-[(2- chlorophenyl)diphenylmethyl]-1<italic>H</italic>-pyrazole) decreased astrogliosis and microglial activation and attenuated memory loss in an AD mouse model (<xref ref-type="bibr" rid="B238">Yi et al., 2016</xref>). Furthermore, reduced microglia activation after blocking IK channels in an ischemic stroke mouse model has also been documented, which resulted in reduced infarction size and improved neurological deficit (<xref ref-type="bibr" rid="B38">Chen Y.J. et al., 2016</xref>). Additionally, application of TRAM-34 alleviated the symptoms of experimental autoimmune encephalomyelitis, a murine model of multiple sclerosis (<xref ref-type="bibr" rid="B167">Reich et al., 2005</xref>). Together, these data suggest that pharmacological blockade or genetic deletion of IK channels may represent a therapeutic target for various neurodegenerative disorders and ischemic stroke. Nonetheless, it is important to point out that although pharmacological blockade of IK channels appeared to be safe and well tolerated in animal models and humans, the genetic deletion induced an increase in blood pressure (<xref ref-type="bibr" rid="B183">Si et al., 2006</xref>). On the other hand, no study has yet reported increased blood pressure with IK channel blockers including treatment of mice with TRAM-34 (<xref ref-type="bibr" rid="B205">Toyama et al., 2008</xref>) or human volunteers taking Senicapoc (<xref ref-type="bibr" rid="B10">Ataga et al., 2008</xref>). Finally, recent evidence suggests that IK inhibitors should be used with caution since they may also increase tonic pain in certain clinical conditions. A recent study demonstrated that pharmacological inhibition of IK channels using TRAM-34 in mice increased formalin-induced nociceptive behavior (<xref ref-type="bibr" rid="B133">Lu et al., 2017</xref>). Conversely, another study showed that blocking IK channels with Senicapoc reversed tactile allodynia in rats with peripheral nerve injury (<xref ref-type="bibr" rid="B188">Staal et al., 2017</xref>).</p>
</sec>
<sec>
<title>Modulators of BK Channels</title>
<p>Zonisamide is an antiepileptic drug used clinically as adjunctive therapy in refractory partial-onset seizures that has also shown beneficial effects in a wide range of epilepsies and neuropsychiatric disorders (<xref ref-type="bibr" rid="B19">Biton, 2007</xref>). In addition to inhibiting neuronal Na<sup>+</sup> and Ca<sup>2+</sup> ion channels, Huang et al. showed that zonisamide activated BK channels in a hippocampal neuron-derived cell line, suggesting that the effects of zonisamide may be mediated, at least partly, by modulation of these channels (<xref ref-type="bibr" rid="B91">Huang et al., 2007</xref>).</p>
<p>A recent study suggests that BK channel activators could have therapeutic potential for cognitive defects in AD patients. Chronic application of the BK channel activator isoprimaric acid (ISO) enhanced non-spatial memory in AD mice, restoring the basic synaptic transmission and LTP at the hippocampal CA1 synapses, which were elevated and suppressed respectively in the disease model (<xref ref-type="bibr" rid="B219">Wang L. et al., 2015</xref>). Interestingly, ISO treatment not only enhanced BK channel activity but also reduced the Aβ fraction suggesting that a two-way relationship exists between BK channels and the Aβ plaque (<xref ref-type="bibr" rid="B219">Wang L. et al., 2015</xref>).</p>
<p>Treatment of <italic>FMR1</italic> knockout mice, an animal model of FXS, with the selective BK channel opener BMS-204352 reversed the abnormal dendritic spine phenotype <italic>in vitro.</italic> Additionally, direct injection of the activator restored hippocampal glutamate homeostasis and corrected disturbances in social recognition and interaction, non-social anxiety and spatial memory (<xref ref-type="bibr" rid="B82">Hebert et al., 2014</xref>). In another study, BMS-204352 efficiently reversed the cortical hyperexcitability and increased acoustic startle seen in <italic>FMR1</italic> knockout mice (<xref ref-type="bibr" rid="B32">Carreno-Munoz et al., 2018</xref>), suggesting that this treatment could alleviate sensory hypersensitivity symptoms in FXS patients.</p>
<p>Finally, BK channel openers have been tested to restore impaired habituation associated to some psychiatric disorders. Systemic administration of BMS-204352 greatly attenuated synaptic depression in the sensorimotor neurons of the caudal pontine reticular nucleus in the brain stem, which was associated with enhanced short-term habituation (<xref ref-type="bibr" rid="B244">Zaman et al., 2017</xref>).</p>
</sec>
</sec>
<sec>
<title>Molecular Strategies and Current Challenges to Target K<sub>Ca</sub> Channels in Drug Discovery</title>
<p>Ion channels are expressed at distinct physiological niches in the human body where they mediate diverse functions. Although numerous drugs are available to modulate K<sup>+</sup> channels, currently no K<sub>Ca</sub> modulators are clinically used. One potential reason for this comparative failure in the drug discovery process relates to the fact that the study of channel complexes in physiological conditions is challenging, due to their intricate functional mechanisms. For instance, the diversity of physiological roles fulfilled by BKα channels in neurons is greatly enhanced by coexpression with tissue specific auxiliary β subunits, which confer tissue- and subcellular-specific characteristics to the BK currents determining the action potential shape, firing rate and pharmacology (<xref ref-type="bibr" rid="B98">Jaffe et al., 2011</xref>; <xref ref-type="bibr" rid="B215">Wang et al., 2014</xref>; <xref ref-type="bibr" rid="B225">Whitt et al., 2016</xref>). This otherwise beautiful example of evolutionary complexity imposes an arduous task on the drug designing process, which must specifically target the various subunit compositions. Although some encouraging results may have been obtained in heterologous expression systems, quite often the potential compounds modulating K<sub>Ca</sub> channels are less potent <italic>in vivo</italic>, leading to undesirable side effects. This section reviews some considerations about the existing technical approaches to test the efficiency and efficacy of potential modulators, as well as the use of other structural and genetic approaches to improve targeting of specific K<sub>Ca</sub> channel subunits to particular tissues.</p>
<p>Electrophysiological testing of ion channel function on heterologous expression systems still remains the backbone for functional validation of potential modulators. However, the major downside of both conventional and automated electrophysiology is that throughput efficiency is limited and operational costs are high, so there is a significant need for the development of novel robust, affordable and effective high-throughput screening methods (<xref ref-type="bibr" rid="B162">Picones et al., 2016</xref>). Membrane potential-based drug assays constitute a robust method for assessing the K<sup>+</sup> channel response to numerous drug candidates, although they seem to be subject to a large number of false positives (<xref ref-type="bibr" rid="B187">Solly et al., 2008</xref>). Ion flux assays are useful tools for screening compounds in drug discovery processes (<xref ref-type="bibr" rid="B72">Gill et al., 2003</xref>) including BK channel modulators (<xref ref-type="bibr" rid="B106">Jorgensen et al., 2008</xref>, <xref ref-type="bibr" rid="B105">2013</xref>). This approach utilizes thallium or rubidium radioisotopes as K<sup>+</sup> ion substitutes providing sensitive, precise and reproducible results, yet with some limitations related to the radioactivity and toxicity of these ions. A novel and imaginative cell free assay is the liposome flux assay (LFA), where purified K<sup>+</sup> channels are reconstituted into lipid vesicles from which K<sup>+</sup> flux is recorded and optically monitored with a high signal-to-noise ratio. <xref ref-type="bibr" rid="B194">Su et al. (2016)</xref> demonstrated the robustness of this technique by screening a library of 300,000 compounds targetting K<sup>+</sup> ion channels, including BK.</p>
<p>Structural data is an essential tool supporting and complementing the discovery of ion channel-modulating drugs by providing information about drug–protein binding interactions. This knowledge is in turn necessary to improve the potency, efficacy and selectivity of the candidate drug compounds. Until very recently, available SK crystal structures were restricted to the Ca<sup>2+</sup>-gating domains (CaM and CaMBD) (<xref ref-type="bibr" rid="B177">Schumacher et al., 2001</xref>, <xref ref-type="bibr" rid="B176">2004</xref>; <xref ref-type="bibr" rid="B126">Li et al., 2009</xref>; <xref ref-type="bibr" rid="B246">Zhang et al., 2012a</xref>,<xref ref-type="bibr" rid="B247">b</xref>, <xref ref-type="bibr" rid="B249">2013</xref>; <xref ref-type="bibr" rid="B248">Zhang M. et al., 2014</xref>; <xref ref-type="bibr" rid="B151">Nam et al., 2017</xref>), lacking information about the transmembrane domains, therefore making the structure-based drug discovery a complicated task. Based on available structural information, some positive modulators of SK channels including PHU, 1-EBIO and NS309 were proposed to bind to the CaM/CaMBD interface (<xref ref-type="bibr" rid="B193">Strobaek et al., 2004</xref>; <xref ref-type="bibr" rid="B247">Zhang et al., 2012b</xref>, <xref ref-type="bibr" rid="B249">2013</xref>; <xref ref-type="bibr" rid="B147">Morales et al., 2013</xref>; <xref ref-type="bibr" rid="B29">Brown et al., 2017</xref>; <xref ref-type="bibr" rid="B151">Nam et al., 2017</xref>). However, these conclusions are now challenged by the cryo-EM full-length IK-CaM structures only recently unveiled by the MacKinnon laboratory, which redefine the native interface between the CaM N-lobe and the C-terminal end of S6, showing a predominant role of the S4-S5 linker in Ca-CaM mediated channel gating (<xref ref-type="bibr" rid="B124">Lee and MacKinnon, 2018</xref>). Previous considerations should be revisited in light of these novel findings, which undoubtedly set an unprecedented ground for SK channels drug discovery. These new IK structures appear barely 1 year after the cryo-EM structures of the full-length BK channel in the open and closed states was obtained (<xref ref-type="bibr" rid="B84">Hite et al., 2017</xref>; <xref ref-type="bibr" rid="B202">Tao et al., 2017</xref>), revealing new and interesting insights in the channel structure–function relationships (<xref ref-type="bibr" rid="B73">Giraldez and Rothberg, 2017</xref>; <xref ref-type="bibr" rid="B251">Zhou et al., 2017</xref>; <xref ref-type="bibr" rid="B118">Kshatri et al., 2018</xref>). In this context, other techniques such as patch-clamp fluorometry (<xref ref-type="bibr" rid="B250">Zheng and Zagotta, 2003</xref>; <xref ref-type="bibr" rid="B231">Wulf and Pless, 2018</xref>) have proven to be useful tools to study conformational changes between subunits at the level of the gating ring during activation of functional BK channels (<xref ref-type="bibr" rid="B74">Giraldez et al., 2005</xref>; <xref ref-type="bibr" rid="B144">Miranda et al., 2013</xref>, <xref ref-type="bibr" rid="B145">2016</xref>), and could also be extended to study other members of the K<sub>Ca</sub> subfamily. Altogether, these approaches are revolutionizing our knowledge about how these ion channels can be selectively drug-targeted.</p>
<p>Developing specific rodent disease models based on characterized mutations has become a standard procedure to understanding their physiological relevance. In most cases, these models recapitulate the disease phenotypes and are useful as probing tools to characterize the channel’s cellular and neuronal functions. Furthermore, they might constitute preclinical tools to attain a better understanding of the disease-causing mechanisms, consequently helping to build therapeutic strategies targeting the disease. The development of the CRISPR genome editing technique has facilitated generation of disease models by introducing loss- or gain-of-function mutations, allowing to study the effects of underlying genetic aberrations (<xref ref-type="bibr" rid="B36">Chen S. et al., 2016</xref>).</p>
<p>In addition, taking advantage of novel molecular techniques, new strategies have been developed to target the mutated genes <italic>in vivo</italic>. One example consists on the administration of antisense oligonucleotides to reduce the levels of mutant proteins that could be responsible for the neurodegenerative diseases. In an animal model of ALS caused by a mutation in the SOD1 protein, direct delivery of antisense oligonucleotides significantly slowed disease progression (<xref ref-type="bibr" rid="B185">Smith et al., 2006</xref>). In this context, the CRISPR technique undoubtedly constitutes a promising molecular approach to reverse the alterations in proteins and restore their physiological activity. <xref ref-type="bibr" rid="B40">Cheng et al. (2013)</xref> demonstrated that injection of CRISPR components into mouse zygotes efficiently activated several endogenous genes. The application of these techniques to target K<sub>Ca</sub> channels and associated pathologies needs further exploration.</p>
<p>A strategy that has progressed toward clinical trials is gene-based therapy. The first and only phase I trial using this approach was performed on human patients with erectile dysfunction (ED). Plasmids encoding BK channels were injected directly into the penis corpus cavernosum of patients with ED, rendering positive encouraging results, suggesting that gene therapy represents a valuable treatment for ED (<xref ref-type="bibr" rid="B139">Melman et al., 2006</xref>, <xref ref-type="bibr" rid="B140">2007</xref>) and could be considered for other K<sub>Ca</sub>-related pathologies.</p>
<p>Finally, combination therapies that integrate tissue delivery of genes and drugs has been shown to be a viable approach enhancing drug specificity (<xref ref-type="bibr" rid="B33">Chen J. et al., 2016</xref>). This is especially relevant in the case of BK channels, which are expressed ubiquitously throughout the body, so systemic drug administration often results in off-target effects (<xref ref-type="bibr" rid="B121">Lappin et al., 2005</xref>).</p>
</sec>
<sec>
<title>Conclusion and Future Perspectives</title>
<p>K<sub>Ca</sub> channels are relevant determinants of neuronal excitability and their dysfunction is implicated in many inherited and acquired neurological and psychiatric diseases, thus constituting appealing targets for pharmacological intervention. Over the last few years, the drug discovery field has significantly advanced to identify lead compounds for K<sub>Ca</sub> channel modulators. Available therapeutic strategies to target these channels are challenging due to their diverse physiological roles and tissue distribution, so the design of modulators that recognize tissue-specific subunit combinations is of special relevance. Structural biology has dramatically advanced over the last decade to reveal many ion channel structures with atomic resolution, including the long-awaited structure of the full-length BK channel and of the human IK-CaM complex. Knowledge of genetic- and drug-induced regulation of K<sub>Ca</sub> channels coupled to investigation of their structure–function relationships will facilitate the development of disease-specific treatment strategies.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>AK, AG-H, and TG designed and wrote the manuscript.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> The authors’ work is supported by grants from the Spanish Ministry of Economy and Competitiveness (BFU2015-66490 and RYC-2012-11349 to TG; FPU15/02528 to AG-H) and the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Program (Grant Agreement 648936 to TG).</p>
</fn>
</fn-group>
<ack>
<p>We thank Ricardo Gomez-Garcia, David Bartolome-Martin, Diego Alvarez de la Rosa, and Tomas Gonzalez-Hernandez for useful comments on the manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>P. R.</given-names></name><name><surname>Constanti</surname><given-names>A.</given-names></name><name><surname>Brown</surname><given-names>D. A.</given-names></name><name><surname>Clark</surname><given-names>R. B.</given-names></name></person-group> (<year>1982</year>). <article-title>Intracellular Ca<sup>2+</sup> activates a fast voltage-sensitive K<sup>+</sup> current in vertebrate sympathetic neurones.</article-title>
<source/><italic>Nature</italic>
<volume>296</volume>
<fpage>746</fpage>–<lpage>749</lpage>. <pub-id pub-id-type="doi">10.1038/296746a0</pub-id><pub-id pub-id-type="pmid">6280066</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adelman</surname><given-names>J. P.</given-names></name></person-group> (<year>2016</year>). <article-title>SK channels and calmodulin.</article-title>
<source/><italic>Channels (Austin)</italic>
<volume>10</volume>
<fpage>1</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1080/19336950.2015.1029688</pub-id>
<pub-id pub-id-type="pmid">25942650</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adelman</surname><given-names>J. P.</given-names></name><name><surname>Maylie</surname><given-names>J.</given-names></name><name><surname>Sah</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Small-conductance Ca2+-activated K<sup>+</sup> channels: form and function.</article-title>
<source/><italic>Annu. Rev. Physiol.</italic>
<volume>74</volume>
<fpage>245</fpage>–<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-physiol-020911-153336</pub-id>
<pub-id pub-id-type="pmid">21942705</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adelman</surname><given-names>J. P.</given-names></name><name><surname>Shen</surname><given-names>K. Z.</given-names></name><name><surname>Kavanaugh</surname><given-names>M. P.</given-names></name><name><surname>Warren</surname><given-names>R. A.</given-names></name><name><surname>Wu</surname><given-names>Y. N.</given-names></name><name><surname>Lagrutta</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>1992</year>). <article-title>Calcium-activated potassium channels expressed from cloned complementary DNAs.</article-title>
<source/><italic>Neuron</italic>
<volume>9</volume>
<fpage>209</fpage>–<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(92)90160-F</pub-id>
<pub-id pub-id-type="pmid">1497890</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>M. A.</given-names></name><name><surname>Darwish</surname><given-names>E. S.</given-names></name><name><surname>Khedr</surname><given-names>E. M.</given-names></name><name><surname>El Serogy</surname><given-names>Y. M.</given-names></name><name><surname>Ali</surname><given-names>A. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer’s dementia.</article-title>
<source/><italic>J. Neurol.</italic>
<volume>259</volume>
<fpage>83</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-011-6128-4</pub-id>
<pub-id pub-id-type="pmid">21671144</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>D.</given-names></name><name><surname>Nakayama</surname><given-names>S.</given-names></name><name><surname>Kuroiwa</surname><given-names>M.</given-names></name><name><surname>Nakano</surname><given-names>T.</given-names></name><name><surname>Palmateer</surname><given-names>J.</given-names></name><name><surname>Kosaka</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>SK2 channels are neuroprotective for ischemia-induced neuronal cell death.</article-title>
<source/><italic>J. Cereb. Blood Flow Metab.</italic>
<volume>31</volume>
<fpage>2302</fpage>–<lpage>2312</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2011.90</pub-id>
<pub-id pub-id-type="pmid">21712833</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez-Fischer</surname><given-names>D.</given-names></name><name><surname>Noelker</surname><given-names>C.</given-names></name><name><surname>Vulinovic</surname><given-names>F.</given-names></name><name><surname>Grunewald</surname><given-names>A.</given-names></name><name><surname>Chevarin</surname><given-names>C.</given-names></name><name><surname>Klein</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse model.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e61700</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0061700</pub-id>
<pub-id pub-id-type="pmid">23637888</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvina</surname><given-names>K.</given-names></name><name><surname>Khodakhah</surname><given-names>K.</given-names></name></person-group> (<year>2010</year>). <article-title>KCa channels as therapeutic targets in episodic ataxia type-2.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>30</volume>
<fpage>7249</fpage>–<lpage>7257</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6341-09.2010</pub-id>
<pub-id pub-id-type="pmid">20505091</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>N.J.</given-names></name><name><surname>Slough</surname><given-names>S.</given-names></name><name><surname>Watson</surname><given-names>W.P.</given-names></name></person-group> (<year>2006</year>). <article-title>In vivo characterisation of the small-conductance KCa (SK) channel activator 1-ethyl-2-benzimidazolinone (1-EBIO) as a potential anticonvulsant.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>546</volume>
<fpage>48</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2006.07.007</pub-id>
<pub-id pub-id-type="pmid">16925994</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ataga</surname><given-names>K. I.</given-names></name><name><surname>Smith</surname><given-names>W. R.</given-names></name><name><surname>De Castro</surname><given-names>L. M.</given-names></name><name><surname>Swerdlow</surname><given-names>P.</given-names></name><name><surname>Saunthararajah</surname><given-names>Y.</given-names></name><name><surname>Castro</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Efficacy and safety of the gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia.</article-title>
<source/><italic>Blood</italic>
<volume>111</volume>
<fpage>3991</fpage>–<lpage>3997</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2007-08-110098</pub-id>
<pub-id pub-id-type="pmid">18192510</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkinson</surname><given-names>N. S.</given-names></name><name><surname>Robertson</surname><given-names>G. A.</given-names></name><name><surname>Ganetzky</surname><given-names>B.</given-names></name></person-group> (<year>1991</year>). <article-title>A component of calcium-activated potassium channels encoded by the <italic>Drosophila</italic> slo locus.</article-title>
<source/><italic>Science</italic>
<volume>253</volume>
<fpage>551</fpage>–<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1126/science.1857984</pub-id>
<pub-id pub-id-type="pmid">1857984</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahia</surname><given-names>P. K.</given-names></name><name><surname>Suzuki</surname><given-names>R.</given-names></name><name><surname>Benton</surname><given-names>D. C.</given-names></name><name><surname>Jowett</surname><given-names>A. J.</given-names></name><name><surname>Chen</surname><given-names>M. X.</given-names></name><name><surname>Trezise</surname><given-names>D. J.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>A functional role for small-conductance calcium-activated potassium channels in sensory pathways including nociceptive processes.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>25</volume>
<fpage>3489</fpage>–<lpage>3498</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0597-05.2005</pub-id>
<pub-id pub-id-type="pmid">15814779</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balderas</surname><given-names>E.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Stefani</surname><given-names>E.</given-names></name><name><surname>Toro</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Mitochondrial BKCa channel.</article-title>
<source/><italic>Front. Physiol.</italic>
<volume>6</volume>:<issue>104</issue>
<pub-id pub-id-type="doi">10.3389/fphys.2015.00104</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bednarczyk</surname><given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>Potassium channels in brain mitochondria.</article-title>
<source/><italic>Acta Biochim. Pol.</italic>
<volume>56</volume>
<fpage>385</fpage>–<lpage>392</lpage>.<pub-id pub-id-type="pmid">19759922</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beecham</surname><given-names>G. W.</given-names></name><name><surname>Hamilton</surname><given-names>K.</given-names></name><name><surname>Naj</surname><given-names>A. C.</given-names></name><name><surname>Martin</surname><given-names>E. R.</given-names></name><name><surname>Huentelman</surname><given-names>M.</given-names></name><name><surname>Myers</surname><given-names>A. J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Genome-wide association meta-analysis of neuropathologic features of Alzheimer’s disease and related dementias.</article-title>
<source/><italic>PLoS Genet.</italic>
<volume>10</volume>:<issue>e1004606</issue>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1004606</pub-id>
<pub-id pub-id-type="pmid">25188341</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beecham</surname><given-names>G. W.</given-names></name><name><surname>Martin</surname><given-names>E. R.</given-names></name><name><surname>Li</surname><given-names>Y. J.</given-names></name><name><surname>Slifer</surname><given-names>M. A.</given-names></name><name><surname>Gilbert</surname><given-names>J. R.</given-names></name><name><surname>Haines</surname><given-names>J. L.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>84</volume>
<fpage>35</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2008.12.008</pub-id>
<pub-id pub-id-type="pmid">19118814</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernheimer</surname><given-names>H.</given-names></name><name><surname>Birkmayer</surname><given-names>W.</given-names></name><name><surname>Hornykiewicz</surname><given-names>O.</given-names></name><name><surname>Jellinger</surname><given-names>K.</given-names></name><name><surname>Seitelberger</surname><given-names>F.</given-names></name></person-group> (<year>1973</year>). <article-title>Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.</article-title>
<source/><italic>J. Neurol. Sci.</italic>
<volume>20</volume>
<fpage>415</fpage>–<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1016/0022-510X(73)90175-5</pub-id>
<pub-id pub-id-type="pmid">4272516</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bielefeldt</surname><given-names>K.</given-names></name><name><surname>Jackson</surname><given-names>M. B.</given-names></name></person-group> (<year>1993</year>). <article-title>A calcium-activated potassium channel causes frequency-dependent action-potential failures in a mammalian nerve terminal.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>70</volume>
<fpage>284</fpage>–<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1152/jn.1993.70.1.284</pub-id>
<pub-id pub-id-type="pmid">8395581</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biton</surname><given-names>V.</given-names></name></person-group> (<year>2007</year>). <article-title>Clinical pharmacology and mechanism of action of zonisamide.</article-title>
<source/><italic>Clin. Neuropharmacol.</italic>
<volume>30</volume>
<fpage>230</fpage>–<lpage>240</lpage>.<pub-id pub-id-type="pmid">17762320</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloodgood</surname><given-names>B. L.</given-names></name><name><surname>Sabatini</surname><given-names>B. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Nonlinear regulation of unitary synaptic signals by CaV(2.3) voltage-sensitive calcium channels located in dendritic spines.</article-title>
<source/><italic>Neuron</italic>
<volume>53</volume>
<fpage>249</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2006.12.017</pub-id>
<pub-id pub-id-type="pmid">17224406</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>C. T.</given-names></name><name><surname>Herson</surname><given-names>P. S.</given-names></name><name><surname>Strassmaier</surname><given-names>T.</given-names></name><name><surname>Hammond</surname><given-names>R.</given-names></name><name><surname>Stackman</surname><given-names>R.</given-names></name><name><surname>Maylie</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Small conductance Ca2+-activated K+ channel knock-out mice reveal the identity of calcium-dependent afterhyperpolarization currents.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>24</volume>
<fpage>5301</fpage>–<lpage>5306</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0182-04.2004</pub-id>
<pub-id pub-id-type="pmid">15190101</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouhy</surname><given-names>D.</given-names></name><name><surname>Ghasemlou</surname><given-names>N.</given-names></name><name><surname>Lively</surname><given-names>S.</given-names></name><name><surname>Redensek</surname><given-names>A.</given-names></name><name><surname>Rathore</surname><given-names>K. I.</given-names></name><name><surname>Schlichter</surname><given-names>L. C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Inhibition of the Ca(2)(+)-dependent K(+) channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>16298</fpage>–<lpage>16308</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0047-11.2011</pub-id>
<pub-id pub-id-type="pmid">22072681</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowen</surname><given-names>T.</given-names></name><name><surname>Williams</surname><given-names>N.</given-names></name><name><surname>Norton</surname><given-names>N.</given-names></name><name><surname>Spurlock</surname><given-names>G.</given-names></name><name><surname>Wittekindt</surname><given-names>O. H.</given-names></name><name><surname>Morris-Rosendahl</surname><given-names>D. J.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Mutation screening of the KCNN3 gene reveals a rare frameshift mutation.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>6</volume>
<fpage>259</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4000128</pub-id>
<pub-id pub-id-type="pmid">11326292</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braff</surname><given-names>D. L.</given-names></name><name><surname>Grillon</surname><given-names>C.</given-names></name><name><surname>Geyer</surname><given-names>M. A.</given-names></name></person-group> (<year>1992</year>). <article-title>Gating and habituation of the startle reflex in schizophrenic patients.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>49</volume>
<fpage>206</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.1992.01820030038005</pub-id><pub-id pub-id-type="pmid">1567275</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brager</surname><given-names>D. H.</given-names></name><name><surname>Johnston</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Channelopathies and dendritic dysfunction in fragile X syndrome.</article-title>
<source/><italic>Brain Res. Bull.</italic>
<volume>103</volume>
<fpage>11</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2014.01.002</pub-id>
<pub-id pub-id-type="pmid">24462643</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>Q. H.</given-names></name><name><surname>Vilaythong</surname><given-names>A.</given-names></name><name><surname>Toney</surname><given-names>G. M.</given-names></name><name><surname>Noebels</surname><given-names>J. L.</given-names></name><name><surname>Aldrich</surname><given-names>R. W.</given-names></name></person-group> (<year>2005</year>). <article-title>BK channel beta4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>8</volume>
<fpage>1752</fpage>–<lpage>1759</lpage>. <pub-id pub-id-type="doi">10.1038/nn1573</pub-id>
<pub-id pub-id-type="pmid">16261134</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brisch</surname><given-names>R.</given-names></name><name><surname>Saniotis</surname><given-names>A.</given-names></name><name><surname>Wolf</surname><given-names>R.</given-names></name><name><surname>Bielau</surname><given-names>H.</given-names></name><name><surname>Bernstein</surname><given-names>H. G.</given-names></name><name><surname>Steiner</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.</article-title>
<source/><italic>Front. Psychiatry</italic>
<volume>5</volume>:<issue>47</issue>. <pub-id pub-id-type="doi">10.3389/fpsyt.2014.00047</pub-id>
<pub-id pub-id-type="pmid">24904434</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brischoux</surname><given-names>F.</given-names></name><name><surname>Chakraborty</surname><given-names>S.</given-names></name><name><surname>Brierley</surname><given-names>D. I.</given-names></name><name><surname>Ungless</surname><given-names>M. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>106</volume>
<fpage>4894</fpage>–<lpage>4899</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0811507106</pub-id>
<pub-id pub-id-type="pmid">19261850</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>B. M.</given-names></name><name><surname>Shim</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Yarov-Yarovoy</surname><given-names>V.</given-names></name><name><surname>Wulff</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1-d]oxazol-2-amine (SKA-121).</article-title>
<source/><italic>Mol. Pharmacol.</italic>
<volume>92</volume>
<fpage>469</fpage>–<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1124/mol.117.109421</pub-id>
<pub-id pub-id-type="pmid">28760780</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>D. A.</given-names></name><name><surname>Passmore</surname><given-names>G. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Neural KCNQ (Kv7) channels.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>156</volume>
<fpage>1185</fpage>–<lpage>1195</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2009.00111.x</pub-id>
<pub-id pub-id-type="pmid">19298256</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>A.</given-names></name><name><surname>Tsunoda</surname><given-names>S.</given-names></name><name><surname>Mccobb</surname><given-names>D. P.</given-names></name><name><surname>Wei</surname><given-names>A.</given-names></name><name><surname>Salkoff</surname><given-names>L.</given-names></name></person-group> (<year>1993</year>). <article-title>mSlo, a complex mouse gene encoding “maxi” calcium-activated potassium channels.</article-title>
<source/><italic>Science</italic>
<volume>261</volume>
<fpage>221</fpage>–<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1126/science.7687074</pub-id>
<pub-id pub-id-type="pmid">7687074</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carreno-Munoz</surname><given-names>M. I.</given-names></name><name><surname>Martins</surname><given-names>F.</given-names></name><name><surname>Medrano</surname><given-names>M. C.</given-names></name><name><surname>Aloisi</surname><given-names>E.</given-names></name><name><surname>Pietropaolo</surname><given-names>S.</given-names></name><name><surname>Dechaud</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Potential involvement of impaired BKCa channel function in sensory defensiveness and some behavioral disturbances induced by unfamiliar environment in a mouse model of Fragile × Syndrome.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>43</volume>
<fpage>492</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2017.149</pub-id>
<pub-id pub-id-type="pmid">28722023</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>Z.</given-names></name><name><surname>Tian</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name></person-group> (<year>2016</year>). <article-title>Production and clinical development of nanoparticles for gene delivery.</article-title>
<source/><italic>Mol. Ther. Methods Clin. Dev.</italic>
<volume>3</volume>
<issue>16023</issue>. <pub-id pub-id-type="doi">10.1038/mtm.2016.23</pub-id>
<pub-id pub-id-type="pmid">27088105</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Deltheil</surname><given-names>T.</given-names></name><name><surname>Turle-Lorenzo</surname><given-names>N.</given-names></name><name><surname>Liberge</surname><given-names>M.</given-names></name><name><surname>Rosier</surname><given-names>C.</given-names></name><name><surname>Watabe</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats.</article-title>
<source/><italic>Int. J. Neuropsychopharmacol.</italic>
<volume>17</volume>
<fpage>1295</fpage>–<lpage>1306</lpage>. <pub-id pub-id-type="doi">10.1017/S1461145714000236</pub-id>
<pub-id pub-id-type="pmid">24661728</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Tian</surname><given-names>L.</given-names></name><name><surname>Macdonald</surname><given-names>S. H.</given-names></name><name><surname>Mcclafferty</surname><given-names>H.</given-names></name><name><surname>Hammond</surname><given-names>M. S.</given-names></name><name><surname>Huibant</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Functionally diverse complement of large conductance calcium- and voltage-activated potassium channel (BK) alpha-subunits generated from a single site of splicing.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>280</volume>
<fpage>33599</fpage>–<lpage>33609</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M505383200</pub-id>
<pub-id pub-id-type="pmid">16081418</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Miao</surname><given-names>K.</given-names></name><name><surname>Deng</surname><given-names>C. X.</given-names></name></person-group> (<year>2016</year>). <article-title>CRISPR-Cas9: from genome editing to cancer research.</article-title>
<source/><italic>Int. J. Biol. Sci.</italic>
<volume>12</volume>
<fpage>1427</fpage>–<lpage>1436</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.17421</pub-id>
<pub-id pub-id-type="pmid">27994508</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Xue</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Xie</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Potassium Channels: a potential therapeutic target for parkinson’s disease.</article-title>
<source/><italic>Neurosci. Bull.</italic>
<volume>34</volume>
<fpage>341</fpage>–<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1007/s12264-017-0177-3</pub-id>
<pub-id pub-id-type="pmid">28884460</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y. J.</given-names></name><name><surname>Nguyen</surname><given-names>H. M.</given-names></name><name><surname>Maezawa</surname><given-names>I.</given-names></name><name><surname>Grossinger</surname><given-names>E. M.</given-names></name><name><surname>Garing</surname><given-names>A. L.</given-names></name><name><surname>Kohler</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke.</article-title>
<source/><italic>J. Cereb. Blood Flow Metab.</italic>
<volume>36</volume>
<fpage>2146</fpage>–<lpage>2161</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X15611434</pub-id>
<pub-id pub-id-type="pmid">26661208</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y. J.</given-names></name><name><surname>Raman</surname><given-names>G.</given-names></name><name><surname>Bodendiek</surname><given-names>S.</given-names></name><name><surname>O’donnell</surname><given-names>M. E.</given-names></name><name><surname>Wulff</surname><given-names>H.</given-names></name></person-group> (<year>2011</year>). <article-title>The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke.</article-title>
<source/><italic>J. Cereb. Blood Flow Metab.</italic>
<volume>31</volume>
<fpage>2363</fpage>–<lpage>2374</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2011.101</pub-id>
<pub-id pub-id-type="pmid">21750563</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>A. W.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Katz</surname><given-names>Y.</given-names></name><name><surname>Theunissen</surname><given-names>T. W.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system.</article-title>
<source/><italic>Cell Res.</italic>
<volume>23</volume>
<fpage>1163</fpage>–<lpage>1171</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2013.122</pub-id>
<pub-id pub-id-type="pmid">23979020</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Church</surname><given-names>T. W.</given-names></name><name><surname>Weatherall</surname><given-names>K. L.</given-names></name><name><surname>Correa</surname><given-names>S. A.</given-names></name><name><surname>Prole</surname><given-names>D. L.</given-names></name><name><surname>Brown</surname><given-names>J. T.</given-names></name><name><surname>Marrion</surname><given-names>N. V.</given-names></name></person-group> (<year>2015</year>). <article-title>Preferential assembly of heteromeric small conductance calcium-activated potassium channels.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>41</volume>
<fpage>305</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1111/ejn.12789</pub-id>
<pub-id pub-id-type="pmid">25421315</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contet</surname><given-names>C.</given-names></name><name><surname>Goulding</surname><given-names>S. P.</given-names></name><name><surname>Kuljis</surname><given-names>D. A.</given-names></name><name><surname>Barth</surname><given-names>A. L.</given-names></name></person-group> (<year>2016</year>). <article-title>BK channels in the central nervous system.</article-title>
<source/><italic>Int. Rev. Neurobiol.</italic>
<volume>128</volume>
<fpage>281</fpage>–<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1016/bs.irn.2016.04.001</pub-id>
<pub-id pub-id-type="pmid">27238267</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contractor</surname><given-names>A.</given-names></name><name><surname>Klyachko</surname><given-names>V. A.</given-names></name><name><surname>Portera-Cailliau</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Altered neuronal and circuit excitability in Fragile × Syndrome.</article-title>
<source/><italic>Neuron</italic>
<volume>87</volume>
<fpage>699</fpage>–<lpage>715</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.06.017</pub-id>
<pub-id pub-id-type="pmid">26291156</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>E. C.</given-names></name><name><surname>Jan</surname><given-names>L. Y.</given-names></name></person-group> (<year>1999</year>). <article-title>Ion channel genes and human neurological disease: recent progress, prospects, and challenges.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>96</volume>
<fpage>4759</fpage>–<lpage>4766</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.9.4759</pub-id>
<pub-id pub-id-type="pmid">10220366</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cotelli</surname><given-names>M.</given-names></name><name><surname>Manenti</surname><given-names>R.</given-names></name><name><surname>Cappa</surname><given-names>S. F.</given-names></name><name><surname>Geroldi</surname><given-names>C.</given-names></name><name><surname>Zanetti</surname><given-names>O.</given-names></name><name><surname>Rossini</surname><given-names>P. M.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Effect of transcranial magnetic stimulation on action naming in patients with Alzheimer disease.</article-title>
<source/><italic>Arch. Neurol.</italic>
<volume>63</volume>
<fpage>1602</fpage>–<lpage>1604</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.63.11.1602</pub-id>
<pub-id pub-id-type="pmid">17101829</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Criado-Marrero</surname><given-names>M.</given-names></name><name><surname>Santini</surname><given-names>E.</given-names></name><name><surname>Porter</surname><given-names>J. T.</given-names></name></person-group> (<year>2014</year>). <article-title>Modulating fear extinction memory by manipulating SK potassium channels in the infralimbic cortex.</article-title>
<source/><italic>Front. Behav. Neurosci.</italic>
<volume>8</volume>:<issue>96</issue>. <pub-id pub-id-type="doi">10.3389/fnbeh.2014.00096</pub-id>
<pub-id pub-id-type="pmid">24715857</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>P. Y.</given-names></name><name><surname>Rotman</surname><given-names>Z.</given-names></name><name><surname>Blundon</surname><given-names>J. A.</given-names></name><name><surname>Cho</surname><given-names>Y.</given-names></name><name><surname>Cui</surname><given-names>J.</given-names></name><name><surname>Cavalli</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels.</article-title>
<source/><italic>Neuron</italic>
<volume>77</volume>
<fpage>696</fpage>–<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.12.018</pub-id>
<pub-id pub-id-type="pmid">23439122</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deschaux</surname><given-names>O.</given-names></name><name><surname>Bizot</surname><given-names>J. C.</given-names></name><name><surname>Goyffon</surname><given-names>M.</given-names></name></person-group> (<year>1997</year>). <article-title>Apamin improves learning in an object recognition task in rats.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>222</volume>
<fpage>159</fpage>–<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1016/S0304-3940(97)13367-5</pub-id>
<pub-id pub-id-type="pmid">9148239</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di</surname><given-names>L.</given-names></name><name><surname>Srivastava</surname><given-names>S.</given-names></name><name><surname>Zhdanova</surname><given-names>O.</given-names></name><name><surname>Ding</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Wulff</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Inhibition of the K<sup>+</sup> channel KCa3.1 ameliorates T cell-mediated colitis.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>107</volume>
<fpage>1541</fpage>–<lpage>1546</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0910133107</pub-id>
<pub-id pub-id-type="pmid">20080610</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz</surname><given-names>L.</given-names></name><name><surname>Meera</surname><given-names>P.</given-names></name><name><surname>Amigo</surname><given-names>J.</given-names></name><name><surname>Stefani</surname><given-names>E.</given-names></name><name><surname>Alvarez</surname><given-names>O.</given-names></name><name><surname>Toro</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Role of the S4 segment in a voltage-dependent calcium-sensitive potassium (hSlo) channel.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>273</volume>
<fpage>32430</fpage>–<lpage>32436</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.273.49.32430</pub-id>
<pub-id pub-id-type="pmid">9829973</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diez-Sampedro</surname><given-names>A.</given-names></name><name><surname>Silverman</surname><given-names>W. R.</given-names></name><name><surname>Bautista</surname><given-names>J. F.</given-names></name><name><surname>Richerson</surname><given-names>G. B.</given-names></name></person-group> (<year>2006</year>). <article-title>Mechanism of increased open probability by a mutation of the BK channel.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>96</volume>
<fpage>1507</fpage>–<lpage>1516</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00461.2006</pub-id>
<pub-id pub-id-type="pmid">16738211</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimitriadi</surname><given-names>M.</given-names></name><name><surname>Kye</surname><given-names>M. J.</given-names></name><name><surname>Kalloo</surname><given-names>G.</given-names></name><name><surname>Yersak</surname><given-names>J. M.</given-names></name><name><surname>Sahin</surname><given-names>M.</given-names></name><name><surname>Hart</surname><given-names>A. C.</given-names></name></person-group> (<year>2013</year>). <article-title>The neuroprotective drug riluzole acts via small conductance Ca2+-activated K+ channels to ameliorate defects in spinal muscular atrophy models.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>33</volume>
<fpage>6557</fpage>–<lpage>6562</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1536-12.2013</pub-id>
<pub-id pub-id-type="pmid">23575853</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolga</surname><given-names>A. M.</given-names></name><name><surname>Culmsee</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Protective roles for potassium SK/K(Ca)2 channels in microglia and Neurons.</article-title>
<source/><italic>Front. Pharmacol.</italic>
<volume>3</volume>:<issue>196</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2012.00196</pub-id>
<pub-id pub-id-type="pmid">23189056</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolga</surname><given-names>A. M.</given-names></name><name><surname>De Andrade</surname><given-names>A.</given-names></name><name><surname>Meissner</surname><given-names>L.</given-names></name><name><surname>Knaus</surname><given-names>H. G.</given-names></name><name><surname>Hollerhage</surname><given-names>M.</given-names></name><name><surname>Christophersen</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Subcellular expression and neuroprotective effects of SK channels in human dopaminergic neurons.</article-title>
<source/><italic>Cell Death Dis.</italic>
<volume>5</volume>:<issue>e999</issue>. <pub-id pub-id-type="doi">10.1038/cddis.2013.530</pub-id>
<pub-id pub-id-type="pmid">24434522</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolga</surname><given-names>A. M.</given-names></name><name><surname>Netter</surname><given-names>M. F.</given-names></name><name><surname>Perocchi</surname><given-names>F.</given-names></name><name><surname>Doti</surname><given-names>N.</given-names></name><name><surname>Meissner</surname><given-names>L.</given-names></name><name><surname>Tobaben</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Mitochondrial small conductance SK2 channels prevent glutamate-induced oxytosis and mitochondrial dysfunction.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>288</volume>
<fpage>10792</fpage>–<lpage>10804</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.453522</pub-id>
<pub-id pub-id-type="pmid">23430260</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doo</surname><given-names>A. R.</given-names></name><name><surname>Kim</surname><given-names>S. T.</given-names></name><name><surname>Kim</surname><given-names>S. N.</given-names></name><name><surname>Moon</surname><given-names>W.</given-names></name><name><surname>Yin</surname><given-names>C. S.</given-names></name><name><surname>Chae</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson’s disease.</article-title>
<source/><italic>Neurol. Res.</italic>
<volume>32 (Suppl 1)</volume>, <fpage>88</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1179/016164109X12537002794282</pub-id>
<pub-id pub-id-type="pmid">20034453</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>W.</given-names></name><name><surname>Bautista</surname><given-names>J. F.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Diez-Sampedro</surname><given-names>A.</given-names></name><name><surname>You</surname><given-names>S. A.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>37</volume>
<fpage>733</fpage>–<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1038/ng1585</pub-id>
<pub-id pub-id-type="pmid">15937479</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duda</surname><given-names>J.</given-names></name><name><surname>Potschke</surname><given-names>C.</given-names></name><name><surname>Liss</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson’s disease.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>139(Suppl 1)</volume>, <fpage>156</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13572</pub-id>
<pub-id pub-id-type="pmid">26865375</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durr</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond.</article-title>
<source/><italic>Lancet Neurol.</italic>
<volume>9</volume>
<fpage>885</fpage>–<lpage>894</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(10)70183-6</pub-id>
<pub-id pub-id-type="pmid">20723845</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engbers</surname><given-names>J. D.</given-names></name><name><surname>Anderson</surname><given-names>D.</given-names></name><name><surname>Zamponi</surname><given-names>G. W.</given-names></name><name><surname>Turner</surname><given-names>R. W.</given-names></name></person-group> (<year>2013</year>). <article-title>Signal processing by T-type calcium channel interactions in the cerebellum.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>7</volume>:<issue>230</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2013.00230</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faber</surname><given-names>E. S.</given-names></name></person-group> (<year>2009</year>). <article-title>Functions and modulation of neuronal SK channels.</article-title>
<source/><italic>Cell Biochem. Biophys.</italic>
<volume>55</volume>
<fpage>127</fpage>–<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1007/s12013-009-9062-7</pub-id>
<pub-id pub-id-type="pmid">19655101</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faber</surname><given-names>E. S.</given-names></name><name><surname>Sah</surname><given-names>P.</given-names></name></person-group> (<year>2002</year>). <article-title>Physiological role of calcium-activated potassium currents in the rat lateral amygdala.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>22</volume>
<fpage>1618</fpage>–<lpage>1628</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-05-01618.2002</pub-id>
<pub-id pub-id-type="pmid">11880492</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faber</surname><given-names>E. S.</given-names></name><name><surname>Delaney</surname><given-names>A. J.</given-names></name><name><surname>Sah</surname><given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>SK channels regulate excitatory synaptic transmission and plasticity in the lateral amygdala.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>8</volume>
<fpage>635</fpage>–<lpage>641</lpage>. <pub-id pub-id-type="doi">10.1038/nn1450</pub-id>
<pub-id pub-id-type="pmid">15852010</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanger</surname><given-names>C. M.</given-names></name><name><surname>Ghanshani</surname><given-names>S.</given-names></name><name><surname>Logsdon</surname><given-names>N. J.</given-names></name><name><surname>Rauer</surname><given-names>H.</given-names></name><name><surname>Kalman</surname><given-names>K.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa Channel, IKCa1.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>274</volume>
<fpage>5746</fpage>–<lpage>5754</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.274.9.5746</pub-id>
<pub-id pub-id-type="pmid">10026195</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fay</surname><given-names>A. J.</given-names></name><name><surname>Qian</surname><given-names>X.</given-names></name><name><surname>Jan</surname><given-names>Y. N.</given-names></name><name><surname>Jan</surname><given-names>L. Y.</given-names></name></person-group> (<year>2006</year>). <article-title>SK channels mediate NADPH oxidase-independent reactive oxygen species production and apoptosis in granulocytes.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>17548</fpage>–<lpage>17553</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0607914103</pub-id>
<pub-id pub-id-type="pmid">17085590</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feetham</surname><given-names>C. H.</given-names></name><name><surname>Nunn</surname><given-names>N.</given-names></name><name><surname>Lewis</surname><given-names>R.</given-names></name><name><surname>Dart</surname><given-names>C.</given-names></name><name><surname>Barrett-Jolley</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>TRPV4 and K(Ca) ion channels functionally couple as osmosensors in the paraventricular nucleus.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>172</volume>
<fpage>1753</fpage>–<lpage>1768</lpage>. <pub-id pub-id-type="doi">10.1111/bph.13023</pub-id>
<pub-id pub-id-type="pmid">25421636</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Fernandez</surname><given-names>J. M.</given-names></name><name><surname>Tomas</surname><given-names>M.</given-names></name><name><surname>Vazquez</surname><given-names>E.</given-names></name><name><surname>Orio</surname><given-names>P.</given-names></name><name><surname>Latorre</surname><given-names>R.</given-names></name><name><surname>Senti</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Gain-of-function mutation in the KCNMB1 potassium channel subunit is associated with low prevalence of diastolic hypertension.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>113</volume>
<fpage>1032</fpage>–<lpage>1039</lpage>. <pub-id pub-id-type="doi">10.1172/JCI200420347</pub-id>
<pub-id pub-id-type="pmid">15057310</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filosa</surname><given-names>J. A.</given-names></name><name><surname>Bonev</surname><given-names>A. D.</given-names></name><name><surname>Straub</surname><given-names>S. V.</given-names></name><name><surname>Meredith</surname><given-names>A. L.</given-names></name><name><surname>Wilkerson</surname><given-names>M. K.</given-names></name><name><surname>Aldrich</surname><given-names>R. W.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Local potassium signaling couples neuronal activity to vasodilation in the brain.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>9</volume>
<fpage>1397</fpage>–<lpage>1403</lpage>. <pub-id pub-id-type="doi">10.1038/nn1779</pub-id>
<pub-id pub-id-type="pmid">17013381</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furness</surname><given-names>J. B.</given-names></name><name><surname>Kearney</surname><given-names>K.</given-names></name><name><surname>Robbins</surname><given-names>H. L.</given-names></name><name><surname>Hunne</surname><given-names>B.</given-names></name><name><surname>Selmer</surname><given-names>I. S.</given-names></name><name><surname>Neylon</surname><given-names>C. B.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Intermediate conductance potassium (IK) channels occur in human enteric neurons.</article-title>
<source/><italic>Auton. Neurosci.</italic>
<volume>112</volume>
<fpage>93</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.autneu.2004.02.003</pub-id>
<pub-id pub-id-type="pmid">15233935</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardos</surname><given-names>G.</given-names></name></person-group> (<year>1958</year>). <article-title>The function of calcium in the potassium permeability of human erythrocytes.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>30</volume>
<fpage>653</fpage>–<lpage>654</lpage>. <pub-id pub-id-type="doi">10.1016/0006-3002(58)90124-0</pub-id><pub-id pub-id-type="pmid">13618284</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghezzi</surname><given-names>A.</given-names></name><name><surname>Krishnan</surname><given-names>H. R.</given-names></name><name><surname>Atkinson</surname><given-names>N. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Susceptibility to ethanol withdrawal seizures is produced by BK channel gene expression.</article-title>
<source/><italic>Addict. Biol.</italic>
<volume>19</volume>
<fpage>332</fpage>–<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1111/j.1369-1600.2012.00465.x</pub-id>
<pub-id pub-id-type="pmid">22734584</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>S.</given-names></name><name><surname>Gill</surname><given-names>R.</given-names></name><name><surname>Lee</surname><given-names>S. S.</given-names></name><name><surname>Hesketh</surname><given-names>J. C.</given-names></name><name><surname>Fedida</surname><given-names>D.</given-names></name><name><surname>Rezazadeh</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Flux assays in high throughput screening of ion channels in drug discovery.</article-title>
<source/><italic>Assay Drug Dev. Technol.</italic>
<volume>1</volume>
<fpage>709</fpage>–<lpage>717</lpage>. <pub-id pub-id-type="doi">10.1089/154065803770381066</pub-id>
<pub-id pub-id-type="pmid">15090243</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giraldez</surname><given-names>T.</given-names></name><name><surname>Rothberg</surname><given-names>B. S.</given-names></name></person-group> (<year>2017</year>). <article-title>Understanding the conformational motions of RCK gating rings.</article-title>
<source/><italic>J. Gen. Physiol.</italic>
<volume>149</volume>
<fpage>431</fpage>–<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201611726</pub-id>
<pub-id pub-id-type="pmid">28246116</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giraldez</surname><given-names>T.</given-names></name><name><surname>Hughes</surname><given-names>T. E.</given-names></name><name><surname>Sigworth</surname><given-names>F. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Generation of functional fluorescent BK channels by random insertion of GFP variants.</article-title>
<source/><italic>J. Gen. Physiol.</italic>
<volume>126</volume>
<fpage>429</fpage>–<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.200509368</pub-id>
<pub-id pub-id-type="pmid">16260837</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girouard</surname><given-names>H.</given-names></name><name><surname>Bonev</surname><given-names>A. D.</given-names></name><name><surname>Hannah</surname><given-names>R. M.</given-names></name><name><surname>Meredith</surname><given-names>A.</given-names></name><name><surname>Aldrich</surname><given-names>R. W.</given-names></name><name><surname>Nelson</surname><given-names>M. T.</given-names></name></person-group> (<year>2010</year>). <article-title>Astrocytic endfoot Ca2+ and BK channels determine both arteriolar dilation and constriction.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>107</volume>
<fpage>3811</fpage>–<lpage>3816</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0914722107</pub-id>
<pub-id pub-id-type="pmid">20133576</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grace</surname><given-names>A. A.</given-names></name></person-group> (<year>1991</year>). <article-title>Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.</article-title>
<source/><italic>Neuroscience</italic>
<volume>41</volume>
<fpage>1</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(91)90196-U</pub-id>
<pub-id pub-id-type="pmid">1676137</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grunnet</surname><given-names>M.</given-names></name><name><surname>Kaufmann</surname><given-names>W. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Coassembly of big conductance Ca2+-activated K+ channels and L-type voltage-gated Ca2+ channels in rat brain.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>279</volume>
<fpage>36445</fpage>–<lpage>36453</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M402254200</pub-id>
<pub-id pub-id-type="pmid">15210719</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>N.</given-names></name><name><surname>Vervaeke</surname><given-names>K.</given-names></name><name><surname>Storm</surname><given-names>J. F.</given-names></name></person-group> (<year>2007</year>). <article-title>BK potassium channels facilitate high-frequency firing and cause early spike frequency adaptation in rat CA1 hippocampal pyramidal cells.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>580</volume>
<fpage>859</fpage>–<lpage>882</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2006.126367</pub-id>
<pub-id pub-id-type="pmid">17303637</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>N.</given-names></name><name><surname>Vervaeke</surname><given-names>K.</given-names></name><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Storm</surname><given-names>J. F.</given-names></name></person-group> (<year>2005</year>). <article-title>Kv7/KCNQ/M and HCN/h, but not KCa2/SK channels, contribute to the somatic medium after-hyperpolarization and excitability control in CA1 hippocampal pyramidal cells.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>566</volume>
<fpage>689</fpage>–<lpage>715</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2005.086835</pub-id>
<pub-id pub-id-type="pmid">15890705</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gueguinou</surname><given-names>M.</given-names></name><name><surname>Chantome</surname><given-names>A.</given-names></name><name><surname>Fromont</surname><given-names>G.</given-names></name><name><surname>Bougnoux</surname><given-names>P.</given-names></name><name><surname>Vandier</surname><given-names>C.</given-names></name><name><surname>Potier-Cartereau</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>KCa and Ca(2+) channels: the complex thought.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1843</volume>
<fpage>2322</fpage>–<lpage>2333</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2014.02.019</pub-id>
<pub-id pub-id-type="pmid">24613282</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannigan</surname><given-names>K. I.</given-names></name><name><surname>Griffin</surname><given-names>C. S.</given-names></name><name><surname>Large</surname><given-names>R. J.</given-names></name><name><surname>Sergeant</surname><given-names>G. P.</given-names></name><name><surname>Hollywood</surname><given-names>M. A.</given-names></name><name><surname>Mchale</surname><given-names>N. G.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The role of Ca(2+)-activated Cl(–) current in tone generation in the rabbit corpus cavernosum.</article-title>
<source/><italic>Am. J. Physiol. Cell Physiol.</italic>
<volume>313</volume>
<volume>C475-C486</volume>. <pub-id pub-id-type="doi">10.1152/ajpcell.00025.2017</pub-id>
<pub-id pub-id-type="pmid">28835432</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hebert</surname><given-names>B.</given-names></name><name><surname>Pietropaolo</surname><given-names>S.</given-names></name><name><surname>Meme</surname><given-names>S.</given-names></name><name><surname>Laudier</surname><given-names>B.</given-names></name><name><surname>Laugeray</surname><given-names>A.</given-names></name><name><surname>Doisne</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by a BKCa channel opener molecule.</article-title>
<source/><italic>Orphanet. J. Rare Dis.</italic>
<volume>9</volume>
<issue>124</issue>. <pub-id pub-id-type="doi">10.1186/s13023-014-0124-6</pub-id>
<pub-id pub-id-type="pmid">25079250</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirschberg</surname><given-names>B.</given-names></name><name><surname>Maylie</surname><given-names>J.</given-names></name><name><surname>Adelman</surname><given-names>J. P.</given-names></name><name><surname>Marrion</surname><given-names>N. V.</given-names></name></person-group> (<year>1999</year>). <article-title>Gating Properties of single SK channels in hippocampal CA1 pyramidal neurons.</article-title>
<source/><italic>Biophys. J.</italic>
<volume>77</volume>
<fpage>1905</fpage>–<lpage>1913</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3495(99)77032-3</pub-id>
<pub-id pub-id-type="pmid">10512811</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hite</surname><given-names>R. K.</given-names></name><name><surname>Tao</surname><given-names>X.</given-names></name><name><surname>Mackinnon</surname><given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Structural basis for gating the high-conductance Ca2<sup>+</sup>-activated K<sup>+</sup> channel.</article-title>
<source/><italic>Nature</italic>
<volume>541</volume>
<fpage>52</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1038/nature20775</pub-id>
<pub-id pub-id-type="pmid">27974801</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honrath</surname><given-names>B.</given-names></name><name><surname>Matschke</surname><given-names>L.</given-names></name><name><surname>Meyer</surname><given-names>T.</given-names></name><name><surname>Magerhans</surname><given-names>L.</given-names></name><name><surname>Perocchi</surname><given-names>F.</given-names></name><name><surname>Ganjam</surname><given-names>G. K.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>SK2 channels regulate mitochondrial respiration and mitochondrial Ca(2+) uptake.</article-title>
<source/><italic>Cell Death Differ.</italic>
<volume>24</volume>
<fpage>761</fpage>–<lpage>773</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2017.2</pub-id>
<pub-id pub-id-type="pmid">28282037</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horrigan</surname><given-names>F. T.</given-names></name><name><surname>Aldrich</surname><given-names>R. W.</given-names></name></person-group> (<year>2002</year>). <article-title>Coupling between voltage sensor activation, Ca<sup>2+</sup> Binding and channel opening in large conductance (BK) potassium channels.</article-title>
<source/><italic>J. Gen. Physiol.</italic>
<volume>120</volume>
<fpage>267</fpage>–<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.20028605</pub-id><pub-id pub-id-type="pmid">12198087</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoshi</surname><given-names>T.</given-names></name><name><surname>Pantazis</surname><given-names>A.</given-names></name><name><surname>Olcese</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Transduction of voltage and Ca<sup>2+</sup> signals by Slo1 BK channels.</article-title>
<source/><italic>Physiology (Bethesda)</italic>
<volume>28</volume>
<fpage>172</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1152/physiol.00055.2012</pub-id>
<pub-id pub-id-type="pmid">23636263</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howarth</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>The contribution of astrocytes to the regulation of cerebral blood flow.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>8</volume>:<issue>103</issue>
<pub-id pub-id-type="doi">10.3389/fnins.2014.00103</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Shao</surname><given-names>L. R.</given-names></name><name><surname>Chavoshy</surname><given-names>S.</given-names></name><name><surname>Gu</surname><given-names>N.</given-names></name><name><surname>Trieb</surname><given-names>M.</given-names></name><name><surname>Behrens</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Presynaptic Ca<sup>2+</sup>-activated K<sup>+</sup> channels in glutamatergic hippocampal terminals and their role in spike repolarization and regulation of transmitter release.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>21</volume>
<fpage>9585</fpage>–<lpage>9597</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-24-09585.2001</pub-id><pub-id pub-id-type="pmid">11739569</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>S.</given-names></name><name><surname>Labuda</surname><given-names>M. Z.</given-names></name><name><surname>Pandolfo</surname><given-names>M.</given-names></name><name><surname>Goss</surname><given-names>G. G.</given-names></name><name><surname>Mcdermid</surname><given-names>H. E.</given-names></name><name><surname>Ali</surname><given-names>D. W.</given-names></name></person-group> (<year>2003</year>). <article-title>Variants of the KCNMB3 regulatory subunit of maxi BK channels affect channel inactivation.</article-title>
<source/><italic>Physiol. Genom.</italic>
<volume>15</volume>
<fpage>191</fpage>–<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1152/physiolgenomics.00110.2003</pub-id>
<pub-id pub-id-type="pmid">14612589</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C. W.</given-names></name><name><surname>Huang</surname><given-names>C. C.</given-names></name><name><surname>Wu</surname><given-names>S. N.</given-names></name></person-group> (<year>2007</year>). <article-title>Activation by zonisamide, a newer antiepileptic drug, of large-conductance calcium-activated potassium channel in differentiated hippocampal neuron-derived H19-7 cells.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>321</volume>
<fpage>98</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.106.116954</pub-id>
<pub-id pub-id-type="pmid">17255467</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inan</surname><given-names>S. Y.</given-names></name><name><surname>Aksu</surname><given-names>F.</given-names></name><name><surname>Baysal</surname><given-names>F.</given-names></name></person-group> (<year>2000</year>). <article-title>The effects of some K(+) channel blockers on scopolamine- or electroconvulsive shock-induced amnesia in mice.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>407</volume>
<fpage>159</fpage>–<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-2999(00)00736-6</pub-id><pub-id pub-id-type="pmid">11050303</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Indriati</surname><given-names>D. W.</given-names></name><name><surname>Kamasawa</surname><given-names>N.</given-names></name><name><surname>Matsui</surname><given-names>K.</given-names></name><name><surname>Meredith</surname><given-names>A. L.</given-names></name><name><surname>Watanabe</surname><given-names>M.</given-names></name><name><surname>Shigemoto</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Quantitative localization of Cav2.1 (P/Q-type) voltage-dependent calcium channels in Purkinje cells: somatodendritic gradient and distinct somatic coclustering with calcium-activated potassium channels.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>33</volume>
<fpage>3668</fpage>–<lpage>3678</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2921-12.2013</pub-id>
<pub-id pub-id-type="pmid">23426693</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaacson</surname><given-names>J. S.</given-names></name><name><surname>Murphy</surname><given-names>G. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Glutamate-mediated extrasynaptic inhibition: direct coupling of NMDA receptors to Ca(2<sup>+</sup>)-activated K<sup>+</sup> channels.</article-title>
<source/><italic>Neuron</italic>
<volume>31</volume>
<fpage>1027</fpage>–<lpage>1034</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(01)00428-7</pub-id><pub-id pub-id-type="pmid">11580901</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>T. M.</given-names></name><name><surname>Maylie</surname><given-names>J.</given-names></name><name><surname>Adelman</surname><given-names>J. P.</given-names></name></person-group> (<year>1997a</year>). <article-title>Determinants of apamin and d-tubocurarine block in SK potassium channels.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>272</volume>
<fpage>23195</fpage>–<lpage>23200</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.272.37.23195</pub-id>
<pub-id pub-id-type="pmid">9287325</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>T. M.</given-names></name><name><surname>Silvia</surname><given-names>C.</given-names></name><name><surname>Hirschberg</surname><given-names>B.</given-names></name><name><surname>Bond</surname><given-names>C. T.</given-names></name><name><surname>Adelman</surname><given-names>J. P.</given-names></name><name><surname>Maylie</surname><given-names>J.</given-names></name></person-group> (<year>1997b</year>). <article-title>A human intermediate conductance calcium-activated potassium channel.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>94</volume>
<fpage>11651</fpage>–<lpage>11656</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.21.11651</pub-id><pub-id pub-id-type="pmid">9326665</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>M.</given-names></name></person-group> (<year>2002</year>). <article-title>Historical review of the significance of the cerebellum and the role of Purkinje cells in motor learning.</article-title>
<source/><italic>Ann. N. Y. Acad. Sci.</italic>
<volume>978</volume>
<fpage>273</fpage>–<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2002.tb07574.x</pub-id>
<pub-id pub-id-type="pmid">12582060</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaffe</surname><given-names>D. B.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Brenner</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Shaping of action potentials by type I and type II large-conductance Ca(2)+-activated K+ channels.</article-title>
<source/><italic>Neuroscience</italic>
<volume>192</volume>
<fpage>205</fpage>–<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.06.028</pub-id>
<pub-id pub-id-type="pmid">21723921</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javaherian</surname><given-names>A. D.</given-names></name><name><surname>Yusifov</surname><given-names>T.</given-names></name><name><surname>Pantazis</surname><given-names>A.</given-names></name><name><surname>Franklin</surname><given-names>S.</given-names></name><name><surname>Gandhi</surname><given-names>C. S.</given-names></name><name><surname>Olcese</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Metal-driven operation of the human large-conductance voltage- and Ca2+-dependent potassium channel (BK) gating ring apparatus.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>286</volume>
<fpage>20701</fpage>–<lpage>20709</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.235234</pub-id>
<pub-id pub-id-type="pmid">21471215</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>B. S.</given-names></name></person-group> (<year>2002</year>). <article-title>BMS-204352: a potassium channel opener developed for the treatment of stroke.</article-title>
<source/><italic>CNS Drug Rev.</italic>
<volume>8</volume>
<fpage>353</fpage>–<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1111/j.1527-3458.2002.tb00233.x</pub-id><pub-id pub-id-type="pmid">12481191</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>B. S.</given-names></name><name><surname>Strobaek</surname><given-names>D.</given-names></name><name><surname>Christophersen</surname><given-names>P.</given-names></name><name><surname>Jorgensen</surname><given-names>T. D.</given-names></name><name><surname>Hansen</surname><given-names>C.</given-names></name><name><surname>Silahtaroglu</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Characterization of the cloned human intermediate-conductance Ca2+-activated K+ channel.</article-title>
<source/><italic>Am. J. Physiol.</italic>
<volume>275</volume>
<fpage>C848</fpage>–<lpage>C856</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.1998.275.3.C848</pub-id>
<pub-id pub-id-type="pmid">9730970</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>H.</given-names></name><name><surname>Shepard</surname><given-names>P. D.</given-names></name></person-group> (<year>2006</year>). <article-title>SK Ca2+-activated K+ channel ligands alter the firing pattern of dopamine-containing neurons in vivo.</article-title>
<source/><italic>Neuroscience</italic>
<volume>140</volume>
<fpage>623</fpage>–<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2006.02.020</pub-id>
<pub-id pub-id-type="pmid">16564639</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>W.</given-names></name><name><surname>Sugaya</surname><given-names>A.</given-names></name><name><surname>Tsuda</surname><given-names>T.</given-names></name><name><surname>Ohguchi</surname><given-names>H.</given-names></name><name><surname>Sugaya</surname><given-names>E.</given-names></name></person-group> (<year>2000</year>). <article-title>Relationship between large conductance calcium-activated potassium channel and bursting activity.</article-title>
<source/><italic>Brain Res.</italic>
<volume>860</volume>
<fpage>21</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(00)01943-0</pub-id><pub-id pub-id-type="pmid">10727620</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joiner</surname><given-names>W. J.</given-names></name><name><surname>Wang</surname><given-names>L. Y.</given-names></name><name><surname>Tang</surname><given-names>M. D.</given-names></name><name><surname>Kaczmarek</surname><given-names>L. K.</given-names></name></person-group> (<year>1997</year>). <article-title>hSK4, a member of a novel subfamily of calcium-activated potassium channels.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>94</volume>
<fpage>11013</fpage>–<lpage>11018</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.20.11013</pub-id>
<pub-id pub-id-type="pmid">9380751</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jorgensen</surname><given-names>S.</given-names></name><name><surname>Dyhring</surname><given-names>T.</given-names></name><name><surname>Brown</surname><given-names>D. T.</given-names></name><name><surname>Strobaek</surname><given-names>D.</given-names></name><name><surname>Christophersen</surname><given-names>P.</given-names></name><name><surname>Demnitz</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>A high-throughput screening campaign for detection of ca(2+)-activated k(+) channel activators and inhibitors using a fluorometric imaging plate reader-based tl(+)-influx assay.</article-title>
<source/><italic>Assay Drug Dev. Technol.</italic>
<volume>11</volume>
<fpage>163</fpage>–<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1089/adt.2012.479</pub-id>
<pub-id pub-id-type="pmid">23198866</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jorgensen</surname><given-names>S.</given-names></name><name><surname>Johansen</surname><given-names>T. H.</given-names></name><name><surname>Dyhring</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Fluorescence-based Tl(+)-influx assays as a novel approach for characterization of small-conductance Ca(2+)-activated K (+) channel modulators.</article-title>
<source/><italic>Methods Mol. Biol.</italic>
<volume>491</volume>
<fpage>257</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-59745-526-8_20</pub-id>
<pub-id pub-id-type="pmid">18998099</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasumu</surname><given-names>A. W.</given-names></name><name><surname>Hougaard</surname><given-names>C.</given-names></name><name><surname>Rode</surname><given-names>F.</given-names></name><name><surname>Jacobsen</surname><given-names>T. A.</given-names></name><name><surname>Sabatier</surname><given-names>J. M.</given-names></name><name><surname>Eriksen</surname><given-names>B. L.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2.</article-title>
<source/><italic>Chem. Biol.</italic>
<volume>19</volume>
<fpage>1340</fpage>–<lpage>1353</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2012.07.013</pub-id>
<pub-id pub-id-type="pmid">23102227</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasumu</surname><given-names>A.</given-names></name><name><surname>Bezprozvanny</surname><given-names>I.</given-names></name></person-group> (<year>2012</year>). <article-title>Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.</article-title>
<source/><italic>Cerebellum</italic>
<volume>11</volume>
<fpage>630</fpage>–<lpage>639</lpage>. <pub-id pub-id-type="doi">10.1007/s12311-010-0182-9</pub-id>
<pub-id pub-id-type="pmid">20480274</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsuki</surname><given-names>H.</given-names></name><name><surname>Shinohara</surname><given-names>A.</given-names></name><name><surname>Fujimoto</surname><given-names>S.</given-names></name><name><surname>Kume</surname><given-names>T.</given-names></name><name><surname>Akaike</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Tetraethylammonium exacerbates ischemic neuronal injury in rat cerebrocortical slice cultures.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>508</volume>
<fpage>85</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2004.11.058</pub-id>
<pub-id pub-id-type="pmid">15680257</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaushal</surname><given-names>V.</given-names></name><name><surname>Koeberle</surname><given-names>P. D.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Schlichter</surname><given-names>L. C.</given-names></name></person-group> (<year>2007</year>). <article-title>The Ca<sup>2+</sup>-activated K<sup>+</sup> channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>27</volume>
<fpage>234</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3593-06.2007</pub-id><pub-id pub-id-type="pmid">17202491</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. I.</given-names></name><name><surname>Yang</surname><given-names>E. J.</given-names></name><name><surname>Lee</surname><given-names>M. S.</given-names></name><name><surname>Kim</surname><given-names>Y. S.</given-names></name><name><surname>Huh</surname><given-names>Y.</given-names></name><name><surname>Cho</surname><given-names>I. H.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Bee venom reduces neuroinflammation in the MPTP-induced model of Parkinson’s disease.</article-title>
<source/><italic>Int. J. Neurosci.</italic>
<volume>121</volume>
<fpage>209</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.3109/00207454.2010.548613</pub-id>
<pub-id pub-id-type="pmid">21265705</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>B.</given-names></name><name><surname>Rizwan</surname><given-names>A. P.</given-names></name><name><surname>Asmara</surname><given-names>H.</given-names></name><name><surname>Heath</surname><given-names>N. C.</given-names></name><name><surname>Engbers</surname><given-names>J. D.</given-names></name><name><surname>Dykstra</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>IKCa channels are a critical determinant of the slow AHP in CA1 pyramidal neurons.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>11</volume>
<fpage>175</fpage>–<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.03.026</pub-id>
<pub-id pub-id-type="pmid">25865881</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleiman-Weiner</surname><given-names>M.</given-names></name><name><surname>Beenhakker</surname><given-names>M. P.</given-names></name><name><surname>Segal</surname><given-names>W. A.</given-names></name><name><surname>Huguenard</surname><given-names>J. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Synergistic roles of GABAA receptors and SK channels in regulating thalamocortical oscillations.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>102</volume>
<fpage>203</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1152/jn.91158.2008</pub-id>
<pub-id pub-id-type="pmid">19386752</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knaus</surname><given-names>H. G.</given-names></name><name><surname>Schwarzer</surname><given-names>C.</given-names></name><name><surname>Koch</surname><given-names>R. O.</given-names></name><name><surname>Eberhart</surname><given-names>A.</given-names></name><name><surname>Kaczorowski</surname><given-names>G. J.</given-names></name><name><surname>Glossmann</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>1996</year>). <article-title>Distribution of high-conductance Ca(2+)-activated K+ channels in rat brain: targeting to axons and nerve terminals.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>16</volume>
<fpage>955</fpage>–<lpage>963</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-03-00955.1996</pub-id>
<pub-id pub-id-type="pmid">8558264</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Köhler</surname><given-names>M.</given-names></name><name><surname>Hirschberg</surname><given-names>B.</given-names></name><name><surname>Bond</surname><given-names>C. T.</given-names></name><name><surname>Kinzie</surname><given-names>J. M.</given-names></name><name><surname>Marrion</surname><given-names>N. V.</given-names></name><name><surname>Maylie</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>1996</year>). <article-title>Small-conductance, calcium-activated potassium channels from mammalian brain.</article-title>
<source/><italic>Science</italic>
<volume>273</volume>
<fpage>1709</fpage>–<lpage>1714</lpage>. <pub-id pub-id-type="doi">10.1126/science.273.5282.1709</pub-id><pub-id pub-id-type="pmid">8781233</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koot</surname><given-names>B. G.</given-names></name><name><surname>Alders</surname><given-names>M.</given-names></name><name><surname>Verheij</surname><given-names>J.</given-names></name><name><surname>Beuers</surname><given-names>U.</given-names></name><name><surname>Cobben</surname><given-names>J. M.</given-names></name></person-group> (<year>2016</year>). <article-title>A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non-cirrhotic portal hypertension.</article-title>
<source/><italic>J. Hepatol.</italic>
<volume>64</volume>
<fpage>974</fpage>–<lpage>977</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhep.2015.11.027</pub-id>
<pub-id pub-id-type="pmid">26658685</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krabbendam</surname><given-names>I. E.</given-names></name><name><surname>Honrath</surname><given-names>B.</given-names></name><name><surname>Culmsee</surname><given-names>C.</given-names></name><name><surname>Dolga</surname><given-names>A. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Mitochondrial Ca(2+)-activated K(+) channels and their role in cell life and death pathways.</article-title>
<source/><italic>Cell Calcium</italic>
<volume>69</volume>
<fpage>101</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2017.07.005</pub-id>
<pub-id pub-id-type="pmid">28818302</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kshatri</surname><given-names>A. S.</given-names></name><name><surname>Gonzalez-Hernandez</surname><given-names>A. J.</given-names></name><name><surname>Giraldez</surname><given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>Functional validation of Ca(2+)-binding residues from the crystal structure of the BK ion channel.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1860</volume>
<fpage>943</fpage>–<lpage>952</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2017.09.023</pub-id>
<pub-id pub-id-type="pmid">28966112</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulawiak</surname><given-names>B.</given-names></name><name><surname>Kudin</surname><given-names>A. P.</given-names></name><name><surname>Szewczyk</surname><given-names>A.</given-names></name><name><surname>Kunz</surname><given-names>W. S.</given-names></name></person-group> (<year>2008</year>). <article-title>BK channel openers inhibit ROS production of isolated rat brain mitochondria.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>212</volume>
<fpage>543</fpage>–<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2008.05.004</pub-id>
<pub-id pub-id-type="pmid">18572168</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>J.</given-names></name><name><surname>Coleman</surname><given-names>N.</given-names></name><name><surname>Garing</surname><given-names>A. L.</given-names></name><name><surname>Wulff</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>The therapeutic potential of small-conductance KCa2 channels in neurodegenerative and psychiatric diseases.</article-title>
<source/><italic>Expert Opin. Ther. Targets</italic>
<volume>17</volume>
<fpage>1203</fpage>–<lpage>1220</lpage>. <pub-id pub-id-type="doi">10.1517/14728222.2013.823161</pub-id>
<pub-id pub-id-type="pmid">23883298</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lappin</surname><given-names>S. C.</given-names></name><name><surname>Dale</surname><given-names>T. J.</given-names></name><name><surname>Brown</surname><given-names>J. T.</given-names></name><name><surname>Trezise</surname><given-names>D. J.</given-names></name><name><surname>Davies</surname><given-names>C. H.</given-names></name></person-group> (<year>2005</year>). <article-title>Activation of SK channels inhibits epileptiform bursting in hippocampal CA3 neurons.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1065</volume>
<fpage>37</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2005.10.024</pub-id>
<pub-id pub-id-type="pmid">16336949</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Large</surname><given-names>R. J.</given-names></name><name><surname>Kshatri</surname><given-names>A.</given-names></name><name><surname>Webb</surname><given-names>T. I.</given-names></name><name><surname>Roy</surname><given-names>S.</given-names></name><name><surname>Akande</surname><given-names>A.</given-names></name><name><surname>Bradley</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Effects of the novel BK (KCa 1.1) channel opener GoSlo-SR-5-130 are dependent on the presence of BKbeta subunits.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>172</volume>
<fpage>2544</fpage>–<lpage>2556</lpage>. <pub-id pub-id-type="doi">10.1111/bph.13085</pub-id>
<pub-id pub-id-type="pmid">25598230</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latorre</surname><given-names>R.</given-names></name><name><surname>Castillo</surname><given-names>K.</given-names></name><name><surname>Carrasquel-Ursulaez</surname><given-names>W.</given-names></name><name><surname>Sepulveda</surname><given-names>R. V.</given-names></name><name><surname>Gonzalez-Nilo</surname><given-names>F.</given-names></name><name><surname>Gonzalez</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Molecular determinants of BK channel functional diversity and functioning.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>97</volume>
<fpage>39</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00001.2016</pub-id>
<pub-id pub-id-type="pmid">27807200</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>MacKinnon</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures.</article-title>
<source/><italic>Science</italic>
<volume>360</volume>
<fpage>508</fpage>–<lpage>513</lpage>. <pub-id pub-id-type="doi">10.1126/science.aas9466</pub-id>
<pub-id pub-id-type="pmid">29724949</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>U. S.</given-names></name><name><surname>Cui</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>BK channel activation: structural and functional insights.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>33</volume>
<fpage>415</fpage>–<lpage>423</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2010.06.004</pub-id>
<pub-id pub-id-type="pmid">20663573</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Halling</surname><given-names>D. B.</given-names></name><name><surname>Hall</surname><given-names>A. W.</given-names></name><name><surname>Aldrich</surname><given-names>R. W.</given-names></name></person-group> (<year>2009</year>). <article-title>EF hands at the N-lobe of calmodulin are required for both SK channel gating and stable SK-calmodulin interaction.</article-title>
<source/><italic>J. Gen. Physiol.</italic>
<volume>134</volume>
<fpage>281</fpage>–<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.200910295</pub-id>
<pub-id pub-id-type="pmid">19752189</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Poschmann</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Fazeli</surname><given-names>W.</given-names></name><name><surname>Oundjian</surname><given-names>N. J.</given-names></name><name><surname>Snoeijen-Schouwenaars</surname><given-names>F. M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>De novo BK channel variant causes epilepsy by affecting voltage gating but not Ca(2+) sensitivity.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>26</volume>
<fpage>220</fpage>–<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1038/s41431-017-0073-3</pub-id>
<pub-id pub-id-type="pmid">29330545</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y.</given-names></name><name><surname>Kristiansen</surname><given-names>A. M.</given-names></name><name><surname>Oksvold</surname><given-names>C. P.</given-names></name><name><surname>Tuvnes</surname><given-names>F. A.</given-names></name><name><surname>Gu</surname><given-names>N.</given-names></name><name><surname>Runden-Pran</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Neuronal Ca2+-activated K+ channels limit brain infarction and promote survival.</article-title>
<source/><italic>PLoS One</italic>
<volume>5</volume>:<issue>e15601</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0015601</pub-id>
<pub-id pub-id-type="pmid">21209897</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>P. A.</given-names></name><name><surname>Marrion</surname><given-names>N. V.</given-names></name></person-group> (<year>2007</year>). <article-title>Mechanisms underlying activation of the slow AHP in rat hippocampal neurons.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1150</volume>
<fpage>74</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2007.02.067</pub-id>
<pub-id pub-id-type="pmid">17395164</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longden</surname><given-names>T. A.</given-names></name><name><surname>Dunn</surname><given-names>K. M.</given-names></name><name><surname>Draheim</surname><given-names>H. J.</given-names></name><name><surname>Nelson</surname><given-names>M. T.</given-names></name><name><surname>Weston</surname><given-names>A. H.</given-names></name><name><surname>Edwards</surname><given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>Intermediate-conductance calcium-activated potassium channels participate in neurovascular coupling.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>164</volume>
<fpage>922</fpage>–<lpage>933</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2011.01447.x</pub-id>
<pub-id pub-id-type="pmid">21506954</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>S.</given-names></name><name><surname>Heils</surname><given-names>A.</given-names></name><name><surname>Kasper</surname><given-names>J. M.</given-names></name><name><surname>Sander</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Allelic association of a truncation mutation of the KCNMB3 gene with idiopathic generalized epilepsy.</article-title>
<source/><italic>Am. J. Med. Genet. B Neuropsychiatr. Genet.</italic>
<volume>144B</volume>, <fpage>10</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30369</pub-id>
<pub-id pub-id-type="pmid">16958040</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Losin</surname><given-names>S.</given-names></name><name><surname>McKean</surname><given-names>C. M.</given-names></name></person-group> (<year>1966</year>). <article-title>Chlorzoxazone (paraflex) in the treatment of severe spasticity.</article-title>
<source/><italic>Dev. Med. Child Neurol.</italic>
<volume>8</volume>
<fpage>768</fpage>–<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-8749.1966.tb01839.x</pub-id><pub-id pub-id-type="pmid">5339683</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>R.</given-names></name><name><surname>Flauaus</surname><given-names>C.</given-names></name><name><surname>Kennel</surname><given-names>L.</given-names></name><name><surname>Petersen</surname><given-names>J.</given-names></name><name><surname>Drees</surname><given-names>O.</given-names></name><name><surname>Kallenborn-Gerhardt</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>KCa3.1 channels modulate the processing of noxious chemical stimuli in mice.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>125</volume>
<fpage>386</fpage>–<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2017.08.021</pub-id>
<pub-id pub-id-type="pmid">28823609</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Lou</surname><given-names>X. J.</given-names></name><name><surname>Horrigan</surname><given-names>F. T.</given-names></name></person-group> (<year>2006</year>). <article-title>Role of charged residues in the S1-S4 voltage sensor of BK channels.</article-title>
<source/><italic>J. Gen. Physiol.</italic>
<volume>127</volume>
<fpage>309</fpage>–<lpage>328</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.200509421</pub-id>
<pub-id pub-id-type="pmid">16505150</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malerba</surname><given-names>M.</given-names></name><name><surname>Amato</surname><given-names>D. M.</given-names></name><name><surname>Radaeli</surname><given-names>A.</given-names></name><name><surname>Giacovelli</surname><given-names>G.</given-names></name><name><surname>Rovati</surname><given-names>L.</given-names></name><name><surname>Arshad</surname><given-names>S. H.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Efficacy of andolast in mild to moderate asthma: a randomized, controlled, double-blind multicenter study (the andast trial).</article-title>
<source/><italic>Curr. Pharm. Des.</italic>
<volume>21</volume>
<fpage>3835</fpage>–<lpage>3843</lpage>. <pub-id pub-id-type="doi">10.2174/1381612821666150407101614</pub-id>
<pub-id pub-id-type="pmid">25845448</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marrion</surname><given-names>N. V.</given-names></name><name><surname>Tavalin</surname><given-names>S. J.</given-names></name></person-group> (<year>1998</year>). <article-title>Selective activation of Ca<sup>2+</sup>-activated K<sup>+</sup> channels by co-localized Ca<sup>2+</sup> channels in hippocampal neurons.</article-title>
<source/><italic>Nature</italic>
<volume>395</volume>
<fpage>900</fpage>–<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1038/27674</pub-id>
<pub-id pub-id-type="pmid">9804423</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>W.</given-names></name><name><surname>Furuta</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>K. C.</given-names></name><name><surname>Hioki</surname><given-names>H.</given-names></name><name><surname>Fujiyama</surname><given-names>F.</given-names></name><name><surname>Arai</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>29</volume>
<fpage>444</fpage>–<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4029-08.2009</pub-id>
<pub-id pub-id-type="pmid">19144844</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>M.</given-names></name><name><surname>Takada</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Distinct representations of cognitive and motivational signals in midbrain dopamine neurons.</article-title>
<source/><italic>Neuron</italic>
<volume>79</volume>
<fpage>1011</fpage>–<lpage>1024</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.07.002</pub-id>
<pub-id pub-id-type="pmid">23932490</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melman</surname><given-names>A.</given-names></name><name><surname>Bar-Chama</surname><given-names>N.</given-names></name><name><surname>Mccullough</surname><given-names>A.</given-names></name><name><surname>Davies</surname><given-names>K.</given-names></name><name><surname>Christ</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trial.</article-title>
<source/><italic>Hum. Gene Ther.</italic>
<volume>17</volume>
<fpage>1165</fpage>–<lpage>1176</lpage>. <pub-id pub-id-type="doi">10.1089/hum.2006.17.1165</pub-id>
<pub-id pub-id-type="pmid">17134370</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melman</surname><given-names>A.</given-names></name><name><surname>Bar-Chama</surname><given-names>N.</given-names></name><name><surname>Mccullough</surname><given-names>A.</given-names></name><name><surname>Davies</surname><given-names>K.</given-names></name><name><surname>Christ</surname><given-names>G.</given-names></name></person-group> (<year>2007</year>). <article-title>Plasmid-based gene transfer for treatment of erectile dysfunction and overactive bladder: results of a phase I trial.</article-title>
<source/><italic>ISR Med. Assoc. J.</italic>
<volume>9</volume>
<fpage>143</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="pmid">17402321</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meredith</surname><given-names>A. L.</given-names></name><name><surname>Wiler</surname><given-names>S. W.</given-names></name><name><surname>Miller</surname><given-names>B. H.</given-names></name><name><surname>Takahashi</surname><given-names>J. S.</given-names></name><name><surname>Fodor</surname><given-names>A. A.</given-names></name><name><surname>Ruby</surname><given-names>N. F.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>BK calcium-activated potassium channels regulate circadian behavioral rhythms and pacemaker output.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>9</volume>
<fpage>1041</fpage>–<lpage>1049</lpage>. <pub-id pub-id-type="doi">10.1038/nn1740</pub-id>
<pub-id pub-id-type="pmid">16845385</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>M. J.</given-names></name><name><surname>Rauer</surname><given-names>H.</given-names></name><name><surname>Tomita</surname><given-names>H.</given-names></name><name><surname>Rauer</surname><given-names>H.</given-names></name><name><surname>Gargus</surname><given-names>J. J.</given-names></name><name><surname>Gutman</surname><given-names>G. A.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Nuclear localization and dominant-negative suppression by a mutant SKCa3 N-terminal channel fragment identified in a patient with schizophrenia.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>276</volume>
<fpage>27753</fpage>–<lpage>27756</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.C100221200</pub-id>
<pub-id pub-id-type="pmid">11395478</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>R. G.</given-names></name><name><surname>Mitchell</surname><given-names>J. D.</given-names></name><name><surname>Moore</surname><given-names>D. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).</article-title>
<source/><italic>Cochrane Database Syst. Rev.</italic>
<volume>2</volume>:<issue>CD001447</issue>. <pub-id pub-id-type="doi">10.1002/14651858.CD001447.pub3</pub-id>
<pub-id pub-id-type="pmid">22419278</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda</surname><given-names>P.</given-names></name><name><surname>Contreras</surname><given-names>J. E.</given-names></name><name><surname>Plested</surname><given-names>A. J.</given-names></name><name><surname>Sigworth</surname><given-names>F. J.</given-names></name><name><surname>Holmgren</surname><given-names>M.</given-names></name><name><surname>Giraldez</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>State-dependent FRET reports calcium- and voltage-dependent gating-ring motions in BK channels.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>110</volume>
<fpage>5217</fpage>–<lpage>5222</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1219611110</pub-id>
<pub-id pub-id-type="pmid">23479636</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda</surname><given-names>P.</given-names></name><name><surname>Giraldez</surname><given-names>T.</given-names></name><name><surname>Holmgren</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Interactions of divalent cations with calcium binding sites of BK channels reveal independent motions within the gating ring.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>113</volume>
<fpage>14055</fpage>–<lpage>14060</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1611415113</pub-id>
<pub-id pub-id-type="pmid">27872281</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mongan</surname><given-names>L. C.</given-names></name><name><surname>Hill</surname><given-names>M. J.</given-names></name><name><surname>Chen</surname><given-names>M. X.</given-names></name><name><surname>Tate</surname><given-names>S. N.</given-names></name><name><surname>Collins</surname><given-names>S. D.</given-names></name><name><surname>Buckby</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>The distribution of small and intermediate conductance calcium-activated potassium channels in the rat sensory nervous system.</article-title>
<source/><italic>Neuroscience</italic>
<volume>131</volume>
<fpage>161</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2004.09.062</pub-id>
<pub-id pub-id-type="pmid">15680700</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>P.</given-names></name><name><surname>Garneau</surname><given-names>L.</given-names></name><name><surname>Klein</surname><given-names>H.</given-names></name><name><surname>Lavoie</surname><given-names>M. F.</given-names></name><name><surname>Parent</surname><given-names>L.</given-names></name><name><surname>Sauve</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Contribution of the KCa3.1 channel-calmodulin interactions to the regulation of the KCa3.1 gating process.</article-title>
<source/><italic>J. Gen. Physiol.</italic>
<volume>142</volume>
<fpage>37</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201210933</pub-id>
<pub-id pub-id-type="pmid">23797421</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mourre</surname><given-names>C.</given-names></name><name><surname>Fournier</surname><given-names>C.</given-names></name><name><surname>Soumireu-Mourat</surname><given-names>B.</given-names></name></person-group> (<year>1997</year>). <article-title>Apamin, a blocker of the calcium-activated potassium channel, induces neurodegeneration of Purkinje cells exclusively.</article-title>
<source/><italic>Brain Res.</italic>
<volume>778</volume>
<fpage>405</fpage>–<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(97)01165-7</pub-id>
<pub-id pub-id-type="pmid">9459560</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mpari</surname><given-names>B.</given-names></name><name><surname>Regaya</surname><given-names>I.</given-names></name><name><surname>Escoffier</surname><given-names>G.</given-names></name><name><surname>Mourre</surname><given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>Differential effects of two blockers of small conductance Ca2+-activated K+ channels, apamin and lei-Dab7, on learning and memory in rats.</article-title>
<source/><italic>J. Integr. Neurosci.</italic>
<volume>4</volume>
<fpage>381</fpage>–<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1142/S0219635205000884</pub-id>
<pub-id pub-id-type="pmid">16178064</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>A.</given-names></name><name><surname>Kukley</surname><given-names>M.</given-names></name><name><surname>Uebachs</surname><given-names>M.</given-names></name><name><surname>Beck</surname><given-names>H.</given-names></name><name><surname>Dietrich</surname><given-names>D.</given-names></name></person-group> (<year>2007</year>). <article-title>Nanodomains of single Ca2+ channels contribute to action potential repolarization in cortical neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>27</volume>
<fpage>483</fpage>–<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3816-06.2007</pub-id>
<pub-id pub-id-type="pmid">17234581</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>Y. W.</given-names></name><name><surname>Orfali</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Yu</surname><given-names>K.</given-names></name><name><surname>Cui</surname><given-names>M.</given-names></name><name><surname>Wulff</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Structural insights into the potency of SK channel positive modulators.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>7178</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-16607-8</pub-id>
<pub-id pub-id-type="pmid">29214998</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navaratnam</surname><given-names>D. S.</given-names></name><name><surname>Bell</surname><given-names>T. J.</given-names></name><name><surname>Tu</surname><given-names>T. D.</given-names></name><name><surname>Cohen</surname><given-names>E. L.</given-names></name><name><surname>Oberholtzer</surname><given-names>J. C.</given-names></name></person-group> (<year>1997</year>). <article-title>Differential distribution of Ca2+-activated K+ channel splice variants among hair cells along the tonotopic axis of the chick cochlea.</article-title>
<source/><italic>Neuron</italic>
<volume>19</volume>
<fpage>1077</fpage>–<lpage>1085</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80398-0</pub-id>
<pub-id pub-id-type="pmid">9390520</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>A. B.</given-names></name><name><surname>Krispel</surname><given-names>C. M.</given-names></name><name><surname>Sekirnjak</surname><given-names>C.</given-names></name><name><surname>Du Lac</surname><given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Long-lasting increases in intrinsic excitability triggered by inhibition.</article-title>
<source/><italic>Neuron</italic>
<volume>40</volume>
<fpage>609</fpage>–<lpage>620</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(03)00641-X</pub-id>
<pub-id pub-id-type="pmid">14642283</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngo-Anh</surname><given-names>T. J.</given-names></name><name><surname>Bloodgood</surname><given-names>B. L.</given-names></name><name><surname>Lin</surname><given-names>M.</given-names></name><name><surname>Sabatini</surname><given-names>B. L.</given-names></name><name><surname>Maylie</surname><given-names>J.</given-names></name><name><surname>Adelman</surname><given-names>J. P.</given-names></name></person-group> (<year>2005</year>). <article-title>SK channels and NMDA receptors form a Ca2+-mediated feedback loop in dendritic spines.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>8</volume>
<fpage>642</fpage>–<lpage>649</lpage>. <pub-id pub-id-type="doi">10.1038/nn1449</pub-id>
<pub-id pub-id-type="pmid">15852011</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>N’Gouemo</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>BKCa channel dysfunction in neurological diseases.</article-title>
<source/><italic>Front. Physiol.</italic>
<volume>5</volume>:<issue>373</issue>
<pub-id pub-id-type="doi">10.3389/fphys.2014.00373</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>H. M.</given-names></name><name><surname>Grossinger</surname><given-names>E. M.</given-names></name><name><surname>Horiuchi</surname><given-names>M.</given-names></name><name><surname>Davis</surname><given-names>K. W.</given-names></name><name><surname>Jin</surname><given-names>L. W.</given-names></name><name><surname>Maezawa</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Differential Kv1.3 KCa3.1 and Kir2.1 expression in “classically” and “alternatively” activated microglia.</article-title>
<comment>Glia 65</comment>
<fpage>106</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1002/glia.23078</pub-id>
<pub-id pub-id-type="pmid">27696527</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieoullon</surname><given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>Dopamine and the regulation of cognition and attention.</article-title>
<source/><italic>Prog. Neurobiol.</italic>
<volume>67</volume>
<fpage>53</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/S0301-0082(02)00011-4</pub-id><pub-id pub-id-type="pmid">12126656</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>M. S.</given-names></name><name><surname>Skinner</surname><given-names>F.</given-names></name><name><surname>Arshadmansab</surname><given-names>M. F.</given-names></name><name><surname>Garcia</surname><given-names>I.</given-names></name><name><surname>Mello</surname><given-names>C. F.</given-names></name><name><surname>Knaus</surname><given-names>H. G.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Altered expression and function of small-conductance (SK) Ca(2+)-activated K+ channels in pilocarpine-treated epileptic rats.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1348</volume>
<fpage>187</fpage>–<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.05.095</pub-id>
<pub-id pub-id-type="pmid">20553876</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ornitz</surname><given-names>E. M.</given-names></name><name><surname>Lane</surname><given-names>S. J.</given-names></name><name><surname>Sugiyama</surname><given-names>T.</given-names></name><name><surname>De Traversay</surname><given-names>J.</given-names></name></person-group> (<year>1993</year>). <article-title>Startle modulation studies in autism.</article-title>
<source/><italic>J. Autism. Dev. Disord.</italic>
<volume>23</volume>
<fpage>619</fpage>–<lpage>637</lpage>. <pub-id pub-id-type="doi">10.1007/BF01046105</pub-id><pub-id pub-id-type="pmid">8106303</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>Y. B.</given-names></name></person-group> (<year>1994</year>). <article-title>Ion selectivity and gating of small conductance Ca(2+)-activated K+ channels in cultured rat adrenal chromaffin cells.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>481 (Pt 3)</volume>, <fpage>555</fpage>–<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1994.sp020463</pub-id>
<pub-id pub-id-type="pmid">7707225</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedarzani</surname><given-names>P.</given-names></name><name><surname>Stocker</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Molecular and cellular basis of small–and intermediate-conductance, calcium-activated potassium channel function in the brain.</article-title>
<source/><italic>Cell Mol. Life Sci.</italic>
<volume>65</volume>
<fpage>3196</fpage>–<lpage>3217</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-008-8216-x</pub-id>
<pub-id pub-id-type="pmid">18597044</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picones</surname><given-names>A.</given-names></name><name><surname>Loza-Huerta</surname><given-names>A.</given-names></name><name><surname>Segura-Chama</surname><given-names>P.</given-names></name><name><surname>Lara-Figueroa</surname><given-names>C. O.</given-names></name></person-group> (<year>2016</year>). <article-title>Contribution of automated technologies to ion channel drug discovery.</article-title>
<source/><italic>Adv. Protein Chem. Struct. Biol.</italic>
<volume>104</volume>
<fpage>357</fpage>–<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1016/bs.apcsb.2016.01.002</pub-id>
<pub-id pub-id-type="pmid">27038379</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Postmes</surname><given-names>L.</given-names></name><name><surname>Sno</surname><given-names>H. N.</given-names></name><name><surname>Goedhart</surname><given-names>S.</given-names></name><name><surname>Van Der Stel</surname><given-names>J.</given-names></name><name><surname>Heering</surname><given-names>H. D.</given-names></name><name><surname>De Haan</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>Schizophrenia as a self-disorder due to perceptual incoherence.</article-title>
<source/><italic>Schizophr. Res.</italic>
<volume>152</volume>
<fpage>41</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2013.07.027</pub-id>
<pub-id pub-id-type="pmid">23973319</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Power</surname><given-names>J. M.</given-names></name><name><surname>Sah</surname><given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title>Competition between calcium-activated K+ channels determines cholinergic action on firing properties of basolateral amygdala projection neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>
<fpage>3209</fpage>–<lpage>3220</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4310-07.2008</pub-id>
<pub-id pub-id-type="pmid">18354024</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>D. L.</given-names></name><name><surname>Ludwig</surname><given-names>J. W.</given-names></name><name><surname>Mi</surname><given-names>H.</given-names></name><name><surname>Schwarz</surname><given-names>T. L.</given-names></name><name><surname>Ellisman</surname><given-names>M. H.</given-names></name></person-group> (<year>2002</year>). <article-title>Distribution of rSlo Ca2+-activated K+ channels in rat astrocyte perivascular endfeet.</article-title>
<source/><italic>Brain Res.</italic>
<volume>956</volume>
<fpage>183</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(02)03266-3</pub-id>
<pub-id pub-id-type="pmid">12445685</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rankin</surname><given-names>C. H.</given-names></name><name><surname>Abrams</surname><given-names>T.</given-names></name><name><surname>Barry</surname><given-names>R. J.</given-names></name><name><surname>Bhatnagar</surname><given-names>S.</given-names></name><name><surname>Clayton</surname><given-names>D. F.</given-names></name><name><surname>Colombo</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Habituation revisited: an updated and revised description of the behavioral characteristics of habituation.</article-title>
<source/><italic>Neurobiol. Learn. Mem.</italic>
<volume>92</volume>
<fpage>135</fpage>–<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2008.09.012</pub-id>
<pub-id pub-id-type="pmid">18854219</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reich</surname><given-names>E. P.</given-names></name><name><surname>Cui</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Pugliese-Sivo</surname><given-names>C.</given-names></name><name><surname>Golovko</surname><given-names>A.</given-names></name><name><surname>Petro</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice.</article-title>
<source/><italic>Eur. J. Immunol.</italic>
<volume>35</volume>
<fpage>1027</fpage>–<lpage>1036</lpage>. <pub-id pub-id-type="doi">10.1002/eji.200425954</pub-id>
<pub-id pub-id-type="pmid">15770697</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ristori</surname><given-names>G.</given-names></name><name><surname>Romano</surname><given-names>S.</given-names></name><name><surname>Visconti</surname><given-names>A.</given-names></name><name><surname>Cannoni</surname><given-names>S.</given-names></name><name><surname>Spadaro</surname><given-names>M.</given-names></name><name><surname>Frontali</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.</article-title>
<source/><italic>Neurology</italic>
<volume>74</volume>
<fpage>839</fpage>–<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181d31e23</pub-id>
<pub-id pub-id-type="pmid">20211908</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudolph</surname><given-names>S.</given-names></name><name><surname>Thanawala</surname><given-names>M. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Location matters: somatic and dendritic SK channels answer to distinct calcium signals.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>114</volume>
<fpage>1</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00181.2014</pub-id>
<pub-id pub-id-type="pmid">25185803</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sah</surname><given-names>P.</given-names></name></person-group> (<year>1996</year>). <article-title>Ca(2+)-activated K+ currents in neurones: types, physiological roles and modulation.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>19</volume>
<fpage>150</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-2236(96)80026-9</pub-id>
<pub-id pub-id-type="pmid">8658599</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sah</surname><given-names>P.</given-names></name><name><surname>McLachlan</surname><given-names>E. M.</given-names></name></person-group> (<year>1992</year>). <article-title>Potassium currents contributing to action potential repolarization and the afterhyperpolarization in rat vagal motoneurons.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>68</volume>
<fpage>1834</fpage>–<lpage>1841</lpage>. <pub-id pub-id-type="doi">10.1152/jn.1992.68.5.1834</pub-id>
<pub-id pub-id-type="pmid">1336045</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sausbier</surname><given-names>M.</given-names></name><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Arntz</surname><given-names>C.</given-names></name><name><surname>Feil</surname><given-names>S.</given-names></name><name><surname>Kamm</surname><given-names>S.</given-names></name><name><surname>Adelsberger</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Cerebellar ataxia and Purkinje cell dysfunction caused by Ca2+-activated K+ channel deficiency.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>101</volume>
<fpage>9474</fpage>–<lpage>9478</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0401702101</pub-id>
<pub-id pub-id-type="pmid">15194823</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savalli</surname><given-names>N.</given-names></name><name><surname>Pantazis</surname><given-names>A.</given-names></name><name><surname>Yusifov</surname><given-names>T.</given-names></name><name><surname>Sigg</surname><given-names>D.</given-names></name><name><surname>Olcese</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>The contribution of RCK domains to human BK channel allosteric activation.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>287</volume>
<fpage>21741</fpage>–<lpage>21750</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.346171</pub-id>
<pub-id pub-id-type="pmid">22556415</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scholl</surname><given-names>E. S.</given-names></name><name><surname>Pirone</surname><given-names>A.</given-names></name><name><surname>Cox</surname><given-names>D. H.</given-names></name><name><surname>Duncan</surname><given-names>R. K.</given-names></name><name><surname>Jacob</surname><given-names>M. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Alternative splice isoforms of small conductance calcium-activated SK2 channels differ in molecular interactions and surface levels.</article-title>
<source/><italic>Channels (Austin)</italic>
<volume>8</volume>
<fpage>62</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.4161/chan.27470</pub-id>
<pub-id pub-id-type="pmid">24394769</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>M.</given-names></name><name><surname>Yuan</surname><given-names>A.</given-names></name><name><surname>Salkoff</surname><given-names>L.</given-names></name></person-group> (<year>1999</year>). <article-title>Transplantable sites confer calcium sensitivity to BK channels.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>2</volume>
<fpage>416</fpage>–<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1038/8077</pub-id>
<pub-id pub-id-type="pmid">10321244</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname><given-names>M. A.</given-names></name><name><surname>Crum</surname><given-names>M.</given-names></name><name><surname>Miller</surname><given-names>M. C.</given-names></name></person-group> (<year>2004</year>). <article-title>Crystal structures of apocalmodulin and an apocalmodulin/SK potassium channel gating domain complex.</article-title>
<source/><italic>Structure</italic>
<volume>12</volume>
<fpage>849</fpage>–<lpage>860</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2004.03.017</pub-id>
<pub-id pub-id-type="pmid">15130477</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname><given-names>M. A.</given-names></name><name><surname>Rivard</surname><given-names>A. F.</given-names></name><name><surname>Bächinger</surname><given-names>H. P.</given-names></name><name><surname>Adelman</surname><given-names>J. P.</given-names></name></person-group> (<year>2001</year>). <article-title>Structure of the gating domain of a Ca2<sup>+</sup>-activated K<sup>+</sup> channel complexed with Ca2+/calmodulin.</article-title>
<source/><italic>Nature</italic>
<volume>410</volume>
<fpage>1120</fpage>–<lpage>1124</lpage>. <pub-id pub-id-type="doi">10.1038/35074145</pub-id>
<pub-id pub-id-type="pmid">11323678</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seidel</surname><given-names>K. N.</given-names></name><name><surname>Derst</surname><given-names>C.</given-names></name><name><surname>Salzmann</surname><given-names>M.</given-names></name><name><surname>Holtje</surname><given-names>M.</given-names></name><name><surname>Priller</surname><given-names>J.</given-names></name><name><surname>Markgraf</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Expression of the voltage- and Ca2+-dependent BK potassium channel subunits BKbeta1 and BKbeta4 in rodent astrocytes.</article-title>
<source/><italic>Glia</italic>
<volume>59</volume>
<fpage>893</fpage>–<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1002/glia.21160</pub-id>
<pub-id pub-id-type="pmid">21438011</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seifert</surname><given-names>G.</given-names></name><name><surname>Henneberger</surname><given-names>C.</given-names></name><name><surname>Steinhauser</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Diversity of astrocyte potassium channels: an update.</article-title>
<source/><italic>Brain Res. Bull.</italic>
<volume>136</volume>
<fpage>26</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2016.12.002</pub-id>
<pub-id pub-id-type="pmid">27965079</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheehan</surname><given-names>J. J.</given-names></name><name><surname>Benedetti</surname><given-names>B. L.</given-names></name><name><surname>Barth</surname><given-names>A. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Anticonvulsant effects of the BK-channel antagonist paxilline.</article-title>
<source/><italic>Epilepsia</italic>
<volume>50</volume>
<fpage>711</fpage>–<lpage>720</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01888.x</pub-id>
<pub-id pub-id-type="pmid">19054419</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Krishnamoorthy</surname><given-names>G.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>L.</given-names></name><name><surname>Chaturvedi</surname><given-names>N.</given-names></name><name><surname>Harilal</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Mechanism of magnesium activation of calcium-activated potassium channels.</article-title>
<source/><italic>Nature</italic>
<volume>418</volume>
<fpage>876</fpage>–<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1038/nature00941</pub-id>
<pub-id pub-id-type="pmid">12192410</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shipston</surname><given-names>M. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Alternative splicing of potassium channels: a dynamic switch of cellular excitability.</article-title>
<source/><italic>Trends Cell Biol.</italic>
<volume>11</volume>
<fpage>353</fpage>–<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1016/S0962-8924(01)02068-2</pub-id>
<pub-id pub-id-type="pmid">11514177</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Si</surname><given-names>H.</given-names></name><name><surname>Heyken</surname><given-names>W. T.</given-names></name><name><surname>Wolfle</surname><given-names>S. E.</given-names></name><name><surname>Tysiac</surname><given-names>M.</given-names></name><name><surname>Schubert</surname><given-names>R.</given-names></name><name><surname>Grgic</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>99</volume>
<fpage>537</fpage>–<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000238377.08219.0c</pub-id>
<pub-id pub-id-type="pmid">16873714</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skalska</surname><given-names>J.</given-names></name><name><surname>Bednarczyk</surname><given-names>P.</given-names></name><name><surname>Piwonska</surname><given-names>M.</given-names></name><name><surname>Kulawiak</surname><given-names>B.</given-names></name><name><surname>Wilczynski</surname><given-names>G.</given-names></name><name><surname>Dolowy</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Calcium ions regulate K(+) uptake into brain mitochondria: the evidence for a novel potassium channel.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>10</volume>
<fpage>1104</fpage>–<lpage>1120</lpage>. <pub-id pub-id-type="doi">10.3390/ijms10031104</pub-id>
<pub-id pub-id-type="pmid">19399240</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>R. A.</given-names></name><name><surname>Miller</surname><given-names>T. M.</given-names></name><name><surname>Yamanaka</surname><given-names>K.</given-names></name><name><surname>Monia</surname><given-names>B. P.</given-names></name><name><surname>Condon</surname><given-names>T. P.</given-names></name><name><surname>Hung</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Antisense oligonucleotide therapy for neurodegenerative disease.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>116</volume>
<fpage>2290</fpage>–<lpage>2296</lpage>. <pub-id pub-id-type="doi">10.1172/JCI25424</pub-id>
<pub-id pub-id-type="pmid">16878173</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soden</surname><given-names>M. E.</given-names></name><name><surname>Jones</surname><given-names>G. L.</given-names></name><name><surname>Sanford</surname><given-names>C. A.</given-names></name><name><surname>Chung</surname><given-names>A. S.</given-names></name><name><surname>Guler</surname><given-names>A. D.</given-names></name><name><surname>Chavkin</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Disruption of dopamine neuron activity pattern regulation through selective expression of a human KCNN3 mutation.</article-title>
<source/><italic>Neuron</italic>
<volume>80</volume>
<fpage>997</fpage>–<lpage>1009</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.07.044</pub-id>
<pub-id pub-id-type="pmid">24206670</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solly</surname><given-names>K.</given-names></name><name><surname>Cassaday</surname><given-names>J.</given-names></name><name><surname>Felix</surname><given-names>J. P.</given-names></name><name><surname>Garcia</surname><given-names>M. L.</given-names></name><name><surname>Ferrer</surname><given-names>M.</given-names></name><name><surname>Strulovici</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Miniaturization and HTS of a FRET-based membrane potential assay for K(ir) channel inhibitors.</article-title>
<source/><italic>Assay Drug Dev. Technol.</italic>
<volume>6</volume>
<fpage>225</fpage>–<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1089/adt.2008.123</pub-id>
<pub-id pub-id-type="pmid">18471076</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staal</surname><given-names>R. G. W.</given-names></name><name><surname>Khayrullina</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Davis</surname><given-names>S.</given-names></name><name><surname>Fallon</surname><given-names>S. M.</given-names></name><name><surname>Cajina</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Inhibition of the potassium channel KCa3.1 by senicapoc reverses tactile allodynia in rats with peripheral nerve injury.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>795</volume>
<fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2016.11.031</pub-id>
<pub-id pub-id-type="pmid">27876619</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stackman</surname><given-names>R. W.</given-names></name><name><surname>Hammond</surname><given-names>R. S.</given-names></name><name><surname>Linardatos</surname><given-names>E.</given-names></name><name><surname>Gerlach</surname><given-names>A.</given-names></name><name><surname>Maylie</surname><given-names>J.</given-names></name><name><surname>Adelman</surname><given-names>J. P.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Small conductance Ca2+-activated K+ channels modulate synaptic plasticity and memory encoding.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>22</volume>
<fpage>10163</fpage>–<lpage>10171</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-23-10163.2002</pub-id>
<pub-id pub-id-type="pmid">12451117</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stocker</surname><given-names>M.</given-names></name><name><surname>Pedarzani</surname><given-names>P.</given-names></name></person-group> (<year>2000</year>). <article-title>Differential distribution of three Ca(2+)-activated K(+) channel subunits, SK1, SK2, and SK3, in the adult rat central nervous system.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>15</volume>
<fpage>476</fpage>–<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1006/mcne.2000.0842</pub-id>
<pub-id pub-id-type="pmid">10833304</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stocker</surname><given-names>M.</given-names></name><name><surname>Krause</surname><given-names>M.</given-names></name><name><surname>Pedarzani</surname><given-names>P.</given-names></name></person-group> (<year>1999</year>). <article-title>An apamin-sensitive Ca2+-activated K+ current in hippocampal pyramidal neurons.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>96</volume>
<fpage>4662</fpage>–<lpage>4667</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.8.4662</pub-id><pub-id pub-id-type="pmid">10200319</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storm</surname><given-names>J. F.</given-names></name></person-group> (<year>1987</year>). <article-title>Action potential repolarization and a fast after-hyperpolarization in rat hippocampal pyramidal cells.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>385</volume>
<fpage>733</fpage>–<lpage>759</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1987.sp016517</pub-id>
<pub-id pub-id-type="pmid">2443676</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strobaek</surname><given-names>D.</given-names></name><name><surname>Teuber</surname><given-names>L.</given-names></name><name><surname>Jorgensen</surname><given-names>T. D.</given-names></name><name><surname>Ahring</surname><given-names>P. K.</given-names></name><name><surname>Kjaer</surname><given-names>K.</given-names></name><name><surname>Hansen</surname><given-names>R. S.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Activation of human IK and SK Ca2+ -activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime).</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1665</volume>
<fpage>1</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2004.07.006</pub-id>
<pub-id pub-id-type="pmid">15471565</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Z.</given-names></name><name><surname>Brown</surname><given-names>E. C.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Mackinnon</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Novel cell-free high-throughput screening method for pharmacological tools targeting K+ channels.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>113</volume>
<fpage>5748</fpage>–<lpage>5753</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1602815113</pub-id>
<pub-id pub-id-type="pmid">27091997</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugunan</surname><given-names>S.</given-names></name><name><surname>Nampoothiri</surname><given-names>S. S.</given-names></name><name><surname>Garg</surname><given-names>T.</given-names></name><name><surname>Krishnamurthy</surname><given-names>R. G.</given-names></name></person-group> (<year>2016</year>). <article-title>Role of KCa3.1 Channels in CNS diseases: a concise review.</article-title>
<source/><italic>CNS Neurol. Disord. Drug Targets</italic>
<volume>15</volume>
<fpage>1299</fpage>–<lpage>1305</lpage>. <pub-id pub-id-type="doi">10.2174/1871527315666160822111913</pub-id>
<pub-id pub-id-type="pmid">27549144</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Yamamoto</surname><given-names>R.</given-names></name><name><surname>Sugai</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Increase in cortical pyramidal cell excitability accompanies depression-like behavior in mice: a transcranial magnetic stimulation study.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>16464</fpage>–<lpage>16472</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1542-11.2011</pub-id>
<pub-id pub-id-type="pmid">22072696</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surmeier</surname><given-names>D. J.</given-names></name><name><surname>Guzman</surname><given-names>J. N.</given-names></name><name><surname>Sanchez-Padilla</surname><given-names>J.</given-names></name><name><surname>Goldberg</surname><given-names>J. A.</given-names></name></person-group> (<year>2010</year>). <article-title>What causes the death of dopaminergic neurons in Parkinson’s disease?</article-title>
<source/><italic>Prog. Brain Res.</italic>
<volume>183</volume>
<fpage>59</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/S0079-6123(10)83004-3</pub-id><pub-id pub-id-type="pmid">20696315</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweet</surname><given-names>T. B.</given-names></name><name><surname>Cox</surname><given-names>D. H.</given-names></name></person-group> (<year>2009</year>). <article-title>Measuring the influence of the BKCa {beta}1 subunit on Ca2+ binding to the BKCa channel.</article-title>
<source/><italic>J. Gen. Physiol.</italic>
<volume>133</volume>
<fpage>139</fpage>–<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.200810129</pub-id>
<pub-id pub-id-type="pmid">19139175</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szewczyk</surname><given-names>A.</given-names></name><name><surname>Kajma</surname><given-names>A.</given-names></name><name><surname>Malinska</surname><given-names>D.</given-names></name><name><surname>Wrzosek</surname><given-names>A.</given-names></name><name><surname>Bednarczyk</surname><given-names>P.</given-names></name><name><surname>Zablocka</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Pharmacology of mitochondrial potassium channels: dark side of the field.</article-title>
<source/><italic>FEBS Lett.</italic>
<volume>584</volume>
<fpage>2063</fpage>–<lpage>2069</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2010.02.048</pub-id>
<pub-id pub-id-type="pmid">20178786</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takano</surname><given-names>T.</given-names></name><name><surname>Tian</surname><given-names>G. F.</given-names></name><name><surname>Peng</surname><given-names>W.</given-names></name><name><surname>Lou</surname><given-names>N.</given-names></name><name><surname>Libionka</surname><given-names>W.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Astrocyte-mediated control of cerebral blood flow.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>9</volume>
<fpage>260</fpage>–<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1038/nn1623</pub-id>
<pub-id pub-id-type="pmid">16388306</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanner</surname><given-names>M. R.</given-names></name><name><surname>Pennington</surname><given-names>M. W.</given-names></name><name><surname>Chamberlain</surname><given-names>B. H.</given-names></name><name><surname>Huq</surname><given-names>R.</given-names></name><name><surname>Gehrmann</surname><given-names>E. J.</given-names></name><name><surname>Laragione</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Targeting KCa1.1 channels with a scorpion venom peptide for the therapy of rat models of rheumatoid arthritis.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>365</volume>
<fpage>227</fpage>–<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.117.245118</pub-id>
<pub-id pub-id-type="pmid">29453198</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>X.</given-names></name><name><surname>Hite</surname><given-names>R. K.</given-names></name><name><surname>Mackinnon</surname><given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Cryo-EM structure of the open high-conductance Ca2<sup>+</sup>-activated K<sup>+</sup> channel.</article-title>
<source/><italic>Nature</italic>
<volume>541</volume>
<fpage>46</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1038/nature20608</pub-id>
<pub-id pub-id-type="pmid">27974795</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>J. M.</given-names></name><name><surname>Ji</surname><given-names>G.</given-names></name><name><surname>Neugebauer</surname><given-names>V.</given-names></name></person-group> (<year>2015</year>). <article-title>Small-conductance calcium-activated potassium (SK) channels in the amygdala mediate pain-inhibiting effects of clinically available riluzole in a rat model of arthritis pain.</article-title>
<source/><italic>Mol. Pain</italic>
<volume>11</volume>
<issue>51</issue>. <pub-id pub-id-type="doi">10.1186/s12990-015-0055-9</pub-id>
<pub-id pub-id-type="pmid">26311432</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tonini</surname><given-names>R.</given-names></name><name><surname>Ferraro</surname><given-names>T.</given-names></name><name><surname>Sampedro-Castaneda</surname><given-names>M.</given-names></name><name><surname>Cavaccini</surname><given-names>A.</given-names></name><name><surname>Stocker</surname><given-names>M.</given-names></name><name><surname>Richards</surname><given-names>C. D.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Small-conductance Ca2+-activated K+ channels modulate action potential-induced Ca2+ transients in hippocampal neurons.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>109</volume>
<fpage>1514</fpage>–<lpage>1524</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00346.2012</pub-id>
<pub-id pub-id-type="pmid">23255726</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyama</surname><given-names>K.</given-names></name><name><surname>Wulff</surname><given-names>H.</given-names></name><name><surname>Chandy</surname><given-names>K. G.</given-names></name><name><surname>Azam</surname><given-names>P.</given-names></name><name><surname>Raman</surname><given-names>G.</given-names></name><name><surname>Saito</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>118</volume>
<fpage>3025</fpage>–<lpage>3037</lpage>. <pub-id pub-id-type="doi">10.1172/JCI30836</pub-id>
<pub-id pub-id-type="pmid">18688283</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuteja</surname><given-names>D.</given-names></name><name><surname>Rafizadeh</surname><given-names>S.</given-names></name><name><surname>Timofeyev</surname><given-names>V.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Cardiac small conductance Ca2+-activated K+ channel subunits form heteromultimers via the coiled-coil domains in the C termini of the channels.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>107</volume>
<fpage>851</fpage>–<lpage>859</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.215269</pub-id>
<pub-id pub-id-type="pmid">20689065</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Typlt</surname><given-names>M.</given-names></name><name><surname>Mirkowski</surname><given-names>M.</given-names></name><name><surname>Azzopardi</surname><given-names>E.</given-names></name><name><surname>Ruth</surname><given-names>P.</given-names></name><name><surname>Pilz</surname><given-names>P. K.</given-names></name><name><surname>Schmid</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Habituation of reflexive and motivated behavior in mice with deficient BK channel function.</article-title>
<source/><italic>Front. Integr. Neurosci.</italic>
<volume>7</volume>:<issue>79</issue>. <pub-id pub-id-type="doi">10.3389/fnint.2013.00079</pub-id>
<pub-id pub-id-type="pmid">24312024</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzingounis</surname><given-names>A. V.</given-names></name><name><surname>Nicoll</surname><given-names>R. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Contribution of KCNQ2 and KCNQ3 to the medium and slow afterhyperpolarization currents.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>105</volume>
<fpage>19974</fpage>–<lpage>19979</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0810535105</pub-id>
<pub-id pub-id-type="pmid">19060215</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzingounis</surname><given-names>A. V.</given-names></name><name><surname>Heidenreich</surname><given-names>M.</given-names></name><name><surname>Kharkovets</surname><given-names>T.</given-names></name><name><surname>Spitzmaul</surname><given-names>G.</given-names></name><name><surname>Jensen</surname><given-names>H. S.</given-names></name><name><surname>Nicoll</surname><given-names>R. A.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>The KCNQ5 potassium channel mediates a component of the afterhyperpolarization current in mouse hippocampus.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>107</volume>
<fpage>10232</fpage>–<lpage>10237</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1004644107</pub-id>
<pub-id pub-id-type="pmid">20534576</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ungless</surname><given-names>M. A.</given-names></name><name><surname>Argilli</surname><given-names>E.</given-names></name><name><surname>Bonci</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Effects of stress and aversion on dopamine neurons: implications for addiction.</article-title>
<source/><italic>Neurosci. Biobehav. Rev.</italic>
<volume>35</volume>
<fpage>151</fpage>–<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2010.04.006</pub-id>
<pub-id pub-id-type="pmid">20438754</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verkerk</surname><given-names>A. J.</given-names></name><name><surname>Pieretti</surname><given-names>M.</given-names></name><name><surname>Sutcliffe</surname><given-names>J. S.</given-names></name><name><surname>Fu</surname><given-names>Y. H.</given-names></name><name><surname>Kuhl</surname><given-names>D. P.</given-names></name><name><surname>Pizzuti</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>1991</year>). <article-title>Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.</article-title>
<source/><italic>Cell</italic>
<volume>65</volume>
<fpage>905</fpage>–<lpage>914</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(91)90397-H</pub-id>
<pub-id pub-id-type="pmid">1710175</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivas</surname><given-names>O.</given-names></name><name><surname>Moreno</surname><given-names>C. M.</given-names></name><name><surname>Santana</surname><given-names>L. F.</given-names></name><name><surname>Hille</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Proximal clustering between BK and CaV1.3 channels promotes functional coupling and BK channel activation at low voltage.</article-title>
<source/><italic>Elife</italic>
<volume>6</volume>:<issue>e28029</issue>. <pub-id pub-id-type="doi">10.7554/eLife.28029</pub-id>
<pub-id pub-id-type="pmid">28665272</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>J. T.</given-names></name><name><surname>Alvina</surname><given-names>K.</given-names></name><name><surname>Womack</surname><given-names>M. D.</given-names></name><name><surname>Chevez</surname><given-names>C.</given-names></name><name><surname>Khodakhah</surname><given-names>K.</given-names></name></person-group> (<year>2006</year>). <article-title>Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>9</volume>
<fpage>389</fpage>–<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1038/nn1648</pub-id>
<pub-id pub-id-type="pmid">16474392</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Bugay</surname><given-names>V.</given-names></name><name><surname>Ling</surname><given-names>L.</given-names></name><name><surname>Chuang</surname><given-names>H. H.</given-names></name><name><surname>Jaffe</surname><given-names>D. B.</given-names></name><name><surname>Brenner</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Knockout of the BK beta4-subunit promotes a functional coupling of BK channels and ryanodine receptors that mediate a fAHP-induced increase in excitability.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>116</volume>
<fpage>456</fpage>–<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00857.2015</pub-id>
<pub-id pub-id-type="pmid">27146987</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Jaffe</surname><given-names>D. B.</given-names></name><name><surname>Brenner</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>Current understanding of iberiotoxin-resistant BK channels in the nervous system.</article-title>
<source/><italic>Front. Physiol.</italic>
<volume>5</volume>:<issue>382</issue>. <pub-id pub-id-type="doi">10.3389/fphys.2014.00382</pub-id>
<pub-id pub-id-type="pmid">25346692</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Rothberg</surname><given-names>B. S.</given-names></name><name><surname>Brenner</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Mechanism of increased BK channel activation from a channel mutation that causes epilepsy.</article-title>
<source/><italic>J. Gen. Physiol.</italic>
<volume>133</volume>
<fpage>283</fpage>–<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.200810141</pub-id>
<pub-id pub-id-type="pmid">19204188</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>P.</given-names></name><name><surname>Luo</surname><given-names>X.</given-names></name><name><surname>Ishigaki</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Improvement of spatial learning by facilitating large-conductance calcium-activated potassium channel with transcranial magnetic stimulation in Alzheimer’s disease model mice.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>97</volume>
<fpage>210</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.05.027</pub-id>
<pub-id pub-id-type="pmid">26051398</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Mateos-Aparicio</surname><given-names>P.</given-names></name><name><surname>Honigsperger</surname><given-names>C.</given-names></name><name><surname>Raghuram</surname><given-names>V.</given-names></name><name><surname>Wu</surname><given-names>W. W.</given-names></name><name><surname>Ridder</surname><given-names>M. C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>IK1 channels do not contribute to the slow afterhyperpolarization in pyramidal neurons.</article-title>
<source/><italic>Elife</italic>
<volume>5</volume>:<issue>e11206</issue>. <pub-id pub-id-type="doi">10.7554/eLife.11206</pub-id>
<pub-id pub-id-type="pmid">26765773</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Kang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Shui</surname><given-names>Y.</given-names></name><name><surname>Yamamoto</surname><given-names>R.</given-names></name><name><surname>Sugai</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Cognitive recovery by chronic activation of the large-conductance calcium-activated potassium channel in a mouse model of Alzheimer’s disease.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>92</volume>
<fpage>8</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.12.033</pub-id>
<pub-id pub-id-type="pmid">25577958</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>P. L.</given-names></name><name><surname>Tang</surname><given-names>J. F.</given-names></name><name><surname>Lin</surname><given-names>J. F.</given-names></name><name><surname>Cai</surname><given-names>X. H.</given-names></name><name><surname>Wang</surname><given-names>X. T.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Potassium channels: possible new therapeutic targets in Parkinson’s disease.</article-title>
<source/><italic>Med. Hypotheses</italic>
<volume>71</volume>
<fpage>546</fpage>–<lpage>550</lpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2008.05.021</pub-id>
<pub-id pub-id-type="pmid">18650029</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waroux</surname><given-names>O.</given-names></name><name><surname>Massotte</surname><given-names>L.</given-names></name><name><surname>Alleva</surname><given-names>L.</given-names></name><name><surname>Graulich</surname><given-names>A.</given-names></name><name><surname>Thomas</surname><given-names>E.</given-names></name><name><surname>Liegeois</surname><given-names>J. F.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>SK channels control the firing pattern of midbrain dopaminergic neurons in vivo.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>22</volume>
<fpage>3111</fpage>–<lpage>3121</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.04484.x</pub-id>
<pub-id pub-id-type="pmid">16367777</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>A. D.</given-names></name><name><surname>Gutman</surname><given-names>G. A.</given-names></name><name><surname>Aldrich</surname><given-names>R.</given-names></name><name><surname>Chandy</surname><given-names>K. G.</given-names></name><name><surname>Grissmer</surname><given-names>S.</given-names></name><name><surname>Wulff</surname><given-names>H.</given-names></name></person-group> (<year>2005</year>). <article-title>International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels.</article-title>
<source/><italic>Pharmacol. Rev.</italic>
<volume>57</volume>
<fpage>463</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1124/pr.57.4.9</pub-id>
<pub-id pub-id-type="pmid">16382103</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitmire</surname><given-names>L. E.</given-names></name><name><surname>Ling</surname><given-names>L.</given-names></name><name><surname>Bugay</surname><given-names>V.</given-names></name><name><surname>Carver</surname><given-names>C. M.</given-names></name><name><surname>Timilsina</surname><given-names>S.</given-names></name><name><surname>Chuang</surname><given-names>H. H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Downregulation of KCNMB4 expression and changes in BK channel subtype in hippocampal granule neurons following seizure activity.</article-title>
<source/><italic>PLoS One</italic>
<volume>12</volume>:<issue>e0188064</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0188064</pub-id>
<pub-id pub-id-type="pmid">29145442</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitt</surname><given-names>J. P.</given-names></name><name><surname>Mcnally</surname><given-names>B. A.</given-names></name><name><surname>Meredith</surname><given-names>A. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Differential contribution of Ca(2+) sources to day and night BK current activation in the circadian clock.</article-title>
<source/><italic>J. Gen. Physiol.</italic>
<volume>150</volume>
<fpage>259</fpage>–<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201711945</pub-id>
<pub-id pub-id-type="pmid">29237755</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitt</surname><given-names>J. P.</given-names></name><name><surname>Montgomery</surname><given-names>J. R.</given-names></name><name><surname>Meredith</surname><given-names>A. L.</given-names></name></person-group> (<year>2016</year>). <article-title>BK channel inactivation gates daytime excitability in the circadian clock.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>7</volume>:<issue>10837</issue>. <pub-id pub-id-type="doi">10.1038/ncomms10837</pub-id>
<pub-id pub-id-type="pmid">26940770</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfart</surname><given-names>J.</given-names></name><name><surname>Roeper</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Selective coupling of T-type calcium channels to SK potassium channels prevents intrinsic bursting in dopaminergic midbrain neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>22</volume>
<fpage>3404</fpage>–<lpage>3413</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-09-03404.2002</pub-id>
<pub-id pub-id-type="pmid">11978817</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Womack</surname><given-names>M. D.</given-names></name><name><surname>Khodakhah</surname><given-names>K.</given-names></name></person-group> (<year>2003</year>). <article-title>Somatic and dendritic small-conductance calcium-activated potassium channels regulate the output of cerebellar Purkinje neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>23</volume>
<fpage>2600</fpage>–<lpage>2607</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-07-02600.2003</pub-id>
<pub-id pub-id-type="pmid">12684445</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Womble</surname><given-names>M. D.</given-names></name><name><surname>Moises</surname><given-names>H. C.</given-names></name></person-group> (<year>1993</year>). <article-title>Muscarinic modulation of conductances underlying the afterhyperpolarization in neurons of the rat basolateral amygdala.</article-title>
<source/><italic>Brain Res.</italic>
<volume>621</volume>
<fpage>87</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(93)90301-3</pub-id><pub-id pub-id-type="pmid">8221077</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Hou</surname><given-names>P.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Kong</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>TRPV1 channels are functionally coupled with BK(mSlo1) channels in rat dorsal root ganglion (DRG) neurons.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e78203</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0078203</pub-id>
<pub-id pub-id-type="pmid">24147119</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Ye</surname><given-names>S.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Structure of the gating ring from the human large-conductance Ca(2+)-gated K(+) channel.</article-title>
<source/><italic>Nature</italic>
<volume>466</volume>
<fpage>393</fpage>–<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1038/nature09252</pub-id>
<pub-id pub-id-type="pmid">20574420</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wulf</surname><given-names>M.</given-names></name><name><surname>Pless</surname><given-names>S. A.</given-names></name></person-group> (<year>2018</year>). <article-title>High-sensitivity fluorometry to resolve ion channel conformational dynamics.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>22</volume>
<fpage>1615</fpage>–<lpage>1626</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.01.029</pub-id>
<pub-id pub-id-type="pmid">29425514</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wulff</surname><given-names>H.</given-names></name><name><surname>Castle</surname><given-names>N. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Therapeutic potential of KCa3.1 blockers: recent advances and promising trends.</article-title>
<source/><italic>Exp. Rev. Clin. Pharmacol.</italic>
<volume>3</volume>
<fpage>385</fpage>–<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1586/ecp.10.11</pub-id>
<pub-id pub-id-type="pmid">22111618</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>X. M.</given-names></name><name><surname>Zeng</surname><given-names>X.</given-names></name><name><surname>Lingle</surname><given-names>C. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Multiple regulatory sites in large-conductance calcium-activated potassium channels.</article-title>
<source/><italic>Nature</italic>
<volume>418</volume>
<fpage>880</fpage>–<lpage>884</lpage>. <pub-id pub-id-type="doi">10.1038/nature00956</pub-id>
<pub-id pub-id-type="pmid">12192411</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>K.</given-names></name><name><surname>Ueta</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Yamamoto</surname><given-names>R.</given-names></name><name><surname>Inoue</surname><given-names>N.</given-names></name><name><surname>Inokuchi</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Suppression of a neocortical potassium channel activity by intracellular amyloid-beta and its rescue with Homer1a.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>11100</fpage>–<lpage>11109</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6752-10.2011</pub-id>
<pub-id pub-id-type="pmid">21813671</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>E. J.</given-names></name><name><surname>Jiang</surname><given-names>J. H.</given-names></name><name><surname>Lee</surname><given-names>S. M.</given-names></name><name><surname>Yang</surname><given-names>S. C.</given-names></name><name><surname>Hwang</surname><given-names>H. S.</given-names></name><name><surname>Lee</surname><given-names>M. S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models.</article-title>
<source/><italic>J. Neuroinflammat.</italic>
<volume>7</volume>:<issue>69</issue>. <pub-id pub-id-type="doi">10.1186/1742-2094-7-69</pub-id>
<pub-id pub-id-type="pmid">20950451</pub-id></mixed-citation>
</ref>
<ref id="B236">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Delaloye</surname><given-names>K.</given-names></name><name><surname>Cui</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Activation of Slo1 BK channels by Mg2+ coordinated between the voltage sensor and RCK1 domains.</article-title>
<source/><italic>Nat. Struct. Mol. Biol.</italic>
<volume>15</volume>
<fpage>1152</fpage>–<lpage>1159</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.1507</pub-id>
<pub-id pub-id-type="pmid">18931675</pub-id></mixed-citation>
</ref>
<ref id="B237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Krishnamoorthy</surname><given-names>G.</given-names></name><name><surname>Saxena</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>An epilepsy/dyskinesia-associated mutation enhances BK channel activation by potentiating Ca2+ sensing.</article-title>
<source/><italic>Neuron</italic>
<volume>66</volume>
<fpage>871</fpage>–<lpage>883</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.05.009</pub-id>
<pub-id pub-id-type="pmid">20620873</pub-id></mixed-citation>
</ref>
<ref id="B238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>P.</given-names></name><name><surname>Lu</surname><given-names>Q.</given-names></name><name><surname>Geller</surname><given-names>H. M.</given-names></name><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer’s disease.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>76</volume>
<fpage>21</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2016.08.008</pub-id>
<pub-id pub-id-type="pmid">27567685</pub-id></mixed-citation>
</ref>
<ref id="B239">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Z. H.</given-names></name><name><surname>Wang</surname><given-names>Y. X.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>H. Z.</given-names></name><name><surname>Hou</surname><given-names>L. N.</given-names></name><name><surname>Cui</surname><given-names>Y. Y.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.</article-title>
<source/><italic>Pharmacol. Res.</italic>
<volume>77</volume>
<fpage>30</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2013.09.002</pub-id>
<pub-id pub-id-type="pmid">24055799</pub-id></mixed-citation>
</ref>
<ref id="B240">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Yu</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Geller</surname><given-names>H. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Targeted inhibition of KCa3.1 attenuates TGF-beta-induced reactive astrogliosis through the Smad2/3 signaling pathway.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>130</volume>
<fpage>41</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.12710</pub-id>
<pub-id pub-id-type="pmid">24606313</pub-id></mixed-citation>
</ref>
<ref id="B241">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>P.</given-names></name><name><surname>Leonetti</surname><given-names>M. D.</given-names></name><name><surname>Hsiung</surname><given-names>Y.</given-names></name><name><surname>Mackinnon</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Open structure of the Ca2+ gating ring in the high-conductance Ca2+-activated K+ channel.</article-title>
<source/><italic>Nature</italic>
<volume>481</volume>
<fpage>94</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1038/nature10670</pub-id>
<pub-id pub-id-type="pmid">22139424</pub-id></mixed-citation>
</ref>
<ref id="B242">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yusifov</surname><given-names>T.</given-names></name><name><surname>Javaherian</surname><given-names>A. D.</given-names></name><name><surname>Pantazis</surname><given-names>A.</given-names></name><name><surname>Gandhi</surname><given-names>C. S.</given-names></name><name><surname>Olcese</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>The RCK1 domain of the human BKCa channel transduces Ca2+ binding into structural rearrangements.</article-title>
<source/><italic>J. Gen. Physiol.</italic>
<volume>136</volume>
<fpage>189</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.200910374</pub-id>
<pub-id pub-id-type="pmid">20624858</pub-id></mixed-citation>
</ref>
<ref id="B243">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yusifov</surname><given-names>T.</given-names></name><name><surname>Savalli</surname><given-names>N.</given-names></name><name><surname>Gandhi</surname><given-names>C. S.</given-names></name><name><surname>Ottolia</surname><given-names>M.</given-names></name><name><surname>Olcese</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>The RCK2 domain of the human BKCa channel is a calcium sensor.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>105</volume>
<fpage>376</fpage>–<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0705261105</pub-id>
<pub-id pub-id-type="pmid">18162557</pub-id></mixed-citation>
</ref>
<ref id="B244">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaman</surname><given-names>T.</given-names></name><name><surname>De Oliveira</surname><given-names>C.</given-names></name><name><surname>Smoka</surname><given-names>M.</given-names></name><name><surname>Narla</surname><given-names>C.</given-names></name><name><surname>Poulter</surname><given-names>M. O.</given-names></name><name><surname>Schmid</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>BK channels mediate synaptic plasticity underlying habituation in rats.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>37</volume>
<fpage>4540</fpage>–<lpage>4551</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3699-16.2017</pub-id>
<pub-id pub-id-type="pmid">28348135</pub-id></mixed-citation>
</ref>
<ref id="B245">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>McBain</surname><given-names>C. J.</given-names></name></person-group> (<year>1995</year>). <article-title>Potassium conductances underlying repolarization and after-hyperpolarization in rat CA1 hippocampal interneurones.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>488(Pt 3)</volume>, <fpage>661</fpage>–<lpage>672</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1995.sp020998</pub-id>
<pub-id pub-id-type="pmid">8576856</pub-id></mixed-citation>
</ref>
<ref id="B246">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Abrams</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Gizzi</surname><given-names>A.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2012a</year>). <article-title>Structural basis for calmodulin as a dynamic calcium sensor.</article-title>
<source/><italic>Structure</italic>
<volume>20</volume>
<fpage>911</fpage>–<lpage>923</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2012.03.019</pub-id>
<pub-id pub-id-type="pmid">22579256</pub-id></mixed-citation>
</ref>
<ref id="B247">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Pascal</surname><given-names>J. M.</given-names></name><name><surname>Schumann</surname><given-names>M.</given-names></name><name><surname>Armen</surname><given-names>R. S.</given-names></name><name><surname>Zhang</surname><given-names>J. F.</given-names></name></person-group> (<year>2012b</year>). <article-title>Identification of the functional binding pocket for compounds targeting small-conductance Ca(2)(+)-activated potassium channels.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>3</volume>:<issue>1021</issue>. <pub-id pub-id-type="doi">10.1038/ncomms2017</pub-id>
<pub-id pub-id-type="pmid">22929778</pub-id></mixed-citation>
</ref>
<ref id="B248">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Meng</surname><given-names>X. Y.</given-names></name><name><surname>Cui</surname><given-names>M.</given-names></name><name><surname>Pascal</surname><given-names>J. M.</given-names></name><name><surname>Logothetis</surname><given-names>D. E.</given-names></name><name><surname>Zhang</surname><given-names>J. F.</given-names></name></person-group> (<year>2014</year>). <article-title>Selective phosphorylation modulates the PIP2 sensitivity of the CaM-SK channel complex.</article-title>
<source/><italic>Nat. Chem. Biol.</italic>
<volume>10</volume>
<fpage>753</fpage>–<lpage>759</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1592</pub-id>
<pub-id pub-id-type="pmid">25108821</pub-id></mixed-citation>
</ref>
<ref id="B249">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Pascal</surname><given-names>J. M.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Unstructured to structured transition of an intrisically disordered protein peptide in coupling Ca2+-sensing and SK channel activation.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>110</volume>
<fpage>4828</fpage>–<lpage>4833</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1220253110</pub-id>
<pub-id pub-id-type="pmid">23487779</pub-id></mixed-citation>
</ref>
<ref id="B250">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J.</given-names></name><name><surname>Zagotta</surname><given-names>W. N.</given-names></name></person-group> (<year>2003</year>). <article-title>Patch-clamp fluorometry recording of conformational rearrangements of ion channels.</article-title>
<source/><italic>Sci. STKE</italic>
<volume>2003</volume>:<issue>PL7</issue>. <pub-id pub-id-type="doi">10.1126/stke.2003.176.pl7</pub-id>
<pub-id pub-id-type="pmid">12671191</pub-id></mixed-citation>
</ref>
<ref id="B251">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Cui</surname><given-names>J.</given-names></name><name><surname>Lingle</surname><given-names>C. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Threading the biophysics of mammalian Slo1 channels onto structures of an invertebrate Slo1 channel.</article-title>
<source/><italic>J. Gen. Physiol.</italic>
<volume>149</volume>
<fpage>985</fpage>–<lpage>1007</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201711845</pub-id>
<pub-id pub-id-type="pmid">29025867</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>